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ABSTRACT OF THE DISSERTATION
Mechanisms mediating adaptive presynaptic muting induction
by
Devon Christine Crawford
Doctor of Philosophy in Neurosciences
Washington University in St. Louis, 2012
Professor Steven Mennerick, Chairperson

Neurons are responsible for information processing within the nervous system, so
strong perturbations of neuronal function have far-reaching consequences within the
neural network. Damage in response to excess excitation, as occurs during stroke or
seizure, is known as excitotoxicity. One method utilized by neurons for reducing
excitotoxicity within an overly activated neuronal network is to arrest excitatory
neurotransmitter release from presynaptic terminals. The mechanisms responsible for
inducing this presynaptic silencing (or “muting”), however, have been elusive. In order
to elucidate the signals responsible, I used molecular techniques in defined networks of
cultured neurons from the mammalian hippocampus, a well-studied brain region known
to be important for learning and memory but susceptible to excitotoxic damage.
Calcium serves as a signal transducer during excitotoxicity and many forms of
synaptic plasticity, but the signaling cascades in presynaptic silencing were previously
unknown. In neurons individually depolarized via heterologous ion channel activation, I
showed that calcium influx led to cell death while channel expression led to synaptic
depression, although muting was not confirmed. Calcium, however, was not necessary
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for presynaptic muting after strong depolarization. Instead, inhibitory G-protein
signaling induced silencing through cyclic adenosine monophosphate (cAMP) reduction
but surprisingly not via activation of likely candidate receptors. This cAMP reduction
contributed to loss of proteins important for vesicle fusion at the presynaptic terminal.
I also found that astrocytes, support cells in the nervous system that have garnered
attention recently for their ability to modulate neuronal function, were required for the
proper development of presynaptic muting in hippocampal neurons. Soluble factors
released by astrocytes were permissive, but not instructive, for silencing induction.
Thrombospondins were identified as the astrocyte-derived factors responsible for muting
competence in neurons, and they act through binding to the α2δ-1 subunit of voltagegated calcium channels. cAMP-activated protein kinase A exhibited dysfunctional
behavior in the absence of thrombospondins, potentially explaining the presynaptic
muting deficit in an astrocyte-deficient environment.
Together these results clarify the molecular mechanisms responsible for an
underappreciated form of neuroprotective synaptic plasticity and provide potential
therapeutic targets for a number of disorders expressing excitotoxic damage.
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Chapter 1
Introduction and thesis objectives

This chapter contains text excerpts and figures (Figures 1, 2, and 4) from a
previously published manuscript:
Crawford DC, Mennerick S (2012). Presynaptically silent synapses: dormancy and
awakening of presynaptic vesicle release. Neuroscientist 18(3): 216.

Author contributions for the citation above:
D.C.C. wrote the paper and made the figures. S.M. edited the manuscript.
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Adaptive presynaptic muting
Neurons transmit electrical signals as the basis of information processing in the
nervous system. Chemical synapses mediate much of the communication between
neurons. Synapses pivotally influence the flow of information throughout the neural
network and are primary sites of malleability that may underlie behavioral alterations and
memory formation. Modulation of synaptic strength takes many forms. One form
includes mature, functioning synapses rendered dormant, but the mechanisms underlying
this are poorly understood. These “silent” synapses are deficient either in
neurotransmitter release or in postsynaptic receptors (Fig. 1). Here I will focus on
presynaptically silent synapses, as postsynaptically silent synapses have been discussed
extensively elsewhere and are not the focus of this dissertation (Kerchner and Nicoll,
2008).
Presynaptically silent synapses are identified throughout the literature also as
“dormant,” “mute,” “non-functional,” or “inactive” presynaptic terminals. They are
characterized by terminals that fail to release transmitter in response to strong calcium
influx and are found in a variety of species and neurotransmitter systems. Dormant
presynapses are distinct from weakly transmitting terminals because they are releaseincompetent even after accounting for the normal heterogeneity of vesicle release
probability at presynaptic terminals. Dormancy, therefore, represents a qualitative
change in release competence. It remains unclear how the absence of vesicle fusion at
strategic synaptic locations alters signaling within a network, but this phenomenon may
play important roles in information processing and in pathology.
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Figure 1. Categories of silent synapses. A. Active synapses consist of presynaptic
terminals with functional vesicle docking, priming, and probabilistic release upon
calcium influx, all powered primarily by mitochondrial ATP production. The probability
of vesicle release (pr) is modulated without altering the qualitative release competence of
the terminal. Neurotransmitter released from active presynaptic terminals binds to
postsynaptic receptors and causes a postsynaptic response. At glutamate synapses, for
example, glutamate released via presynaptic vesicle fusion will bind to AMPA receptors,
allowing net cation influx that directly depolarizes the target cell and relieves voltagedependent magnesium block of NMDA receptors (not depicted). Depolarizing effects of
activated AMPA and NMDA receptors contribute to action potential generation. B. In
presynaptically silent synapses, vesicle docking is intact, but priming and fusion are
impaired, even with strong depolarization and calcium influx that overcomes low vesicle
release probability. Without transmitter release, there is no postsynaptic response. C.
Postsynaptically silent synapses maintain active presynaptic terminals, but the
postsynaptic membrane is missing receptors necessary to generate a response. At
glutamate synapses, AMPA receptors are absent, leaving NMDA receptors unable to
overcome voltage-dependent block.
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Evidence for presynaptic muting:
Early evidence for presynaptic silencing, or muting, came from studies using
quantal analysis to calculate the number of release sites for neurotransmitter. By
analyzing the underlying statistical structure of transmitter release, quantal analysis
describes the size of postsynaptic current due to fusion of a single vesicle (quantal size,
q), the number of functional release sites (n), and the probability that an action potential
will cause vesicle fusion (probability of vesicle release, pr) (Del Castillo and Katz, 1954;
Redman, 1990). These calculations allow for inferences about the function of a synaptic
connection. Using quantal analysis in multiple systems, including crayfish and rodent
neurons, studies have demonstrated that quantal n is smaller than the number of physical
synaptic connections between neurons (Neale et al., 1983; Wojtowicz et al., 1991). In
other words, there are typically some non-functional synaptic connections present.
Strong evidence for a presynaptic locus of dormancy came from studies of the
Mauthner cell, which functions in an auditory escape response pathway in goldfish.
Membrane potential changes are reliably transmitted from stimulated presynaptic fibers
to the lateral dendrite of the Mauthner cell through electrotonic coupling via gap
junctions. Some presynaptic fibers, however, fail to transmit information through parallel
chemical synapses (Faber et al., 1991). The maintained amplitude of the electrotonic
potential argues against action potential conduction failure as an explanation for synaptic
inefficacy between some neuron pairs. A small minority of the chemical synapses,
however, can be activated by loading the presynaptic neuron with a cesium-containing
solution (Faber et al., 1991). This manipulation blocks potassium channels, which
broadens the action potential and provides prolonged depolarization to the presynaptic
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terminal. The ability to awaken the synapse with a presynaptic manipulation suggests a
presynaptic deficit but a full complement of postsynaptic receptors. Although the
awakened terminals could simply have low vesicle release probability, the synapses that
could not be awakened may represent truly dormant terminals. This discovery prompted
studies of the induction and expression mechanisms for silent synaptic connections.
More recently, fluorescence visualization of presynaptic function has allowed the
direct study of presynaptic muting without ambiguities introduced by calculating n from
statistical models. Styryl dyes like FM1-43 partition into extracellularly-exposed
membrane to reveal recycling vesicles. The number of active terminals, labeled with
FM1-43 staining, is smaller than the total number of synaptic varicosities in dissociated
hippocampal neurons (Ma et al., 1999), supporting the findings from previous studies that
not all structurally-defined synapses are active. Dormant presynaptic terminals are
presently defined as those terminals that label positively for synaptic proteins but not
with styryl dyes during strong stimulation that should empty all release-competent
vesicles. For example, synapses from cultured neurons that immunolabel for
synaptophysin, Piccolo, GABAA receptors, or vesicular glutamate transporter 1 but not
with FM1-43 are stereotypic examples of inactive presynaptic terminals (Kannenberg et
al., 1999; Altrock et al., 2003; Moulder et al., 2004; Fig. 2). Typically, these terminals
have normal ultrastructure, including vesicle arrangement, and normal postsynaptic
receptor function (Moulder et al., 2004; Moulder et al., 2006).
An increase in silent presynaptic terminals is registered in electrophysiological
measures of excitatory postsynaptic currents as a decrease in the size of a neuron’s
readily releasable pool of vesicles rather than a decrease in the vesicle release probability
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(Moulder et al., 2004). Dormant presynaptic terminals cannot be forced to release
vesicles by strong stimulation or by secretagogues that elicit calcium-independent vesicle
fusion. These findings suggest that dormant presynaptic terminals are structurally mature
and intact but have a deficit in vesicle fusion that renders the synapse unable to function.
Some evidence suggests that this deficit is at the level of vesicle priming (Moulder et al.,
2006; Jiang et al., 2010), the maturation of release competence after vesicle docking but
prior to calcium-dependent fusion. Thus, altered presynaptic priming protein function
may induce dormancy.

Induction of presynaptic muting:
Silent presynaptic terminals are present in the absence of any manipulations, but
the mechanisms controlling dormancy can be examined by manipulating the number of
dormant terminals. In cultured hippocampal neurons, prolonged strong depolarization
increases dormancy selectively in glutamatergic terminals (Fig. 2A, B), and this is slowly
reversible (Moulder et al., 2004). Weaker depolarization and increased spiking over
several days also increase dormancy in a tetrodotoxin-sensitive manner (Moulder et al.,
2006). Hypoxic depolarization also induces dormancy (Hogins et al., 2011; also see
Appendix). Dormancy does not simply represent arrested synaptic development because
the dormant terminals identified after depolarization come from a previously active
population (Moulder et al., 2004). One major outstanding unknown in the literature has
been the pathway leading from depolarization to silent presynaptic terminals.
Prior studies have found that reduced cyclic adenosine monophosphate (cAMP)
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Figure 2. Malleability of the number of dormant presynaptic terminals. A. The
percentage of active glutamate terminals is measured using FM1-43 dye uptake (green)
and its co-localization with a presynaptic marker (vesicular glutamate transporter 1 or
vGluT-1; red); dormant terminals are, therefore, represented by red puncta without any
overlying green. Activity also modulates the number of dormant terminals. For example,
co-localization occurs more often in control than in depolarized (4 h 30 mM KCl)
cultured hippocampal neurons. This suggests that fewer glutamatergic presynaptic
terminals are competent to recycle vesicles after depolarization. Modified with
permission from Crawford et al., 2011 (Chapter 3). B. The percentage of active terminals
correlates with the size of the readily releasable pool of vesicles. Excitatory postsynaptic
currents (EPSCs) measured in autaptic cultured hippocampal neurons are depressed after
prolonged (16 hr) depolarization with 30 mM KCl. Top: EPSCs were elicited after action
potential stimulation, which are probabilistically dependent on calcium influx into the
presynaptic terminal. Bottom: EPSCs were elicited by application of hypertonic sucrose,
which causes calcium-independent fusion of all release-ready vesicles. Because both
types of EPSCs are depressed after depolarization, this suggests that the size of the
readily releasable pool of vesicles is decreased rather than the probability of vesicle
release. C. The percentage of glutamatergic (red) terminals in cultured hippocampal
neurons that take up the dye FM1-43 (green) increases after 4 h 50 μM forskolin
treatment, which increases adenylyl cyclase activity and, therefore, cAMP production.
This suggests that more terminals are release-competent after increased cAMP signaling.
Modified with permission from Moulder et al., 2008. D. EPSCs in autaptic hippocampal
neurons are increased after 4 h 50 μM forskolin application. Because both calciumdependent action-potential evoked EPSCs and calcium-independent sucrose-evoked
EPSCs are increased after forskolin, this suggests that the readily releasable pool is
increased rather than the probability of vesicle release. Modified with permission from
Moulder et al., 2008.
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signaling increases the number of dormant presynaptic terminals (Moulder et al., 2008).
This suggests that dormancy can be modulated through alterations in cAMP levels,
potentially implicating adenylyl cyclase signaling as the upstream control point in
dormancy induction. Because a major target of cAMP is protein kinase A (PKA), PKA
substrates may modulate presynaptic vesicle release during dormancy induction (Fig. 3).
One PKA substrate that is also involved in vesicle priming is the presynaptic protein
Rim1 (Lonart et al., 2003; Calakos et al., 2004). Rim1 levels, and levels of an associated
priming protein Munc13-1, are decreased in cultured hippocampal neurons after
induction of depolarization-induced dormancy (Jiang et al., 2010). This is consistent
with prior literature that suggests loss of Munc13-1 increases presynaptic muting
(Augustin et al., 1999). Overexpression of Rim1 prevents depolarization from inducing
presynaptic dormancy (Jiang et al., 2010), strengthening the evidence that the levels of
priming proteins at the presynaptic terminal are vital for determining dormancy status.
Although Rim1 and Munc13-1 are the only proteins found to be degraded during
depolarization-induced muting at glutamatergic terminals (Jiang et al., 2010), genetic loss
of other presynaptic proteins, like bassoon, also increases dormancy (Altrock et al.,
2003). Interestingly, activity deprivation also reduces connectivity between CA3
pyramidal neurons in the hippocampus via presynaptic dormancy in a cyclin-dependent
kinase 5 (CDK5)-dependent, but cAMP-independent, manner (Mitra et al., 2012). CDK5
may reduce connectivity between CA3 neurons by removing vesicles from the recycling
pool (Kim and Ryan, 2010), although this remains unclear. Presynaptic proteins involved
in vesicle coordination and release, therefore, appear to modulate dormancy through
altered levels or function.
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Figure 3. Signaling cascades participating in presynaptic dormancy induction.
Prolonged strong depolarization or increased action potential firing induces presynaptic
dormancy through reduction of cAMP signaling cascades and through activation of the
ubiquitin-proteasome system. Depolarization increases proteasome activity through
unknown mechanisms. Reduced cAMP likely reduces protein kinase A (PKA) signaling
during silencing induction. PKA phosphorylates presynaptic priming proteins like Rim1,
a modification that may render Rim1 resistant to proteasome degradation; therefore, less
Rim1 phosphorylation is expected after depolarization. Increased proteasome activity,
combined with a vulnerable presynaptic protein population, may then lead to priming
protein degradation. This model provides a plausible mechanism for priming protein level
reduction and dormancy induction by depolarization. Postsynaptic protein levels are
unaltered by induction of presynaptic dormancy. Modified from Crawford and
Mennerick, 2012.
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The ubiquitin-proteasome system, a protein tagging and degradation pathway, is
in a unique position to manipulate presynaptic dormancy. Increased degradation could
decrease presynaptic protein levels and, therefore, cause dormancy in protein-deficient
terminals. In fact depolarization- and hypoxia-induced silencing of presynaptic terminals
are prevented by pharmacological proteasome inhibition (Jiang et al., 2010; Hogins et al.,
2011). Together, these studies suggest that depolarization activates pathways to reduce
cAMP and upregulate proteasome-dependent degradation of proteins vital for vesicle
fusion at the presynaptic terminal (Fig. 3).

Induction of presynaptic unsilencing:
Depolarization increases dormancy, but neuronal inactivity reduces dormancy.
Thus, activity levels appear to set the percentage of release-competent terminals. The
percentage of active glutamate terminals in primary hippocampal cultures increases after
6-10 days of tetrodotoxin treatment to block action potentials (Moulder et al., 2006).
Postsynaptic receptor blockade, but not activity deprivation, produces presynaptic
unsilencing in less than 24 h (Jakawich et al., 2010). Unsilencing occurs within 4 h when
dormancy-inducing depolarization is removed from neurons, which accounts for a return
to baseline synaptic functionality (Moulder et al., 2004). Together, these studies suggest
that presynaptic silencing is a compensatory, homeostatic adaptation to altered neuronal
activity.
Signaling cascades for both silencing and unsilencing of presynaptic terminals
appear to utilize cAMP. As described earlier, decreased cAMP signaling increases
dormancy. In turn, increased cAMP signaling reduces dormancy (Fig. 2C, 2D, and 4).
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Sp-cAMPS, a phosphodiesterase-resistant cAMP analog that activates downstream
protein kinases like PKA, increases the number of functional release sites (Bolshakov et
al., 1997; Ma et al., 1999; Kohara et al., 2001). This same effect is induced by forskolin,
which increases adenylyl cyclase activity (Kohara et al., 2001; Moulder et al., 2008; Fig.
2C, D). Recovery from depolarization-induced silencing of glutamate terminals depends
on adenylyl cyclase 8 and PKA signaling, suggesting that cAMP signaling is important
for this type of unsilencing as well (Moulder et al., 2008). Interestingly, Sp-cAMPSinduced increases in the number of functional terminals are blocked with protein
synthesis inhibitors (Ma et al., 1999), and the presynaptic protein synapsin has been
implicated in a PKA-dependent form of presynaptic awakening (Cousin and Evans,
2011). A non-cAMP-dependent form of unsilencing requires postsynaptic brain-derived
neurotrophic factor (BDNF) synthesis and release (Jakawich et al., 2010), although
retrograde signaling of BDNF is contentious because BDNF is localized presynaptically
(Dieni et al., 2012). The dependence of unsilencing on protein synthesis mirrors the
evidence that protein degradation induces dormancy and strengthens the hypothesis that
presynaptic protein levels or function are important for modulating dormancy status of
presynaptic terminals.
Although dormancy is modulated homeostatically in some contexts, it may also
be modulated in a Hebbian fashion. Some stimuli that induce long-term potentiation
(LTP), a persistent enhancement of synaptic efficacy, also unsilence presynaptic
terminals. Although the role of the presynaptic terminal in LTP induction is debated in
the literature (Voronin and Cherubini, 2004; Kerchner and Nicoll, 2008; Kullmann,
2012), there are a few studies that show an increase in the number of active presynaptic
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Figure 4. Signaling cascades participating in presynaptic dormancy reduction.
Under some conditions, inactivity and increased cAMP activate previously dormant
terminals. Calcium-dependent adenylyl cyclase VIII (AC8) knockout prevents recovery
of active terminals when elevated neuronal activity is removed, so AC8 may be the
cAMP source responsible for this form of unsilencing. In other contexts multiple bursts
of high frequency stimulation (HFS), which often causes strong calcium influx and longterm potentiation, lead to presynaptic awakening. Both activity reduction and HFS
require protein kinase A (PKA) signaling for presynaptic activation, but how ostensibly
opposite changes in activity both recruit PKA in different experimental contexts remains
unknown. Once PKA is activated, phosphorylation events may slow priming protein
degradation.
Additionally, PKA phosphorylates and thereby activates nuclear
transcription factors (blue arrow and inset) like cAMP response element-binding protein
(CREB), and this may increase synthesis of presynaptic proteins vital for vesicle priming
and release (purple arrow and inset). A third pathway to unsilencing is via phorbol esters,
which enhance function of the priming protein Munc13-1. Under this model of dormancy
reduction, postsynaptic responses are restored once the presynaptic terminal regains the
ability to release neurotransmitter.
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terminals after LTP has been induced. In one study, for example, Sp-cAMPS, known to
reduce dormancy, potentiates synapses and increases quantal n in rodent hippocampal
slices (Bolshakov et al., 1997). Another study used multiple bursts of high frequency
stimulation in cultured dentate granule neurons to induce a form of PKA-dependent LTP.
Using a slowly reversible NMDA receptor antagonist, MK801, to block postsynaptic
receptors at all active synapses, this study showed that new active release sites appear
after LTP induction (Tong et al., 1996). PKA is also important for activation of
presynaptic terminals in immature cultured hippocampal neurons after repetitive
depolarization challenges, although the possibility of enhanced synaptic maturation rather
than awakening of established terminals is not ruled out (Yao et al., 2006). Another
study in more mature cultured hippocampal neurons showed that glutamate-induced
synaptic potentiation increases the number of terminals that stain for FM1-43 (Ninan and
Arancio, 2004). Hebbian unsilencing of presynaptic terminals is also induced by
serotonin in Aplysia sensory neurons prior to subsequent synaptogenesis (Kim et al.,
2003). Presynaptic dormancy modulation, therefore, may be important for some Hebbian
forms of synaptic plasticity, and the direction of cAMP change may critically determine
whether silencing or unsilencing results from a particular stimulus.
Phorbol esters, which are analogues of diacylglycerol, also potentiate synaptic
function. Among other presynaptic effects, phorbol esters unsilence presynaptic
terminals within two minutes application to cultured hippocampal neurons (Chang et al.,
2010). This form of unsilencing is much faster than the cAMP-dependent forms of
unsilencing described previously. Phorbol esters upregulate protein kinase C signaling,
but they also act directly on Munc13-1 (Betz et al., 1998). Although PKA-induced
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unsilencing may involve protein synthesis, phorbol ester-induced unsilencing is likely too
rapid to require protein synthesis. Instead, phorbol esters appear to alter Munc13-1
function, potentially via translocation to the plasma membrane (Betz et al., 1998).
Altogether, these findings suggest that there are multiple signaling cascades that cause
presynaptic unsilencing (Fig. 4). These cascades alter synaptic function on very different
time scales, but they likely converge on presynaptic proteins responsible for vesicle
maturation or fusion.

Implications of presynaptic dormancy:
Because dormant presynaptic terminals are widespread and modulated by a
variety of mechanisms, dormancy status may represent an important facet of synaptic
malleability. It is currently unknown how dormancy levels affect network function and
what role this may play during neuropathology. Why should some synapses exist but not
function? What benefit or difference in function is gained from dormancy over a more
classical presynaptic change, like acute, reversible G-protein-coupled receptor (GPCR)mediated depression of calcium influx and the corresponding decreased vesicle release
probability (Brown and Sihra, 2008)? An intriguing possibility is that dormancy is an
activity-dependent mechanism for modulating connectivity between neurons. This would
add another dimension to neural computation since dormancy provides a digital signal
that is either “on” or “off,” similar to synaptogenesis and synaptic pruning but without
the same resource requirements of these mechanisms. Having multiple methods for
modulating synaptic connectivity likely increases flexibility of neural computation in the
system.
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It is also interesting that dormancy can be adaptive or reinforcing, depending on
the context and the direction of cAMP change. Presynaptic muting of glutamate
terminals often increases with prolonged elevated neuronal activity but decreases with
inactivity. This counteractive change in excitatory neurotransmitter release could
potentially maintain signaling within an optimal range, one of the hypothesized roles of
homeostatic synaptic plasticity (Pozo and Goda, 2010). For example, induction of
dormancy occurs during pathological insults, leading to reduced glutamate release and
enhanced neuronal survival (Hogins et al., 2011; Appendix). In this context, all-or-none
muting seems well-tailored to self-defense; other forms of presynaptic depression through
reduced calcium influx might quickly be overwhelmed by hypoxic or ischemic
depolarizing insults. Dormancy can also be decreased rather than increased after
stimulation, however, leading to potentiated synapses. Some of these Hebbian forms of
unsilencing utilize cAMP signaling, which, like LTP, has been linked to memory
processing in multiple systems (Alberini et al., 1995). So in addition to its potentially
homeostatic role, modulation of dormancy may also play a role in Hebbian plasticity and
memory. Therapeutic exploitation of the signaling cascades increasing or decreasing
dormancy could have valuable clinical implications.
Dormancy may also be more efficient than ostensibly similar forms of synaptic
plasticity. Modulation of dormancy achieves similar changes in neuronal connectivity as
synaptogenesis and synaptic pruning but appears to work on a faster time scale (minutes
to hours rather than hours to days). This likely preserves physical resources the cell
would otherwise require for large-scale structural alterations and allows the neuron to
respond more quickly to perturbations to the system. Additionally, it is important to note
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that presynaptic function requires a large amount of energy, as evidenced by the nearly
ubiquitous presence of mitochondria in presynaptic terminals (Palay, 1956). If the
system requires a dormant synaptic connection, it would arguably waste less energy to
preserve postsynaptic function and shut down presynaptic vesicle cycling than to
preserve transmitter release onto a non-receptive postsynaptic membrane for the duration
of the dormancy period. Although it is unclear whether unsilencing a presynaptic
terminal would require more energy than unsilencing a postsynaptic terminal,
maintaining presynaptically silent synapses may be more energy efficient than
maintaining postsynaptically silent synapses. Therefore, it is unclear how presynaptically
silent and postsynaptically silent synapses interact. It is also unclear how the relatively
fast digital changes in information flow created by dormancy alter neural computation,
but it is evident that presynaptically silent terminals are a potentially economical way to
introduce this dimension into the system. Clearly, understanding the mechanisms
responsible for muting induction and its implications would be of benefit.
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Mediators of synaptic plasticity

Calcium:
Calcium is a well-studied participant in neuronal and synaptic plasticity induction,
but it is unknown if presynaptic muting induction requires calcium signaling. Calcium
influx into the presynaptic terminal is vital for action potential-evoked synaptic
transmission (Sudhof, 2004, 2012), but calcium can also modulate other signaling
cascades within the neuron, including cAMP levels (Hanoune and Defer, 2001).
Induction of many persistent, Hebbian forms of synaptic plasticity requires calcium
signaling (Malenka, 1991; Malenka, 1994; Teyler et al., 1994). For example, NMDA
receptor-dependent LTP of synapses onto CA1 pyramidal neurons in the hippocampus
require postsynaptic calcium influx (Wigstrom et al., 1979; Lynch et al., 1983; Malenka
et al., 1988; Malenka et al., 1992). LTP of inhibitory synapses onto CA1 pyramidal cells
after theta burst electrical stimulation and LTP of mossy fiber synapses onto CA3
pyramidal cells are likewise dependent on postsynaptic calcium (Williams and Johnston,
1989; Patenaude et al., 2003). Both LTP and its Hebbian counterpart, long-term
depression (LTD), onto dentate granule cells in the hippocampus are inhibited by
postsynaptic calcium chelation (Xie et al., 1992). LTD onto CA1 pyramidal neurons as
well as mossy fiber LTD onto CA3 neurons also require calcium (Wickens and Abraham,
1991; Mulkey and Malenka, 1992; Tzounopoulos et al., 1998). Calcium is vital,
therefore, for many Hebbian forms of plasticity.
Calcium dependence of Hebbian plasticity is not just observed in intact
hippocampal networks, however. LTP induced in cultured dentate granule neurons and
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the awakening of presynaptic terminals in dissociated hippocampal neurons after highfrequency stimulation both require presynaptic calcium (Tong et al., 1996; Shen et al.,
2006). Autaptic hippocampal neurons grown in culture require the release of calcium
from intracellular calcium stores for maintenance of CB1 cannabinoid receptordependent LTD (Kellogg et al., 2009). These culture systems recapitulate basic findings
found in more intact networks.
Despite the large number of Hebbian forms of plasticity that require calcium,
some do not. For example, some hippocampal forms of LTD that depend on
metabotropic glutamate receptors (mGluRs) are induced despite calcium chelation
(Fitzjohn et al., 2001; Ireland and Abraham, 2009; Kasten et al., 2012). Similarly,
unsilencing of cerebellular granule presynaptic terminals via cAMP signaling does not
require calcium (Chavis et al., 1998). Depotentiation of Schaffer collateral LTP by
temporoammonic path stimulation does not require L-type calcium channels, although it
is unclear if calcium from other sources contributes (Izumi and Zorumski, 2008).
Calcium is, therefore, a common but not ubiquitous signal mediating many forms of
Hebbian plasticity.
The contributions of calcium signaling to other forms of neuronal and synaptic
plasticity have also been studied in detail. Subtypes of homeostatic and short-term
plasticity have been found to require calcium (Fisher et al., 1997; Fioravante and Regehr,
2011; Mochida, 2011; Turrigiano, 2012). For example, activity in CA1 pyramidal
neurons causes calcium influx through L-type channels that subsequently increases spike
adaptation via potassium channels (Wu et al., 2008). Although this may be a homeostatic
mechanism for reducing excitability, some calcium-dependent changes in intrinsic
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excitability are reinforcing, like the increased excitability in layer V cortical neurons after
electrical stimulation (Cudmore and Turrigiano, 2004). In Drosophila, postsynaptic
glutamate receptor blockade increases presynaptic glutamate release via increased vesicle
release probability. This homeostatic effect is blocked in mutants with reduced
functional CaV2.1, a presynaptic voltage-gated calcium channel (Frank et al., 2006). In
cultured rat cortical neurons, activity blockade homeostatically increases postsynaptic
AMPA receptor levels in a process known as synaptic scaling. The AMPA receptor
increase is triggered by decreased calcium influx into the postsynaptic neuron (Ibata et
al., 2008). Although short-term depression of synaptic transmission via vesicle depletion
does not require calcium (Betz, 1970; Stevens and Tsujimoto, 1995; Garcia-Perez et al.,
2008), recovery from this depression does (Garcia-Perez and Wesseling, 2008). Other
forms of synaptic plasticity that do not require calcium include nitric oxide-induced
neurotransmitter release via vesicle-associated protein assembly as well as hormoneinduced increases in AMPA receptor levels (Meffert et al., 1996; Zadran et al., 2009).
Calcium is an important messenger for many forms of plasticity, but it remains unknown
if calcium mediates presynaptic muting induction.

G-proteins:
Another group of molecular signals important for many forms of synaptic
plasticity is that of guanine nucleotide-binding proteins (G-proteins). G-proteins are
heterotrimeric protein complexes associated with GPCRs, which are transmembrane
receptors that alter their conformation upon ligand binding. Activated receptors convert
guanosine diphosphate bound to the Gα subunit to guanosine triphosphate. Canonically,
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this causes dissociation of the Gα subunit and the Gβγ subunit complex from the receptor,
allowing these subunits to bind to and alter the activity of downstream effectors. In the
nervous system, G-proteins mediate multiple functional and modulatory roles, including
synaptic plasticity (Brown and Sihra, 2008). G-protein signaling cascades, therefore, are
well-poised to modulate neural communication, but it is unknown if they play a role
during glutamatergic synaptic muting.
Many different signaling cascades lie downstream of G-protein activation, but one
important downstream target is cAMP. The Gαs subunit stimulates cAMP production
through activation of adenylyl cyclase, an enzyme that catalyzes the formation of cAMP
from adenosine triphosphate (ATP). In contrast, Gαi and Gαo, which are sensitive to
pertussis toxin, inhibit adenylyl cyclase. In neurons, acute activation of inhibitory Gproteins (Gi/o) also induces rapidly reversible effects on ion channels through Gβγ
signaling. Gβγ causes synaptic depression through presynaptic inhibition of calcium
channels that reduces vesicle pr. Gβγ signaling also decreases neuronal excitability
through postsynaptic activation of inwardly rectifying potassium channels that
hyperpolarizes the neuron (Brown and Sihra, 2008). These acute effects of Gβγ on ion
channels do not desensitize quickly, as evidenced by their ability to be elicited after 4 h
exposure to GPCR agonist (Wetherington and Lambert, 2002a, b), suggesting that this is
a robust mechanism for altering neuronal function. G-protein signaling cascades are
diverse but utilize common mechanisms to alter intracellular processes.
G-protein signaling is involved in more slowly induced synaptic changes as well.
One well-studied example is LTD of excitatory synapses onto CA1 pyramidal neurons in
the hippocampus. This form of LTD is induced by stimulation of mGluRs, which are one
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type of GPCR expressed in the hippocampus (Oliet et al., 1997; Palmer et al., 1997;
Kasten et al., 2012). Similarly, mossy fiber synapses onto CA3 pyramidal neurons in the
hippocampus produce an NMDA receptor-independent, mGluR-dependent LTD that
requires decreases in cAMP levels (Tzounopoulos et al., 1998). Interestingly, mGluRindependent depotentiation of Schaffer collateral LTP by temporoammonic path
stimulation requires A1 adenosine receptor activation (Izumi and Zorumski, 2008), a
GPCR in excitatory presynaptic terminals and astrocytes (Yoon and Rothman, 1991;
Biber et al., 1997). Although LTD of inhibitory synapses onto CA1 pyramidal neurons
can be induced by mGluR stimulation (Patenaude et al., 2003), CB1 cannabinoid
receptors, another class of hippocampal GPCR, also mediate a form of inhibitory synapse
LTD in this region (Chevaleyre and Castillo, 2004). Activation of CB1 cannabinoid
receptors also produces presynaptic muting of GABAergic terminals in hippocampal
slices (Losonczy et al., 2004), but it is unclear how this interacts with LTD. It is also
unknown if G-protein signaling is involved in other forms of muting like in hippocampal
glutamatergic synapses.
Classical G-protein signaling requires extracellular ligand binding to GPCRs, so
intercellular communication mediates most G-protein signals. Cell autonomous
mechanisms for activating GPCRs exist, however. Some GPCRs or downstream targets
are voltage-sensitive (Reddy et al., 1995; Ben-Chaim et al., 2006; Parnas and Parnas,
2007; Okamura et al., 2009), so neuronal depolarization or increased action potential
firing could modulate G-protein signaling through voltage signals. Additionally,
activators of G-protein signaling (AGS proteins) are recently-described modulators of Gprotein subunits that do not require GPCR activation (Cismowski, 2006; Blumer et al.,
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2007; Blumer et al., 2012). AGS proteins are expressed in the brain, including the
hippocampus, but their role in neuronal function and their activation mechanisms are still
being investigated (Fang et al., 2000; Takahashi et al., 2003; Schwendt and McGinty,
2010). These examples highlight the diversity in G-protein signaling cascades that alter
neuronal and synaptic function.

Astrocyte-derived molecular signals:
Glial cells have historically been regarded as support cells for the neurons that
relay information in the nervous system. The name “glia” was originally derived from a
Greek word for “glue” to describe their role in physically supporting neural networks.
Glial promotion of blood-brain barrier integrity, neuronal development, electrical signal
propagation, immune function, and transporting waste from the extracellular space have
been well-studied (Abbott et al., 2010; Sofroniew and Vinters, 2010; Saijo and Glass,
2011; Nualart-Marti et al., 2012; Parpura et al., 2012). One important contribution that
astrocytes, one glial type, make to neuronal development is promotion of synaptogenesis
(Eroglu and Barres, 2010). Factors released by astrocytes increase the total number of
synapses and speed synaptic development (Hama et al., 2004; Christopherson et al.,
2005; Eroglu et al., 2009; Xu et al., 2010; Kucukdereli et al., 2011). Astrocytes and other
glial cells are important for the development and function of neurons.
Recently, it was discovered that astrocytes communicate with neurons to
modulate neuronal and synaptic function more acutely than previously thought.
Astrocytes release neurotransmitters, neuromodulators, and precursors to
neuromodulators via transporters or vesicle fusion to modulate neural function (Volterra
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and Meldolesi, 2005; Bergersen and Gundersen, 2009; Hamilton and Attwell, 2010;
Paixao and Klein, 2010; Debanne and Rama, 2011; Santello et al., 2011; Min and
Nevian, 2012). Examples of these “gliotransmitters” include the neurotransmitter
glutamate (Parpura et al., 1994; Bonansco et al., 2011), the NMDA receptor co-agonist
D-serine (Mothet et al., 2005; Oliet and Mothet, 2006; Debanne and Rama, 2011), and
ATP that is converted to adenosine in the extracellular space (Queiroz et al., 1997;
Pascual et al., 2005; Butt, 2011). This newly described ability of glial cells is
controversial and its physiological relevance remains to be determined.
Many reports have described effects of astrocytes on synaptic plasticity.
Although astrocytes are thought to mediate many forms of synaptic function via
downstream events after intracellular calcium rises (Volterra and Meldolesi, 2005; Perea
et al., 2009; Dityatev et al., 2010; Halassa and Haydon, 2010; Di Castro et al., 2011;
Dityatev and Rusakov, 2011; Honsek et al., 2012), this property is not universal and is
sometimes contentious (Fiacco et al., 2007; Agulhon et al., 2010; Halassa and Haydon).
In the hippocampus, calcium-dependent D-serine release from astrocytes is required for
LTP of Schaffer collateral synapses onto CA1 pyramidal neurons (Henneberger et al.,
2010). Additionally, astrocyte-derived tumor necrosis factor α is required, but not
directly instructive, in hippocampal and cortical neurons for homeostatic scaling of
glutamate receptor levels after activity deprivation (Beattie et al., 2002; Stellwagen and
Malenka, 2006; Perea et al., 2009; Steinmetz and Turrigiano, 2010; Sullivan et al., 2011).
SPARC (secreted protein, acidic, rich in cysteine) is a factor released by astrocytes that
promotes AMPA receptor stabilization and prevents their over-accumulation and may,
therefore, modulate synaptic strength (Jones et al., 2011; Kucukdereli et al., 2011).
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Interestingly, microglia increase spontaneous activity onto CA1 pyramidal neurons
through activation of astrocytic purinergic receptors upstream of neuronal mGluR
activation (Pascual et al., 2011). Outside of the hippocampus, glial cells have been linked
to synaptic plasticity or acute changes in neuronal function in rodent barrel cortex
(Eroglu et al., 2009; Benedetti et al., 2011; Takata et al., 2011), hypothalamus (Gordon et
al., 2009), thalamus (Pirttimaki et al., 2011), cerebellum (Lee et al., 2010), septal nucleus
(Navarrete et al., 2012), trigeminal ganglion (Ceruti et al., 2011), and neuromuscular
junction (Todd et al., 2010). One study, however, found that controlled calcium
elevations in astrocytes did not increase spontaneous EPSC frequency or amplitude onto
CA1 pyramidal neurons and had no effect on LTP (Agulhon et al., 2010). This study
questions the role of astrocytic calcium transients in synaptic plasticity but does not rule
out the possibility that astrocytes communicate through other means to modulate
synapses. Additionally, the source of adenosine involved in synaptic depression after
excitatory synapse stimulation was found to be neuronal and not astrocytic (Lovatt et al.,
2012), as had been hypothesized. Despite the evidence that astrocytes play an important
role in synapse development and plasticity in some contexts, it remains unclear whether
astrocytes modulate presynaptic muting induction.
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Summary and thesis objectives
Clarifying the induction signals responsible for presynaptic muting will increase
our understanding of synaptic modulation and also potentially lead to new therapeutics
for nervous system insults. For this reason, the overall aim for this dissertation project is
to elucidate the molecular signals responsible for muting induction. Downstream
expression mechanisms are better understood than upstream induction signals, so I will
focus on upstream triggers for muting. I will study muting in response to depolarization
because it is a robust phenomenon with clear neuroprotective effects during excitotoxic
injury.
Cultured hippocampal neurons are used as the model system for studying muting
induction for many reasons. Not only is the hippocampus a vital structure for learning
and memory (Naber et al., 2000; Silva et al., 2009), but it is also well-known for longterm synaptic plasticity and is vulnerable to excitotoxic injury (Cervos-Navarro and
Diemer, 1991; Davolio and Greenamyre, 1995; Harry and Lefebvre d'Hellencourt, 2003;
Kemp and Manahan-Vaughan, 2007; De Roo et al., 2008; Howland and Wang, 2008).
Studying hippocampal synaptic plasticity, therefore, could have broad implications in
human health and disease. Additionally, early work from our lab found muting of
glutamatergic hippocampal synapses to be robust, reproducible, and induced with
relatively brief challenges that do not cause other, confounding synaptic changes
(Moulder et al., 2004; Moulder et al., 2006). Small networks of neurons also allow for
clear separation and interpretation of electrical and optical signals gathered from
electrophysiology and microscopy, respectively. Importantly, manipulation of molecular
signals is more simply and completely achieved in a culture system where cell layers,
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density, and identity are controlled. Dissociated hippocampal cultures, therefore, are a
useful model system for this project.
A major underlying question for the work described herein is whether muting
induction is cell autonomous or whether it requires intercellular signaling. If muting
induction is cell autonomous, for example via calcium influx during neuronal
depolarization, then neurons likely sense increased activity and subsequently decrease
their output of neurotransmitter without further input from the environment. For this
reason, I will attempt to develop methods for depolarizing individual neurons for long
periods of time through heterologous cation channel expression. The involvement of
non-cell autonomous mechanisms, like ligand-gated GPCR activation or astrocytic
modulation of muting, would imply that the neural network contributes to this
homeostatic process. Calcium, G-proteins, and astrocyte signaling will be tested because
of their established roles in synaptic plasticity and potential to interact with known
mediators of muting. Clarifying mechanisms of muting induction could answer
fundamental questions about how the nervous system adapts to changes in network
activity levels.
In summary, synapses represent the main junctures of communication between
neurons in the nervous system. In many neurotransmitter systems, a fraction of
presynaptic terminals fails to release vesicles in response to action potential stimulation
and strong calcium influx. These silent presynaptic terminals exhibit a reversible
functional dormancy beyond low vesicle release probability, and dormancy status may
have important implications in neural function. Recent advances have implicated
presynaptic proteins interacting with vesicles downstream of cAMP and protein kinase A
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signaling cascades in modulating the number of these mute presynaptic terminals, but it
remains unclear how these changes are induced. Muting may represent a homeostatic
neuroprotective mechanism active during pathological insults involving excitotoxicity,
but it may also be induced during Hebbian plasticity. The goals of this dissertation are to
ask whether important mediators of other forms of synaptic plasticity, like calcium, Gproteins, and factors released by astrocytes, also mediate muting induction. This project
aims to clarify molecular signaling cascades responsible for muting induction and
identify potential targets for therapeutic intervention.
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Abstract
Heterologous channel expression can be used to control activity in select neuronal
populations, thus expanding the tools available to modern neuroscience. However, the
secondary effects of exogenous channel expression are often left unexplored. We
expressed two transient receptor potential (TRP) channel family members, TRPV1 and
TRPM8, in cultured hippocampal neurons. We compared functional expression levels
and secondary effects of channel expression and activation on neuronal survival and
signaling. We found that activation of both channels with appropriate agonist caused
large depolarizing currents in voltage-clamped hippocampal neurons, exceeding the
amplitude responses to a calibrating 30 mM KCl stimulation. Both TRPV1 and TRPM8
currents were reduced but not eliminated by 4 hr incubation in saturating agonist
concentration. In the case of TRPV1, but not TRPM8, prolonged agonist exposure
caused strong calcium-dependent toxicity. In addition, TRPV1 expression depressed
synaptic transmission dramatically without overt signs of toxicity, possibly due to lowlevel TRPV1 activation in the absence of exogenous agonist application. Despite
evidence of expression at presynaptic sites, in addition to somatodendritic sites, TRPM8
expression alone exhibited no effects on synaptic transmission. Therefore, by a number
of criteria, TRPM8 proved the superior choice for control over neuronal membrane
potential. This study also highlights the need to explore potential secondary effects of
long-term expression and activation of heterologously introduced channels.
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Introduction
There has been strong recent interest in heterologous control over electrical
activity in neurons and other excitable cells (Miesenbock, 2004; Deisseroth et al., 2006;
Gorostiza and Isacoff, 2008). These approaches offer the possibility of remotely
controlling the activity of select populations of neurons, thereby gaining experimental or
therapeutic influence over network activity. For instance, heterologously introduced
channels have been used recently to control courtship and escape behavior in flies and
fish (Clyne and Miesenbock, 2008; Douglass et al., 2008; Peabody et al., 2009;
Zimmermann et al., 2009) and to control sleep-wake behavior and motor behavior,
including Parkinsonian and epileptic symptoms, in mammals (Adamantidis et al., 2007;
Aravanis et al., 2007; Arenkiel et al., 2007; Arenkiel et al., 2008; Gradinaru et al., 2009;
Tonnesen et al., 2009). Because electrical activity is critical for neuronal survival,
development, and plasticity (Zito and Svoboda, 2002; Akerman and Cline, 2007; Li et al.,
2009), these techniques also have experimental potential to help unravel the downstream
signaling mechanisms responsible for these important facets of neuronal function
(Burrone et al., 2002; Sohal et al., 2009).
Heterologous expression of ligand-gated receptors and leak channels received
initial attention (Burrone et al., 2002; Zemelman et al., 2003; Lima and Miesenbock,
2005; Hou et al., 2008; Okada and Matsuda, 2008), but this approach has largely been
supplanted by optogenetic approaches that employ channels directly activated by light
(Chambers et al., 2006; Zhang et al., 2006; Szobota et al., 2007; Han et al., 2009).
Multiple approaches for heterologous control over activity are probably needed, however,
as one single method is unlikely to be appropriate in all situations. Introduction of leak
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channels (Burrone et al., 2002; Hou et al., 2008; Okada and Matsuda, 2008) suffers from
a lack of control over the degree of activity change and typically is limited to an
inhibitory influence, and one obvious disadvantage of optogenetic approaches is the need
for a light source. A light source of appropriate wavelength will not be feasible or costeffective in all circumstances. In the intact nervous system, light implantation may be
prohibitively invasive. Furthermore, some applications may require activation of a
spatially dispersed set of neurons over a large area, in which case a single light source
may not be adequate.
For these reasons, we have explored further the advantages and disadvantages of a
heterologous ligand-gated receptor approach. This approach offers the possibility of
global administration of ligand for activating populations of heterologously transfected
neurons. We explored two candidate heterologous ligand-gated channels: transient
receptor potential vanilloid receptor 1 (TRPV1) and transient receptor potential cation
channel, subfamily M, member 8 (TRPM8), which normally are responsible for pain and
temperature signal transduction in sensory neurons and respond to the pharmacological
ligands capsaicin and menthol, respectively (Caterina et al., 1997; McKemy et al., 2002;
Peier et al., 2002). These channels were chosen for their ability to be controlled readily
by agonist application and their lack of strong endogenous role in hippocampal function.
To test advantages and disadvantages of expressing each channel in hippocampal
neurons, we used sparse transfection of neurons to avoid complications and confounds of
widespread neuronal activation and associated release of neurotransmitters and
modulators. We tested the activation of these channels relative to depolarizing currents
activated by elevated extracellular potassium as a calibration standard.
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Acute activation of both TRPV1 and TRPM8 induced large currents in response
to saturating agonist concentration. Both showed evidence of desensitization with
prolonged receptor activation, although these responses still compared favorably with
non-desensitizing potassium-induced depolarizing currents. TRPM8 exhibited less
agonist-induced toxicity and less interference with normal synaptic communication in the
absence of agonist. In addition to soma expression of channels, we observed evidence for
direct depolarization of axon terminals of TRPM8- and TRPV1-transfected neurons,
suggesting cell-wide expression. Because our results suggest that TRPM8 is expressed
throughout the cell with no detectable secondary effects on cell function, TRPM8 is the
better choice for studies requiring exogenous control over the membrane potential of
neuronal subpopulations. Our results also stress the importance of fully characterizing a
heterologous expression system to avoid confounding and other unintended effects of
manipulating that system.
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Materials and Methods

Tissue culture and transfection:
All experimental procedures involving animals were performed using protocols
approved by the Washington University in St. Louis School of Medicine Animal Studies
Committee as well as the Guide for the Care and Use of Laboratory Animals published
by the U.S. National Institutes of Health. Primary hippocampal neuron cultures were
prepared as previously described (Mennerick et al., 1995). Briefly, postnatal day 0-3 rat
pups were anesthetized with isofluorane and decapitated. Hippocampi were removed, cut
into 500 μM-thick transverse slices, and treated enzymatically with 1 mg/mL papain.
Cells were then mechanically dissociated and plated as mass cultures (~650 cells/mm2
onto a uniform layer of collagen) or as microcultures (~100 cells/mm2 onto “islands”
made of collagen droplets). The plating medium used was Eagle’s medium (Invitrogen,
Carlsbad, CA, USA) supplemented with heat-inactivated horse serum (5%), fetal bovine
serum (5%), 17 mM D-glucose, 400 μM glutamine, 50 U/mL penicillin, and 50 μg/mL
streptomycin. Cultures were housed in a humidified incubator at 37ºC under controlled
atmospheric conditions (5% CO2 / 95% air). To inhibit cell division 3-4 days after
plating, 6.7 μM cytosine arabinoside was added. Half of the culture medium was
replaced with Neurobasal medium (Invitrogen) with B27 supplement 4-5 days after
plating. Transfections were performed 8-12 days after plating using a
DNA:Lipofectamine 2000 (Invitrogen) ratio of 1:1.5-2 according to the manufacturer’s
protocol. Dishes were transfected with synaptophysin-YFP (0.5-2.5 μg), TRPV1 (2 μg),
and/or TRPM8 (1.5 μg). Experiments were performed usually 1 day, but up to 3 days,
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after transfection.

Electrophysiology:
Whole-cell voltage-clamp and cell-attached patch experiments were performed
using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA, USA), Digidata
1322A acquisition board (Molecular Devices), and pClamp software (Molecular
Devices). All recordings were made in voltage-clamp mode at room temperature
(~25ºC). Whenever solutions were acutely applied to neurons, a multi-barrel perfusion
system was used with the perfusion port placed < 0.5 mm from the neuron under study.
For all experiments, controls consisted of either neurons from sibling cultures plated the
same day or non-transfected neurons within the same dish as the transfected neurons
under study unless otherwise described. All experiments, except for those depicted in
Figure 6, were performed in conventional mass cultures.
Membrane potential was held at -70 mV for experiments unless otherwise
indicated. Electrode resistances of 6-11 MΩ were used for cell-attached patch
recordings. For all other recordings, electrode resistances were 2.5-6 MΩ. A 5 kHz lowpass filter was used for all experiments except cell-attached patches in which 1kHz
filtering was utilized. Access resistance was compensated 85-100% for all experiments
except where small currents were measured: cell-attached patches, miniature postsynaptic
current recordings, acute agonist applications to non-transfected neurons, and acute
ruthenium red applications to transfected and non-transfected neurons. Action potential
stimulation for the autaptic recordings was achieved by 1.5 ms voltage pulses from -70
mV to 0 mV (Mennerick et al., 1995).
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Extracellular recording media consisted of 138 mM NaCl, 4 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES, and 25 µM D-APV (Tocris,
Bristol, UK) with a pH of 7.25. For all agonist-induced current recordings (i.e. excluding
microisland autaptic current and miniature postsynaptic current recordings), 1 μM NBQX
(Tocris) was added to the extracellular media to inhibit secondary glutamate-mediated
synaptic currents. For most experiments, internal pipette solution consisted of 130 mM
cesium methanesulfonate (CsMeSO4), 4 mM NaCl, 0.5 mM CaCl2, 5 mM EGTA, and 10
mM HEPES at a pH of 7.25. For cell-attached patch experiments, however, 140 mM Kgluconate was substituted for CsMeSO4, and for microisland autaptic recordings, 140
mM KCl was substituted for CsMeSO4 to provide similar driving force on excitatory and
inhibitory postsynaptic currents (PSCs) at the holding potential of -70 mV.
For some experiments, agonist-induced responses were compared with responses
elicited by 30 mM KCl application. Prolonged exposure (4 hr) to 30 mM KCl has been
shown to induce strong synaptic change in cultured hippocampal neurons and clamps the
membrane potential near -20 mV (Moulder et al., 2004; Moulder et al., 2006).
Normalizing the agonist-induced current to the KCl current, therefore, controls for
variability in absolute current size due to neuronal geometry and provides a within-cell
comparator to a calibrated depolarizing stimulus.

Epifluorescence imaging and cell counts:
All imaging was performed using an Eclipse TE2000-S inverted microscope
(Nikon, Melville, NY, USA) with epifluorescence provided by a metal halide lamp.
Light was routed through Chroma filter set 41001 (Chroma Technology Corp.,
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Rockingham, VT, USA), with an HQ480/40 nm excitation filter and an HQ535/50 nm
emission filter, and through Chroma filter set 41002 (Chroma Technology Corp.), with an
HQ535/50 nm excitation filter and an HQ610/75 nm emission filter. Images were
acquired using Metamorph software (Universal Imaging, Downingtown, PA, USA) with
a cooled 12-bit CCD camera (Photometrics, Tucson, AZ, USA) through a 40X objective
(0.6 numerical aperture). To determine transfection efficiency, the number of transfected
and non-transfected neurons was counted in 10 randomly-selected fields for each culture
dish by an observer naïve to the DNA combination. For cell health experiments, dishes
were fixed for 10 min in 4% paraformaldehyde / 0.2% glutaraldehyde after agonist
treatments. After washing 3 times in phosphate-buffered saline, transfected neurons were
assessed for health under 40X magnification by an observer naïve to both the treatment
conditions and the DNA combination.

Data analysis:
For all electrophysiological experiments, data were analyzed using Clampfit 9.2
(Molecular Devices) and Excel (Microsoft, Redmond, WA, USA) software. Graphs and
traces were plotted using SigmaPlot software (SPSS Science, Chicago, IL, USA).
Transfection efficiency was calculated by averaging the percentage of transfected
neurons in each dish. This percentage was determined by dividing the number of
transfected neurons by the total number of neurons counted in 10 fields and multiplying
by 100. For Figures 1 and 3, an action potential was counted if there was a 1-10 pA
transient and primarily negative current deflection above noise lasting ≥ 1 ms. Except for
electrically-evoked currents elicited in autaptic neurons in microisland culture, current
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amplitudes were measured by averaging ~500 ms of baseline and subtracting this from
the average of ~500 ms around the peak and/or steady state amplitude. For Figure 4, the
current ratio is measured by dividing the agonist-induced current amplitude by the KClinduced current amplitude. For Figure 6, the baseline leak amplitude was subtracted
from the peak amplitude for at least 3 traces from each cell and averaged. For autaptic
experiments, cells with leak currents > 300 pA were excluded from analysis. To
determine the percentage of healthy transfected neurons after agonist treatment, the
number of healthy neurons was divided by the total number of transfected neurons
counted in a particular culture dish and multiplied by 100. Miniature postsynaptic current
frequency was calculated from 10 s of recording using MiniAnalysis software
(Synaptosoft, Decatur, GA, USA). Baseline frequency was measured before application
of agonist while the frequency in agonist was measured beginning ~1 s after application
onset. The percentage of baseline frequency was calculated by dividing the frequency in
agonist by the frequency at baseline and multiplying by 100. Data are presented in the
text and figures as mean ± SEM unless otherwise stated. Student’s unpaired t test,
ANOVA, post hoc Tukey honestly significant difference test for multiple comparisons,
Tukey-Kramer method for unequal sample sizes, binomial test, and Fisher’s exact test
were used to determine statistical significance where described in the text. A p-value of
less than 0.05 was required for significance.

Materials:
Alexa Fluor 568 was purchased from Invitrogen. Synaptophysin-YFP and
TRPV1 constructs were graciously provided by Dr. Ann Marie Craig (University of

50

British Columbia) and Dr. David Julius (University of California San Francisco),
respectively. TRPM8 has been used previously (Macpherson et al., 2006; Cruz-Orengo
et al., 2008). The calcium-free culture medium used for toxicity experiments was made
by the Tissue Culture Support Center at Washington University by excluding 1.8 mM
calcium chloride from Neurobasal medium recipe (Brewer et al., 1993). Unless
otherwise stated, all other chemicals and reagents were purchased from Sigma (St. Louis,
MO, USA). When DMSO concentration in experimental solutions was > 0.1% after
addition of reagents from DMSO stock solutions, control and experimental conditions
were matched for final DMSO concentration.
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Results

TRPV1 transfection:
We transfected neurons in our primary mass hippocampal cultures with
heterologous ligand-gated ion channels to spatially and temporally control neuronal
depolarization. We co-transfected a yellow fluorescent protein-tagged synaptophysin
construct (Syn-YFP), which served as a marker for somata and presynaptic terminals in
transfected neurons (Fig 1A, 3A). We first co-expressed the ligand-gated, nonselective
cation channel TRPV1 (Fig 1A, B). Whole-cell currents (see Fig 1E, F) from YFPpositive and YFP-negative neurons in cultures co-transfected with TRPV1 showed that,
at a 1:4 Syn-YFP:TRPV1 DNA ratio, no neurons expressed one construct without the
other (N = 38 transfected and 19 non-transfected neurons). Assessed by YFP
fluorescence, transfection efficiency was 1.1 ± 0.3% (N = 3 dishes).
To determine whether current amplitudes generated by TRPV1 were sufficiently
large to cause action potentials in transfected cells, we performed cell-attached patch
recordings from neurons. Cell-attached patch methods were used in order to prevent cell
rupture, which would cause cytosolic mixing with internal patch pipette solution and,
therefore, potentially alter the intracellular milieu and neuronal responses to
environmental manipulation. Application of a saturating concentration (500 nM) of the
TRPV1 agonist capsaicin (Caterina et al., 1997; Tominaga et al., 1998), which was
chosen in order to maximize neuronal depolarization and potential secondary effects of
channel activation, induced a pattern of 1-9 action potentials in TRPV1-expressing
neurons but no action potentials in non-transfected neurons (Fig 1C, D; N = 15
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Figure 1. TRPV1-transfected neurons respond strongly to the agonist capsaicin. A.
Fluorescence image of a neuron in mass culture transfected with synaptophysin-YFP
(Syn-YFP) and TRPV1. Scale bar denotes 100 μm. B. Phase contrast image of the same
field as A. C. Example of a Syn-YFP/TRPV1-transfected neuron recorded in cellattached patch configuration in voltage-clamp mode during 5 s 500 nM capsaicin
application (top trace) or 5 s 30 mM KCl application (bottom trace). Note that action
potentials could be elicited by both treatments in the same cell. The suboptimal seal,
evident in the slow current excursions, was characteristic of nearly all TRPV1-transfected
neurons. D. Example of a non-transfected neuron recorded under the same conditions as
53

C. Note that action potentials were only elicited during KCl application. E. Example of a
Syn-YFP/TRPV1-transfected neuron recorded in whole-cell voltage-clamp mode during
10 s acute 500 nM capsaicin or 30 mM KCl application. TRPV1-transfected neurons
responded with robust currents to both capsaicin and KCl application. F. Example of a
non-transfected neuron recorded under the same conditions as E. Non-transfected
neurons never responded to capsaicin but always responded with robust KCl-induced
currents.
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transfected and 5 non-transfected neurons). From the same cells, 30 mM KCl application
caused 1-6 action potentials in both transfected and non-transfected neurons (Fig 1C, D;
N = 19 neurons). Hippocampal neurons are capable of sustaining action potential firing
for periods of at least as long as our 5 s agonist application shown in Figure 1C, but
spiking typically ceased soon after the start of capsaicin application. This may result
from small or rapidly desensitizing capsaicin-induced currents or from very large currents
that cause strong inactivation of the sodium channels necessary for spiking. This latter
explanation almost certainly applied to the effects of KCl, a strong depolarizing stimulus
(Hodgkin, 1947; Hodgkin and Horowicz, 1959; Moulder et al., 2006).
To determine if rapid desensitization of capsaicin-induced current is responsible
for abbreviated spiking in response to capsaicin, we examined capsaicin- and KClelicited currents in voltage-clamped neurons. YFP-positive neurons, unlike nontransfected neurons (5.3 ± 4.4 pA; N = 4), reliably responded to the TRPV1 agonist
capsaicin with robust (-1385.7 ± 574.8 pA; N = 6) currents measured via whole-cell
voltage clamp (Fig 1E, F). As a comparison, we examined the response to current
induced by 30 mM KCl application, which is known to clamp the membrane potential at
steady state near -20 mV (Moulder et al., 2006). Non-transfected neurons responded with
a KCl-induced current amplitude of -159.5 ± 62.3 pA (N = 4) while transfected neurons
responded with a similar amplitude of -204.0 ± 30.8 pA (N = 6). The capsaicin current
desensitized but remained large during the application period, suggesting that rapid
desensitization of capsaicin-induced current is not likely to be responsible for the
abbreviated spiking observed in cell-attached patch experiments. The robust sustained
current in capsaicin, however, does implicate voltage-gated sodium channel inactivation
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or other voltage-dependent processes as a possible explanation. We conclude that
currents elicited by capsaicin in transfected neurons are similar to or larger on average
than those elicited by KCl and, therefore, that 500 nM capsaicin elicits a strong yet
selective depolarization in TRPV1-transfected neurons.
These observations were confirmed by neuronal responses to exogenous
compounds recorded in whole-cell current-clamp, where transfected neurons produced a
burst of 4-6 action potentials in response to 5 s 500 nM capsaicin and depolarized to a
steady state of -4.0 ± 1.7 mV (N = 5) while non-transfected neurons did not respond to
capsaicin (N = 5; Fig S1A, B; Text S1). Both transfected and non-transfected neurons
produced a burst of 0 (in 1/10 cells) to 9 action potentials in response to 5 s 30 mM KCl
while the membrane potential depolarized to a non-steady state value of -33.9 ± 3.4 mV
during application. These results support the conclusion that acute application of
capsaicin to transfected neurons can meet or exceed the strength of depolarization
achieved by a calibrating KCl stimulation.
We noticed that TRPV1-transfected neurons tended to have larger basal holding
currents (-177.7 ± 60.9 pA; N = 30) than control neurons (-51.1 ± 10.0 pA; N = 32;
Student’s unpaired t test, p < 0.05) when voltage-clamped at -70 mV. We wondered
whether this observation could reflect non-ligand-gated channel opening of TRPV1. We
tested this explicitly by applying the non-competitive TRPV1 antagonist ruthenium red
(10 µM), which blocked 91.8 ± 5.3% of the capsaicin-gated current in our TRPV1transfected (500 nM capsaicin; N = 11) but caused no effect in non-transfected (N = 8)
neurons (Fig 2A). When we applied 10 µM ruthenium red to agonist-naïve, TRPV1transfected neurons at the holding potential of -70 mV, we noticed that ruthenium red
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Figure 2. Capsaicin-induced and capsaicin-independent currents are blocked by
ruthenium red in TRPV1-transfected neurons. A. Examples of TRPV1-transfected
(left panel) and non-transfected (right panel) neurons exposed to acute application of 500
nM capsaicin for 15 s with 10 µM ruthenium red added during the last 5 s. TRPV1transfected neurons, but not non-transfected neurons, respond to capsaicin with a robust
current that is blocked by ruthenium red. B. Examples of TRPV1-transfected (left panel)
and non-transfected (right panel) neurons exposed to acute application of 10 µM
ruthenium red in the absence of capsaicin. Leaky (more than -200 pA standing inward
current) TRPV1-transfected neurons reliably responded to ruthenium red while non-leaky
TRPV1-transfected neurons and non-transfected neurons did not.
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blocked standing inward current, especially in the leakiest (> -200 pA) TRPV1transfected cells (Fig 2B). Ruthenium red blocked 12.3 ± 3.1% (N = 15) of standing
inward current in TRPV1-transfected neurons while not affecting non-transfected
neurons (1.5 ± 1.8%; N = 9; Student’s unpaired t test, p < 0.05). This suggests that at
least some TRPV1-transfected neurons exhibit capsaicin-independent channel openings,
even in defined recording media, which could be detrimental to the goal of controlling
TRPV1-mediated depolarization.

TRPM8 transfection:
We also transfected cultured hippocampal neurons with the ligand-gated
nonselective cation channel TRPM8 (Fig 3A, B). At a 1:3 Syn-YFP:TRPM8 DNA ratio,
we confirmed that transfected neurons responded to acute application of the TRPM8
agonist menthol at a saturating concentration (100 μM; N = 38) (McKemy et al., 2002;
Liu and Qin, 2005), once again chosen to maximize effects of channel activation, while
non-transfected cells did not respond (N = 10). Similar to the experiments above with
TRPV1, transfection efficiency was 1.2 ± 0.4% as assessed by YFP fluorescence (N = 3
dishes).
YFP-positive neurons recorded in the cell-attached patch configuration responded
with a pattern of 1-7 action potentials during 100 μM menthol application, as they did
during KCl application (Fig 3C; N = 13 transfected neurons). These action potential
responses were similar to those seen in TRPV1-transfected neurons (Fig 1C), and nontransfected neurons responded to KCl with 1-8 action potentials but did not respond to
menthol (Fig 3D; N = 26 non-transfected neurons). When we applied these exogenous
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Figure 3. Menthol induces large depolarizing currents in TRPM8-transfected
neurons. A. Fluorescence image of a neuron in mass culture transfected with
synaptophysin-YFP (Syn-YFP) and TRPM8. Scale bar denotes 50 μm. B. Phase contrast
image of the same field as A. C. Example of a Syn-YFP/TRPM8-transfected neuron
recorded in cell-attached patch configuration in voltage-clamp mode during 5 s 100 μM
menthol application (top trace) or 5 s 30 mM KCl application (bottom trace). Note that
action potentials were elicited by both treatments in the same cell. D. Example of a nontransfected neuron recorded under the same conditions as C. Note that action potentials
were only elicited during KCl application. E. Example of a Syn-YFP/TRPM8-transfected
neuron recorded in whole-cell voltage-clamp during 10 s acute 100 μM menthol or 30
mM KCl application. TRPM8-transfected neurons responded with robust currents to both
menthol and KCl application. F. Example of a non-transfected neuron recorded under the
same conditions as E. Non-transfected neurons did not respond to menthol but always
responded with robust currents to KCl at the holding potential of -70 mV. G. A nontransfected neuron recorded in whole-cell voltage clamp held at 0 mV during 15 s acute
application of 100 μM menthol with 100 μM picrotoxin added during the last 5 s. Note
that picrotoxin decreased the current gated by menthol.
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compounds while recording from TRPM8-transfected neurons in current-clamp, we again
observed bursts of 1-6 action potentials and a steady state membrane potential of -13.1 ±
6.2 mV elicited by 5 s 100 µM menthol application (N = 6; Fig S1C; Text S1). Nontransfected neurons did not respond to menthol application (N = 5; Fig S1D). In these
experiments, 30 mM KCl consistently elicited 1-3 action potentials in all cells and a
membrane potential after 5 s, though not yet at steady state, of -37.1 ± 1.9 mV. TRPM8transfected neurons exhibited large inward currents measured in voltage-clamp during
acute menthol application (-396.4 ± 69.6 pA; N = 28) while YFP-negative neurons did
not respond with inward current (23.9 ± 20.1 pA; N = 10) at -70 mV (Fig 3E, F). As seen
with TRPV1-transfected neurons, these menthol-induced currents in TRPM8-transfected
neurons were similar to or larger than currents induced by 30 mM KCl (-153.4 ± 27.8 pA;
N = 8 transfected neurons; -326.6 ±96.2 pA; N = 10 non-transfected neurons). We
conclude that both TRPV1 and TRPM8 generate sufficiently large currents in transfected
hippocampal neurons to cause strong, sustained (for several seconds) depolarization with
acute agonist application, equivalent to or larger than the effects of 30 mM KCl
application.
Standing inward current in TRPM8-transfected neurons (-44.7 ± 16.9 pA; N = 32)
was not significantly different from non-transfected cells (-57.2 ± 36.5 pA; N = 8),
suggesting that TRPM8 does not suffer from the same non-ligand-gated channel opening
as TRPV1. However, in some non-transfected cells held at 0 mV, we observed a small
sustained outward current in the presence of 100 μM menthol (13.1 ± 1.3 pA; Fig 3G; N
= 8). This current was observed even in the presence of 0.5 μM TTX and changed
direction appropriately with alterations in the chloride gradient (Fig S2; Text S1). This
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latter result excludes the possibility that the current is mediated by endogenous TRPM8
in non-transfected neurons, and no published evidence currently indicates endogenous
TRPM8 expression in rodent hippocampus. A previous report suggests, however, that
menthol can directly gate GABAA receptor-mediated chloride currents in hippocampal
neurons (Zhang et al., 2008). Picrotoxin (100 μM), a noncompetitive GABAA receptor
antagonist, reduced the outward current in non-transfected neurons by 85.4 ± 12.9% (Fig
3G; N = 8 neurons). Therefore, these data provide evidence that menthol may weakly
gate endogenous GABAA receptors in cultured neurons.

Prolonged channel activation:
To control neuronal activity and evaluate the effects on development, synaptic
function, or network activity, it may be desirable to depolarize neurons for long periods
of time. For this reason, we activated TRPV1 and TRPM8 in cultured neurons for 4 hr to
determine if depolarization was sustained throughout the period of agonist exposure. We
chose to activate these channels for hours, instead of a shorter time period, to account for
slow forms of channel desensitization or inactivation that may be induced (i.e. by cellular
adaptation). These slower changes may be important considerations for studies using
heterologous channels in vivo or for studies of neuronal circuit activity that utilize
changes in activity of subsets of neurons for long periods. To activate TRPV1, we added
500 nM capsaicin to the culture media in the presence of D-APV (25 µM) and NBQX (1
µM) while the neurons remained at 37 oC in an atmospherically-controlled incubator.
Similarly, TRPM8-transfected cultures were exposed to 100 μM menthol under the same
conditions.
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At the end of incubation, neurons were recorded in the continued presence of
agonist, and agonist-induced currents were determined by removing the agonist with a
fresh saline wash and measuring the change in current amplitude. This amplitude was
then compared to the current amplitude of an acute application of 30 mM KCl in the
same cell (Fig 4A, B). Compared to brief (0-30 min) application of agonist, normalized
current amplitudes for both TRPV1- and TRPM8-transfected neurons were significantly
decreased after 4 hr application of their respective agonists (Fig 4C, D). The ratio of
capsaicin current to KCl current in TRPV1-transfected neurons decreased from 3.04 ±
0.73 (N = 32 neurons treated acutely with capsaicin) to 0.32 ± 0.08 (N = 11 neurons
treated 4 hr with capsaicin; Student’s unpaired t test, p < 0.05). The ratio of menthol
current to KCl current in TRPM8-transfected neurons decreased from 8.28 ± 3.24 (N = 7
neurons treated acutely with menthol) to 1.56 ± 0.40 (N = 10 neurons treated 4 hr with
menthol; Student’s unpaired t test, p < 0.05). The inward current present after 4 hr,
however, was still comparable to the current induced by acute 30 mM KCl. In both acute
and prolonged protocols, the average KCl-normalized menthol current in TRPM8transfected neurons trended toward being larger than the corresponding normalized
capsaicin current in TRPV1-transfected cells. In summary prolonged agonist application
produced sustained, effective depolarization for both channels, although the amplitude
was reduced with time.
The smaller average agonist-gated current after prolonged exposure probably
results partly from receptor desensitization. However, it is also possible that strong,
prolonged channel activation is toxic to neurons, and the smaller average currents arise as
a result of selective survival of cells with weaker channel expression and smaller
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Figure 4. Agonist-induced currents in both TRPV1- and TRPM8-transfected
neurons are decreased after prolonged exposure. A. Examples of TRPV1-transfected
neurons exposed to bath application of 500 nM capsaicin, 25 µM D-APV, and 1 µM
NBQX acutely (top panel) or for 4 hr (bottom panel) prior to recording in whole-cell
voltage clamp. Capsaicin was retained in the bath recording solution. After the wholecell recording was established, capsaicin was briefly removed by perfusing fresh
recording saline for 10 s before 5 s application of 30 mM KCl. B. Examples of TRPM8transfected neurons exposed to bath application of 100 μM menthol, 25 µM D-APV, and
1 µM NBQX acutely (top panel) or for 4 hr (bottom panel) prior to recording in wholecell voltage clamp. Similar to A, menthol was added to the bath recording solution.
Menthol was removed by perfusing fresh, menthol-free recording saline for 10 s before 5
s application of 30 mM KCl. C. The average ratio of capsaicin current amplitude to KCl
current amplitude was calculated for acute and 4 hr applications of capsaicin. Error bars
represent SEM. The ratio of capsaicin to KCl current is significantly decreased after 4 hr
capsaicin exposure (Student’s unpaired t test, p < 0.05). D. Similar to C except the ratio
of menthol to KCl currents in TRPM8-transfected neurons is depicted. Error bars
represent SEM, and the menthol to KCl current ratio is significantly decreased after 4 hr
exposure to menthol (Student’s unpaired t test, p < 0.05).
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resulted in many unsuccessful electrophysiological recordings of cells with abnormally
swollen morphology. To determine more systematically whether prolonged channel
activation affects neuronal health, mass cultures were transfected with Syn-YFP control
DNA with or without TRPV1 or TRPM8. Neurons were assigned a binary (“healthy” or
“unhealthy”) survival designation by a naïve observer using cell appearance under phase
contrast optics. Healthy neurons had a phase-bright soma and thin neurites. Unhealthy
neurons had distorted or swollen somata and neurites (Fig 5A). In some cases,
classification was verified by patch-clamp recordings; membrane seals were never
possible on neurons designated unhealthy.
Neurons were assessed for health after 4 hr of channel activation using the same
treatment protocol as the electrophysiology experiments in Figure 4. It is possible that
transfection alone caused some baseline toxicity; however, after 4 hr of capsaicin
exposure, the percentage of healthy TRPV1-transfected neurons was significantly
decreased from control cultures transfected with only Syn-YFP (Fig 5B; ANOVA, p <
0.01; post hoc Tukey honestly significant difference test, p < 0.05; N = 5 dishes per
condition with each dish representing 19.9 ± 1.3 transfected neurons). In contrast, a 4 hr
menthol challenge to TRPM8-transfected neurons caused no significant change in the
percentage of healthy neurons relative to sibling cultures transfected with Syn-YFP (Fig
5C; N = 5 dishes per condition with each dish representing 22.3 ± 2.4 transfected
neurons).
Calcium influx may differ between transfected neurons due to differences in
TRPV1 and TRPM8 calcium permeability (Caterina et al., 1997; McKemy et al., 2002).
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Figure 5. Agonist-induced toxicity in transfected neurons. A. An example TRPV1transfected neuron designated “unhealthy” (arrow) in the same field as a “healthy” nontransfected neuron (arrowhead). Syn-YFP fluorescence (left panel) and phase contrast
(right panel) images are shown. Note the swollen cell body of the unhealthy cell. Scale
bar represents 30 μm. B. Transfected neurons treated 4 hr with 500 nM capsaicin, 25 μM
D-APV, and 1 μM NBQX in culture media with (2 mM) or without (0 mM plus 500 µM
EGTA) calcium were assessed as “healthy” or “unhealthy” by a naïve observer.
Significantly fewer TRPV1-transfected neurons treated in calcium were healthy than
either YFP-transfected neurons treated in calcium or TRPV1-transfected neurons treated
without calcium (ANOVA, p < 0.01; post hoc Tukey test, p < 0.05). C. Transfected
neurons treated 4 hr with 100 μM menthol, 25 μM D-APV, and 1 μM NBQX in culture
media with or without calcium were assessed as “healthy” or “unhealthy” as in B. There
was no significant change in health of TRPM8-transfected neurons compared to YFPtransfected neurons regardless of whether or not they were exposed to extracellular
calcium. Error bars represent SEM.
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Because calcium influx is known to contribute to some forms of cellular toxicity (Choi,
1987; Stout et al., 1998; Mattson et al., 2000), we wished to determine if toxicity in
TRPV1-transfected neurons after prolonged channel activation was due to calcium influx.
We assayed toxicity after 4 hr of agonist exposure in calcium-free extracellular media
supplemented with 500 μM of the calcium chelator ethylene glycol-bis (β-aminoethyl
ether)-N, N, N ′, N ′-tetraacetic acid (EGTA). Calcium-free media protected TRPV1expressing neurons exposed to 500 nM capsaicin compared to those in calciumcontaining media (Fig 5B); neurons exposed to capsaicin in calcium-free media appeared
similar to control neurons not expressing TRPV1. Survival of TRPM8-expressing
neurons exposed to 100 μM menthol in calcium-free media did not differ from either
Syn-YFP-transfected controls or from TRPM8-transfected neurons treated in calciumcontaining media (Fig 5C). This suggests that calcium influx during TRPV1 activation,
but not during TRPM8 activation, is toxic to neurons.

Effects of channel expression on synaptic transmission:
For the utility of heterologous channels to be realized, it is important to ensure
that channel introduction alone does not alter endogenous neuronal function outside of
intended experimental manipulations. To determine if expression of heterologous ion
channels alters synaptic properties of cultured hippocampal neurons, we transfected
neurons in microisland culture with TRPV1 or TRPM8. Microisland cultures, unlike
mass cultures, contain isolated “islands” of astrocytes with neurons plated on top (Fig
6A). Measuring the autaptic responses of single neurons that synapse only onto
themselves is a useful method for studying synaptic efficacy in the absence of
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Figure 6. TRPV1 transfection, but not TRPM8 transfection, alters synaptic
transmission. A. Fluorescence (left panel) and phase contrast (right panel) images of a
single-neuron (autaptic) island in microisland culture transfected with synaptophysinYFP (Syn-YFP). Scale bar denotes 50 μM. B. Representative examples of excitatory
postsynaptic currents (EPSCs) evoked in transfected autaptic neurons 1 day after
transfection. Stimulus artifact has been blanked in each trace for clarity. Note that
TRPV1-transfected neurons produced EPSCs with smaller amplitudes than TRPM8transfected neurons or Syn-YFP-transfected controls. C. Quantification of average PSC
amplitudes for transfected autaptic neurons. Error bars represent SEM. TRPV1transfected neurons produced significantly smaller evoked PSCs than Syn-YFPtransfected or TRPM8-transfected neurons (ANOVA, p < 0.01; Tukey-Kramer method, p
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< 0.01). D. Percentage of transfected autaptic neurons that did not respond to electrical
stimulation with a detectable PSC. When non-responders were analyzed as “failures”
from a binomial distribution, the percentage of TRPV1-transfected neurons that
successfully responded to stimulation was significantly decreased from YFP-transfected
controls (binomial test, p < 0.01). Error bars represent SEM based on the binomial
distribution.
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polysynaptic complications (Mennerick et al., 1995). Only a minority of island cultures
contains a solitary autaptic cell. Because of this low percentage, combined with low
transfection efficiency, we pooled synaptic responses from glutamatergic and
GABAergic cells. We used KCl internal pipette solution to create a driving force of
approximately 70 mV for both excitatory postsynaptic currents (EPSCs) and inhibitory
postsynaptic currents (IPSCs) at the holding potential of -70 mV.
TRPV1-transfected autaptic neurons exhibited action potential-evoked autaptic
PSC amplitudes (-790.9 ± 228.3 pA; N = 9) that were significantly decreased from SynYFP-transfected controls (-3870.9 ± 444.1 pA; N = 28; Fig 6B, C; ANOVA, p < 0.01;
Tukey-Kramer method, p < 0.01). TRPM8-transfected autaptic neurons, however,
exhibited PSC amplitudes of -3590.8 ± 557.3 pA (N = 17), which were comparable to
Syn-YFP-transfected controls (Fig 6B, C). In addition to smaller amplitudes of evoked
PSCs, we observed that more cells in TRPV1-transfected cultures exhibited no PSC in
response to action potential stimulation. In autaptic neurons, 50% of TRPV1-transfected
neurons failed to produce a response, which was significantly more than Syn-YFPtransfected controls (21%; Fig 6D; binomial test, p < 0.01; N = 18 TRPV1-transfected
and 33 Syn-YFP-transfected autaptic neurons recorded in microisland culture). With a
failure rate of 11%, TRPM8-transfected neurons were not significantly different from
controls (N = 19 TRPM8-transfected neurons). This phenomenon appears to be an
extension of the observation of smaller evoked PSCs in TRPV1-transfected neurons. In
summary TRPV1 transfection, in the absence of added ligand, depressed evoked synaptic
transmission in autaptic hippocampal neurons whereas TRPM8 transfection had no
effect.
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One possible reason that TRPM8 does not interfere with synaptic transmission is
that neurons may not express the channel at synaptic sites. TRPM8 seems targeted
robustly to the somatodendritic compartment as evidenced by currents recorded from the
soma (Fig 3E). Whether the channel is targeted to presynaptic terminals is less clear. If
it is, axon terminal expression of TRPM8 could also be useful for probing functional
connections between neurons of disparate brain regions. We used a functional test of
presynaptic TRPM8 expression by investigating if TRPM8 drives synaptic
neurotransmitter release independent of action potential propagation. We recorded from
non-transfected target cells apposed to Syn-YFP-positive puncta (Fig 7A). We applied
100 μM menthol to neurons in the presence of 0.5 µM TTX to block action potentialdriven transmitter release. If agonist-induced miniature EPSCs (mEPSCs) were not
observed at a holding potential of -70 mV when using a cesium methanesulfonate internal
pipette solution, then the holding potential was switched to 0 mV to record miniature
IPSCs (mIPSCs). Baseline mPSC frequency, which presumably arose from mEPSCs and
mIPSCs from both transfected and non-transfected presynaptic terminals, was highly
variable in postsynaptic targets of both TRPM8-transfected (0.1-119.8 Hz) and control
(0.4-108.0 Hz) neurons. Therefore, we expressed the changes in frequency that occurred
during menthol application as a percentage of baseline frequency. Acute menthol
application to TRPM8-transfected neurons (N = 26) increased mPSC frequency in the
postsynaptic cell to 1090.4 ± 532.1% of baseline frequency from before menthol
application. This was significantly increased from non-transfected neurons or neurons
transfected with only Syn-YFP (N = 13), which produced a mPSC frequency in menthol
of 104.1 ± 6.3% of baseline frequency (Fig 7B, C; Fisher’s exact test, p < 0.005). We
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conclude that it possible to depolarize presynaptic terminals directly with menthol, which
suggests that functional TRPM8 protein is expressed on or very near axon terminals.
Since synaptic transmission is depressed in TRPV1-transfected neurons (Fig 6),
we tested whether TRPV1 is expressed near synaptic sites and whether presynaptic
release is hindered. The baseline mPSC frequency, like with TRPM8 transfection, varied
greatly in the postsynaptic targets of control (0.5-93.2 Hz) and, less so, TRPV1transfected (1.0-35.1 Hz) neurons, although the mean baseline mPSC frequency (9.5 ±
7.1 Hz and 15.3 ± 5.2 Hz, respectively) did not differ significantly. When 500 nM
capsaicin was applied to Syn-YFP-positive puncta of TRPV1-transfected neurons
apposed to non-transfected neurons in the presence of 0.5 µM TTX, the mPSC frequency
increased to 1016.8 ± 323.2% of baseline frequency (N = 7; Fig 7D). This significantly
differed from control neurons not in contact with transfected neurons (N = 9), for which
capsaicin induced a mPSC frequency of only 121.3 ± 34.7% of baseline frequency (Fig
7D; Fisher’s exact test, p < 0.01). Like with TRPM8-transfected neurons, this suggests
that functional TRPV1 protein is expressed on or very near axon terminals.
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Figure 7. Agonist treatment in 0.5 μM tetrodotoxin (TTX) increases presynaptic
transmitter release in transfected neurons. A. Fluorescence image of a TRPM8transfected neuron (green) forming presumed presynaptic contacts onto a
postsynaptically-recorded cell (red) filled with Alexa Fluor 568, which was included in
the recording pipette. Scale bar denotes 50 μM. B. Example of miniature excitatory
postsynaptic currents (mEPSCs) recorded from non-transfected postsynaptic partners of
TRPM8-transfected neurons (bottom panel) or from non-transfected neurons not in
contact with transfected neurons (top panel) in 0.5 μM TTX. During 100 μM menthol
application, mEPSC and mIPSC frequency increased in neurons postsynaptic to TRPM8transfected neurons but not in control neurons. C. Quantification of the mPSC frequency
during 100 μM menthol application compared to the baseline frequency (dashed line).
Error bars represent SEM. In neurons postsynaptic to TRPM8-transfected neurons, but
not in control neurons, the mPSC frequency increased significantly in menthol (Fisher’s
exact test, p < 0.005). D. Quantification of the mPSC frequency during 500 nM capsaicin
application compared to baseline frequency (dashed line) in neurons postsynaptic to
TRPV1-transfected neurons or to control neurons. Error bars represent SEM. In neurons
postsynaptic to TRPV1-transfected neurons, but not to non-transfected neurons, the
mPSC frequency in capsaicin increased significantly (Fisher’s exact test, p < 0.01).
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Discussion
In this study we compared transfection of cultured hippocampal neurons with
TRPV1 or TRPM8 nonselective cation channels, which both allow specific activation of
a small subset of neurons within the neuronal network (Fig 1, 3). Although TRPM8
activation mediates similar current densities to TRPV1 (Fig 4), TRPV1 has larger
secondary effects on cell function, including interference with endogenous synaptic
transmission in the absence of exogenous agonist stimulation (Fig 6) and overt calciumdependent toxicity with agonist exposure (Fig 5). Our results highlight substantial
differences between two related channels and suggest that care is needed in investigating
secondary effects of heterologous channels before employing them as tools.
Our observations suggest that transfection of TRPV1 alone, in the absence of
capsaicin stimulation, has important effects on neuronal function. Although we did not
detect overt cell loss or swelling of capsaicin-naïve TRPV1-transfected cells in estimates
of transfection efficiency 24 hr following transfection, cell-attached patch recordings
from TRPV1-transfected cells exhibited markedly more seal instability (Fig 1C) and
spontaneous rupture compared with TRPM8-transfected cells (Fig 3C). In addition,
evidence suggests that at least some TRPV1 channels are activated in the absence of
exogenous capsaicin application (Fig 2). Seal instability could represent an early sign of
toxicity from low-probability non-ligand-gated channel openings and/or from low-level
presence of endogenous activators in the culture medium (e.g. pH, lipid compounds, or
heat) in the absence of capsaicin (Tominaga and Tominaga, 2005). Since the effects of
TRP channel agonists are enhanced at more depolarized membrane potentials (Voets et
al., 2004), it is possible that spontaneous activity may shift the heat sensitivity of TRPV1
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enough to cause a persistent leak current while in the incubator. However, this cannot
explain the persistent current measured electrophysiologically (Fig 2) since all recordings
were performed at room temperature. Alternatively, TRPV1 overexpression itself (in the
absence of channel activity) could promote these signs of compromised membrane
integrity.
These same explanations (low-level channel openings or channel overexpression
itself) may account for the strong synaptic depression observed in TRPV1-transfected
neurons in the absence of capsaicin stimulation (Fig 6). Since these synaptic changes
were measured in autaptic neurons, they could be presynaptic or postsynaptic. Because
action potential-independent transmitter release from TRPV1-tranfected presynaptic
terminals appeared intact (Fig 7), autaptic depression may represent a postsynaptic
change, but it is also possible that TRPV1 expression disrupts presynaptic action
potential propagation (e.g. as a result of a leaky axonal membrane) and/or action potential
coupling to transmitter release. We have previously found that neuronal depolarization in
cultured hippocampal neurons leads to a homeostatic decrease in EPSC amplitude and
mEPSC frequency (Moulder et al., 2004). It is possible that low-level TRPV1 channel
openings induce a similar phenomenon, although we might have expected stronger
evidence of reduced mPSC frequency from TRPV1-transfected neurons (Fig 7). One
possibility is that contributions from non-transfected presynaptic cells reduced the
sensitivity of this experiment to detect synaptic depression. The autaptic experiments did
not suffer this limitation. Regardless of the mechanism, this autaptic depression in the
absence of added exogenous agonist is a poorly controlled, unintended consequence of
TRPV1 overexpression and represents a major disadvantage of heterologous TRPV1
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expression.
Prolonged capsaicin-induced TRPV1 activation led to increased overt signs of cell
toxicity (Fig 5B). This again contrasted with TRPM8-transfected cells (Fig 5C) despite
similar normalized depolarizing currents (Fig 4). By activating TRPV1 in the absence of
extracellular calcium, we determined that the toxicity most likely results from calcium
influx into the cell (Fig 5B). Since ionotropic glutamate receptor blockers were present
during these experiments, toxicity cannot be attributed to calcium influx through NMDA
receptors via indirect increases in network excitability. Thus, the high calcium
permeability of the TRPV1 channel relative to TRPM8 (Caterina et al., 1997; McKemy et
al., 2002) is likely a strong contributor to toxicity. These results are akin to higher
toxicity of calcium-permeable NMDA receptor activation relative to AMPA receptor
activation (Choi, 1987; Iino et al., 1990; Goldberg and Choi, 1993; Spruston et al., 1995).
It is possible that activation-dependent pore dilation, which occurs in TRPV1 (Meyers et
al., 2003; Chung et al., 2008) but not TRPM8 (Chen et al., 2009), also participates in the
stronger toxicity induced by capsaicin treatment. Using saturating concentrations of
agonists for these treatments may have exacerbated toxicity, so it is possible that lower
concentrations could be titered to produce significant depolarizations without concurrent
toxicity or other secondary effects.
Together, the experiments in this study suggest serious disadvantages of TRPV1
overexpression. To complicate matters, recent evidence also suggests that functional
TRPV1 is expressed endogenously in the central nervous system (e.g. the hippocampus)
in addition to its well-known expression in the peripheral nervous system (Toth et al.,
2005; Cristino et al., 2008; Gibson et al., 2008). Use of heterologous channels for
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selective stimulation obviously requires the demonstrated absence of contributions from
endogenous channels. In our experiments, we never observed capsaicin-induced effects
in non-transfected neurons (e.g. Fig 1D, 1F, 2, 7D, and S1B), suggesting that endogenous
receptor had a negligible contribution. This lack of detection of endogenous TRPV1
activation may be due to differences in expression in cultured neurons or to experimental
manipulations that, for whatever reason, did not measure the effects of endogenous
channel activation.
TRPM8 appears to be a much better candidate than TRPV1 for studies utilizing
heterologous channel expression. TRPM8 activation produced robust currents (Fig 3, 4)
but induced less toxicity than TRPV1 (Fig 5C) and did not alter baseline synaptic
transmission (Fig 6). Additionally, we have demonstrated that TRPM8, like TRPV1, can
be used to manipulate local presynaptic function. Agonist application to transfected
neurites in the absence of action potentials increased miniature PSC frequency in the
postsynaptic cell (Fig 7). This suggests that agonist application stimulates calcium entry
into presynaptic terminals through the TRP channel and/or through local voltage-gated
calcium channels to cause neurotransmitter release. Using menthol as a TRPM8 agonist,
however, has its caveats; menthol induced a small current mediated by GABAA receptors
(Fig 3G, S2). This current, however, was easily reduced by applying the GABAA
antagonist picrotoxin, and other agonist choices for TRPM8 activation exist (McKemy et
al., 2002). We conclude that TRPM8 is superior for most purposes and has fewer caveats
than TRPV1.
Our study has shown how two related ligand-gated ion channels, TRPV1 and
TRPM8, behave differently when expressed in the same neuronal preparation. Although
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we have shown that these channels, but especially TRPM8, are useful tools for
controlling neuronal activity, this study also emphasizes the care needed in characterizing
the nature of a newly introduced tool like heterologous channel expression. In the future,
it will be important to ensure that other heterologous channels or proteins used to
manipulate neuronal activity behave as predicted, especially after long periods of
activation. Controlling neuronal activity in subsets of neurons within a network will
facilitate studies of neuronal development, functional anatomy, synaptogenesis, and
synaptic plasticity as well as provide a framework for studies manipulating neuronal
populations in vivo.
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Text S1
Materials and Methods

Electrophysiology:
Whole-cell current-clamp experiments were performed on DIV 12-13 neurons in
mass culture 1 day after transfection with TRPV1 or TRPM8. External recording media
contained 138 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 10
mM HEPES, 25 µM D-APV, and 1 μM NBQX (pH = 7.25). Internal pipette solution
contained 140 mM K-gluconate, 4 mM NaCl, 0.5 mM CaCl2, 5 mM EGTA, and 10 mM
HEPES at a pH of 7.25. Recording electrode resistances of 6-9 MΩ and a 10 kHz lowpass filter were used for these experiments. The membrane potential of each cell was
manually adjusted to -65 mV by injecting bias current before the start of recording.
For voltage-clamp experiments measuring small menthol-induced currents in nontransfected neurons, methods from the main text were utilized except that an internal
pipette solution of 130 mM cesium chloride, 3 mM NaCl, 0.5 mM CaCl2, 5 mM EGTA,
and 10 mM HEPES (pH of 7.25) was used as described in addition to the solution with
130 mM cesium methanesulfonate, 4 mM NaCl, 0.5 mM CaCl2, 5 mM EGTA, and 10
mM HEPES (pH of 7.25). Also, the external recording media was as described above
except that 0.5 μM tetrodotoxin was added. The multi-barrel perfusion system described
in the main text was utilized for locally applying compounds.
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Figure S1. Agonist application to transfected neurons causes action potentials and
strong depolarization. A. Example of a TRPV1-transfected neuron exposed to 5 s acute
30 mM KCl (black trace) or 500 nM capsaicin (red trace). Neurons were recorded in
whole-cell current-clamp after adjusting the baseline membrane potential to -65 mV with
small bias current when necessary. Although capsaicin-induced voltage changes were
slow to return to baseline, they did so within ~20 s. B. The same as A except recording
from a non-transfected neuron in the same culture. C. Example of a TRPM8-transfected
neuron exposed to 5 s acute 30 mM KCl (black trace) or 100 µM menthol (red trace).
Neurons were recorded in current clamp after adjusting the baseline membrane potential
to -65 mV as described in A. D. The same as C except recording from a non-transfected
neuron in the same culture.
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Figure S2. Menthol application to non-transfected neurons induces a current that
changes direction with the chloride gradient. A. Example of a non-transfected neuron
recorded in whole-cell voltage-clamp in the presence of 0.5 μM tetrodotoxin (TTX) with
a cesium methanesulfonate internal pipette solution held at various membrane potentials
during a local 5 s 100 μM menthol application. Note the change in current direction with
potentials above and below ~-60 mV. B. Example of a non-transfected neuron recorded
in the presence of 0.5 μM TTX with a cesium chloride internal pipette solution held at
various membrane potentials during a local 5 s 100 μM menthol application. Note the
change in current direction with potentials above and below ~-20 mV. These data are
consistent with menthol gating a small GABAA receptor-mediated current in nontransfected hippocampal neurons (see Fig 3G).
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Chapter 3
Calcium-independent inhibitory G-protein
signaling induces persistent presynaptic muting of
hippocampal synapses

This chapter contains a previously published manuscript:
Crawford DC, Chang CY, Hyrc KL, Mennerick S (2011). Calcium-independent
inhibitory G-protein signaling induces persistent presynaptic muting of hippocampal
synapses. J Neurosci 31(3): 979.

Author contributions for the citation above:
D.C.C. designed and performed experiments, analyzed data, and wrote the paper. C.Y.C.
performed electrophysiological experiments for Figure 2. K.L.H. performed calcium
imaging experiments for Figure 1. S.M. designed experiments, performed experiments
for Figure 2, analyzed data, and wrote the paper.
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Abstract
Adaptive forms of synaptic plasticity that reduce excitatory synaptic transmission
in response to prolonged increases in neuronal activity may prevent runaway positive
feedback in neuronal circuits. In hippocampal neurons, for example, glutamatergic
presynaptic terminals are selectively silenced, creating “mute” synapses, after periods of
increased neuronal activity or sustained depolarization. Previous work suggests that
cAMP-dependent and proteasome-dependent mechanisms participate in silencing
induction by depolarization, but upstream activators are unknown. We, therefore, tested
the role of calcium and G-protein signaling in silencing induction in cultured
hippocampal neurons. We found that silencing induction by depolarization was not
dependent on rises in intracellular calcium, either from extracellular or intracellular
sources. Silencing was, however, pertussis toxin-sensitive, which suggests that inhibitory
G-proteins are recruited. Surprisingly, blocking four common inhibitory G-proteincoupled receptors (GPCRs; adenosine A1 receptors, GABAB receptors, metabotropic
glutamate receptors, and CB1 cannabinoid receptors) and one ionotropic receptor with
metabotropic properties (kainate receptors) failed to prevent depolarization-induced
silencing. Activating a subset of these GPCRs (A1 and GABAB) with agonist application
induced silencing, however, which supports the hypothesis that G-protein activation is a
critical step in silencing. Overall our results suggest that depolarization activates
silencing through an atypical GPCR or through receptor-independent G-protein
activation. GPCR agonist-induced silencing exhibited dependence on the ubiquitinproteasome system, as was previously shown for depolarization-induced silencing,
implicating the degradation of vital synaptic proteins in silencing by GPCR activation.
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These data suggest that presynaptic muting in hippocampal neurons employs a G-proteindependent but calcium-independent mechanism to depress presynaptic vesicle release.

89

Introduction
Adaptive forms of plasticity, including homeostatic synaptic plasticity, help
maintain neuronal firing rates and prevent over-excitation, excitotoxicity, and
information degradation caused by positive feedback inherent in glutamate signaling
(Turrigiano, 1999; Turrigiano and Nelson, 2004; Maffei and Fontanini, 2009; Pozo and
Goda, 2010). We have described adaptive presynaptic silencing after increased neuronal
activity (Moulder et al., 2004; Moulder et al., 2006). Indeed, presynaptically silent
(mute) synapses have been observed in several preparations, but induction and expression
mechanisms remain unclear (Malenka and Nicoll, 1997; Voronin and Cherubini, 2004;
Atasoy and Kavalali, 2006).
In hippocampal neurons, depolarization-induced presynaptic silencing is induced
rapidly by strong depolarization akin to that generated by stroke, seizure, and spreading
depression (Gido et al., 1997; Walz, 2000; Somjen, 2001; Moulder et al., 2004).
Physiological action potential firing induces silencing over more protracted periods
(Moulder et al., 2006), so presynaptic muting operates over a range of physiological, and
perhaps pathophysiological, conditions. Adaptive presynaptic silencing is selective for
glutamatergic terminals and is slowly reversible (Moulder et al., 2004). Expression
involves altered vesicle priming and requires the ubiquitin-proteasome system (Moulder
et al., 2006; Jiang et al., 2010), but upstream induction mechanisms remain uncertain.
Circumstantial evidence implicates calcium and cyclic adenosine monophosphate
(cAMP) alterations in silencing induction. Calcium is involved in many forms of
synaptic plasticity (Malenka, 1994; Fisher et al., 1997; Turrigiano, 2008). Prolonged
decreases in cAMP signaling produce presynaptic silencing, and cAMP increases occlude

90

depolarization-induced silencing (Moulder et al., 2008). Furthermore, calcium-sensitive
adenylyl cyclase activity, which increases cAMP levels, is important for normal recovery
from silencing (Moulder et al., 2008). If decreased cAMP signaling is needed for
depolarization-induced presynaptic silencing, we might expect involvement of inhibitory
G-proteins in its induction. Despite this evidence, double knockout mice of the two
major calcium-sensitive isoforms of adenylyl cyclase exhibit intact depolarizationinduced silencing (Moulder et al., 2008), thereby questioning a direct role for either
calcium or G-protein signaling. Clarification of how adaptive presynaptic silencing is
induced will be crucial in identifying potential targets for therapies aimed at
excitotoxicity-related dysfunction.
Here we explored whether calcium and inhibitory G-protein signaling are
necessary for hippocampal adaptive presynaptic silencing. Surprisingly, intracellular
calcium rises are unnecessary. However, we found that pertussis toxin, which inhibits
Gi/o signaling, reduced depolarization-induced silencing. Direct agonist activation of two
classes of G-protein-coupled receptors (GPCRs) induced silencing, supporting the
hypothesis that silencing is G-protein-dependent. In contrast, pharmacological blockade
of five candidate receptors, including the two that induced silencing, failed to block
depolarization-induced silencing. This suggests that depolarization activates an
uncommon GPCR or a pertussis toxin-sensitive G-protein through a receptor-independent
mechanism. Nevertheless, depolarization- and GPCR-induced muting share downstream
mechanisms because both are sensitive to proteasome inhibition. Thus, adaptive
presynaptic silencing is a unique form of calcium-independent, G-protein-dependent
synaptic plasticity. Furthermore, we show that prolonged G-protein activation leads to
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persistent presynaptic silencing, an effect distinct from classical acute presynaptic GPCR
effects on vesicle release probability.
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Materials and Methods

Cell culture:
Cultures of primary hippocampal neurons were prepared as previously described
(Mennerick et al., 1995). Briefly, hippocampi were removed from postnatal 0-3 d male
and female Sprague Dawley rat pups and enzymatically treated with papain (1 mg/ml)
before mechanical dissociation. Cells were then plated in 35 mm culture dishes precoated with 0.15% agarose as either mass cultures, seeded at ~650 cells/mm2 on a
confluent layer of type I collagen (0.5 mg/ml), or as microisland cultures, seeded at ~100
cells/mm2 on microdots of collagen. Plating medium contained Eagle’s medium
(Invitrogen) supplemented with 5% heat-inactivated horse serum, 5% fetal bovine serum,
17 mM D-glucose, 400 μM glutamine, 50 U/ml penicillin, and 50 μg/ml streptomycin.
Cultures were maintained at 37ºC in a humidified incubator under controlled atmospheric
conditions (5% CO2/95% air). Cytosine arabinoside (6.7 μM) was added 3-4 d after
plating to inhibit cell division. One half of the culture media was exchanged with
Neurobasal medium (Invitrogen) plus B27 supplement 4-5 d after plating. All
experiments were performed 10-14 d in vitro, and controls consisted of sibling cultures
from the same litter that were treated and/or recorded on the same day to control for
synapse development and culture conditions that vary by age and plating conditions. All
4 hr treatments were performed in the presence of ionotropic glutamate receptor blockers
D-(-)-2-amino-5-phosphonopentanoic acid (D-APV; 50 μM; Tocris) and 2,3-dioxo-6nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 1 μM; Tocris), and
non-depolarized controls always consisted of equimolar NaCl addition to the media to
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control for osmotic changes. Controls for calcium-free Neurobasal medium (Washington
University Medical School Tissue Culture Support Center) supplemented with B27 and
ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) were given the
identical medium except with 2 mM calcium and without EGTA.

Electrophysiology:
All whole-cell voltage-clamp recordings were performed on autaptic neurons in
microisland culture. To control for variability in maturity and development, all
experiments utilized similar numbers of neurons from sibling cultures on any given day.
Data were collected with an Axopatch 200B or Multiclamp 700B amplifier interfaced to
a Digidata 1322A or 1440A data acquisition board (Molecular Devices).
Before recording, the culture medium was exchanged for saline solution
containing 138 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 10
mM HEPES, and 25 µM D-APV with a pH of 7.25. For most experiments measuring
excitatory postsynaptic currents (EPSCs), internal pipette solution consisted of 140 mM
K-gluconate, 4 mM NaCl, 0.5 mM CaCl2, 5 mM EGTA, and 10 mM HEPES at a pH of
7.25. For experiments measuring both EPSCs and inhibitory postsynaptic currents
(IPSCs), 140 mM KCl was substituted for K-gluconate to provide a similar PSC driving
force at the holding potential of -70 mV.
Electrode pipettes pulled from borosilicate glass (World Precision Instruments)
had resistances of 2.5-6 MΩ, and access resistance was compensated 85-100%. Signals
were sampled at 5-10 kHz and low-pass filtered at 2-5 kHz. Recordings were performed
at room temperature, and membrane potential was typically clamped at -70 mV. Neurons
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were recorded within 1 hr of exchanging the culture medium with the saline solution.
PSCs were evoked by a brief (1.5 ms) depolarization to 0 mV. Paired-pulse
responses were evoked by 2 such depolarizations with an inter-stimulus interval of 50 ms.
Sucrose-evoked EPSCs were elicited by 3 s local application of 0.5 M sucrose. All local
solution applications utilized a multi-barrel perfusion system with the common perfusion
port placed within 0.5 mm of the neuron under study and yielding solution exchange
times of ~100 ms.

Calcium imaging:
All calcium imaging experiments utilized mass cultures. For fura-2 experiments,
neurons were plated on glass-bottom dishes (MatTek Corporation). Cells were loaded
with fura-2 by 60 min incubation with 5 μM fura-2-acetoxymethyl ester (Invitrogen) and
0.1% Pluronic F-127 (Invitrogen) in Neurobasal medium (pH of 7.2) at room
temperature, washed with Neurobasal medium and incubated for another 60 min to allow
for ester hydrolysis. After loading, the cells were imaged on an Eclipse TE300 inverted
microscope using a 40x (1.3 numerical aperture) oil immersion objective (Nikon). The
microscope was equipped with a 75 W xenon arc lamp and a cooled CCD camera (Cooke
Corp.). The fluorescence excitation was provided by a band-specific filter (340 and 380
nm; Semrock) in combination with DM400 dichroic beam splitter (Nikon). Pairs of
images were collected at alternate excitation wavelengths. The images were divided by
one another to yield ratio values for individual cell bodies after subtracting the matching
background. Imaging was performed at room temperature, but cultures were returned to
37ºC for the period between images early in the treatment and images at the end of the 4
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hr treatment. For this reason, the same neurons were represented at baseline and 5 min
time points, but separate fields of neurons were used for 4 hr time points in Figure 1.
MetaFluor software (Molecular Devices) was used for image acquisition and analysis.
Fluo-4 was loaded into cells by addition of Fluo-4 AM (2 μM; Invitrogen) to the
culture media 30 min prior to the end of the 4 hr KCl treatment. Medium was then
exchanged for extracellular recording saline containing elevated KCl (34 mM total) and 0
mM CaCl2. Cells were imaged at room temperature using an Eclipse TE2000-S inverted
microscope with 40x (0.6 numerical aperture) objective (Nikon) and a cooled 12-bit CCD
camera (Photometrics). Epifluorescence was provided by a metal halide lamp, and
images were acquired at 1 Hz using MetaMorph software (Molecular Devices). Calcium
was briefly elevated to 0.5 mM for 5-10 s after 5 s of baseline in 0 mM calcium.

FM1-43 loading and immunocytochemistry:
All FM1-43 imaging experiments utilized mass cultures plated on glass
coverslips. FM1-43 loading and vesicular glutamate transporter 1 (vGluT-1)
immunolabeling experiments were performed as previously described (Moulder et al.,
2006; Moulder et al., 2010). Briefly, within 60 s of replacing media with fresh saline,
active presynaptic terminals were labeled for 2 min with 10 μM fixable FM1-43 (FM143FX; Invitrogen) in recording saline supplemented with 45 mM KCl and 1 μM NBQX.
Cultures were immediately washed for 5 s with extracellular recording saline containing
500 μM Advasep-7 (CyDex) and 1 μM NBQX followed by saline plus 1 μM NBQX for
10 min. Afterwards, cells were fixed for 10 min in 4% paraformaldehyde/0.2%
glutaraldehyde in phosphate buffered saline (PBS), washed with PBS, and incubated in a
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blocking solution (2% normal goat serum/0.08% Triton X-100) for 15 min before 3 hr
incubation in guinea pig anti-vGluT-1 antibody (Millipore) diluted 1:2000 in blocking
solution. After washing with PBS, cells were incubated for 40 min in Alexa Fluor 647conjugated anti-guinea pig antibody (Invitrogen) diluted 1:500 in PBS. After washing
again with PBS, coverslips were removed from culture dishes and mounted onto glass
microscope slides with Fluoromount-G (Southern Biotechnology).
Confocal images were acquired at random locations throughout the dish by an
observer naïve to the experimental conditions using a C1 scanning confocal laser attached
to an inverted Eclipse TE300 microscope with a 60x objective (1.4 numerical aperture)
and EZ-C1 software (Nikon). Alternating 543 nm and 633 nm laser lines were used to
obtain z-stack images while pixel dwell time, image resolution, gain settings, field of
view size, and z-stack parameters were held constant throughout all conditions from a
single experiment. Monochrome images were converted into two-dimensional projected
images and analyzed using MetaMorph software.

Trypan blue staining:
For experiments assessing toxicity via trypan blue staining, mass cultures were
treated for 5 min with 0.4% trypan blue at 37ºC in a humidified incubator under
controlled atmospheric conditions (5% CO2/95% air). After one PBS wash at room
temperature, neurons were fixed for 10 min in 4% paraformaldehyde/0.2%
glutaraldehyde in PBS. After 3 additional PBS washes, 10 random fields of cells were
counted in each dish using a 20x objective. Trypan-positive nuclei were counted under
bright field and identified as unhealthy neurons, and phase-bright cell bodies devoid of
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trypan staining were counted under phase contrast and identified as healthy neurons.

Data analysis:
Electrophysiology data were collected and analyzed with pClamp 9 software
(Molecular Devices). For electrically-evoked PSCs, leak was subtracted offline before
measuring peak amplitude, and the amplitudes of at least three responses were averaged
for each cell. For sucrose-evoked EPSCs, currents were integrated over the rise and
decay of the response to 10% of the steady-state current. This provided an estimate of
the postsynaptic charge transfer corresponding to the readily releasable vesicle pool.
In calcium-imaging experiments using fura-2, the ratio values were normalized to
the baseline values (in which no treatment had been applied) to control for differences in
baseline calcium concentration. Normalization was achieved by dividing by the first
value for each cell under baseline conditions, and 4 hr time points were normalized to the
average of the ratios at baseline. Values from at least 5 images were averaged for each
neuron at each time point. To calculate the change in fluorescence in fluo-4 experiments,
somatic fluorescence intensities from three images were averaged at baseline and
subtracted from the average intensity of three images near the peak of fluorescence. The
change in fluorescence was normalized to the average baseline fluorescence value to
account for variability in fluo-4 loading.
To determine the percentage of active glutamatergic synapses, regions were
manually drawn around 10 vGluT-1 puncta each from 5 images (fields) for each
coverslip in a single experiment by an observer naïve to experimental conditions. The
strategy of using 5 fields per condition equalized the contribution of a single condition to
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the final results. Regions were drawn to include the pixels above threshold in the vGluT1-positive punctum but not larger than the punctum in order to minimize the contribution
of background pixels and/or neighboring puncta to the analysis. Thresholds were applied
to all FM1-43FX images before vGluT-1 regions were loaded into the FM1-43FX image.
“Active” synapses were defined as those regions that reached at least 10 pixels above
threshold in the FM1-43FX image (Moulder et al., 2006). Cluster correlation analyses
(Galbraith et al., 2010) and ANOVA statistics applied to the first FM1-43FX/vGluT-1
correspondence experiment (Fig. 1D) found no significant correlations between fields
within an experiment (data not shown), so we treated the percentage of active synapses
from each field as statistically independent samples throughout the manuscript.
For trypan blue toxicity experiments, the total numbers of healthy and unhealthy
neurons were added together from all 10 fields in each dish. The percentage of healthy
neurons was then calculated as the number of healthy neurons divided by the total
neurons counted (healthy and unhealthy) in each dish.
Graphs were created using SigmaPlot software (Systat Software Inc.). All data
were presented as mean ± SEM unless otherwise indicated. To reduce type 1 error that
may result from non-significant cluster correlations (Galbraith et al., 2010), all
experiments utilized yoked controls (e.g. sibling cultures; see methods above), and we
analyzed data conservatively using unpaired statistics with additional corrections (i.e. for
multiple comparisons) as appropriate. Unpaired Student’s t test was used to determine
significance for comparisons of two groups while Bonferroni correction for multiple
comparisons was applied to analyses of experiments involving more than two conditions.
A p value of < 0.05 was required for significance.

99

Materials:
SCH50911, bicuculline, LY341495, (1S,3R)-ACPD (ACPD), and 2-chloro-N6cyclopentyladenosine (CCPA) were purchased from Tocris. BAPTA-AM
(acetoxymethyl ester derivative of bis(2-aminophenoxy)ethane tetraacetic acid) was
purchased from Invitrogen while 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) was
purchased from Research Biochemicals Inc. Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal
(MG-132) was purchased from Enzo Life Sciences. All other chemicals and reagents
were purchased from Sigma unless otherwise stated.
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Results

Depolarization silences presynaptic terminals in the absence of extracellular calcium:
Calcium is necessary for multiple forms of hippocampal synaptic plasticity, so we
determined the role of calcium influx in adaptive presynaptic silencing by removing
calcium from the extracellular media during a depolarizing induction challenge known to
produce strong presynaptic muting. We used an induction paradigm of 30 mM KCl for 4
hr in the presence of ionotropic glutamate receptor blockers D-APV (50 μM) and NBQX
(1 μM). The short, strong induction circumvents inevitable developmental confounds of
longer interventions with calcium and G-protein signaling and mimics pathophysiological
extracellular potassium concentrations during stroke or seizure (Gido et al., 1997; Walz,
2000). 30 mM KCl clamps the membrane potential at -20 to -30 mV (Moulder et al.,
2003; Crawford et al., 2009) and induces adaptive presynaptic silencing without
detectable changes in synaptic structure, vesicle release probability (pr), or postsynaptic
function (Moulder et al., 2004; Moulder et al., 2006). We incubated mass cultures in
either calcium-rich culture media or calcium-free culture media supplemented with 500
µM EGTA to buffer residual free calcium. Using the ratiometric calcium indicator fura2, we verified that calcium-free media prevented rises in cytosolic free calcium
concentration normally produced by KCl depolarization (Fig. 1A, B). Control neurons
also exhibited a late rise in cytosolic free calcium concentration (Fig. 1B). We speculate
that temperature and pH variations between imaging sessions (at room temperature) and
intervening periods (at 37°C) may have contributed to cellular stress and calcium influx
in non-depolarized neurons. Regardless, calcium-free media prevented the rise in
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Figure 1. Depolarization-induced presynaptic silencing is not dependent on calcium
influx. A. Pseudo-colored images of the fura-2 ratio (indicating calcium concentration) in
neuronal cell bodies before (baseline) and < 1 min after (depolarized) application of 30
mM KCl. Neurons were switched from calcium-containing media to either calciumcontaining (control) media or to calcium-free media supplemented with 500 μM EGTA
when KCl depolarization began. Scale bar denotes 25 μm. B. Summary of fura-2 ratio
normalized to baseline values in neurons similar to A at two time points following
addition of either 30 mM NaCl (control) or 30 mM KCl (depolarized) to calciumcontaining media or calcium-free media supplemented with 500 μM EGTA. All
comparisons within a single time point were significantly different (p < 0.05 with
Bonferroni correction for multiple comparisons) except those indicated with “N.S.”
meaning “not significant” (n = 17-62 neurons). Thus, the calcium-free media with EGTA
effectively prevented cytosolic free calcium level rises in both control and depolarized
neurons. C. Vesicular glutamate transporter 1 (vGluT-1) immunoreactivity to identify
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glutamatergic presynaptic terminals (red) with superimposed FM1-43FX labeling of
active presynaptic terminals (green). Neurons were treated 4 hr with either 30 mM NaCl
(baseline) or 30 mM KCl (depolarized) in either calcium-containing media (control) or
calcium-free media supplemented with 500 μM EGTA (calcium-free). Scale bar denote 5
μm. D. Summary of the percentage of active glutamatergic presynaptic terminals based
on vGluT-1/FM1-43FX correspondence as shown in C. All comparisons were
significantly different (p < 0.05 with Bonferroni correction for multiple comparisons)
except those indicated with “N.S.” (n = 20 fields of 10 vGluT-1 puncta each from 4
independent experiments).
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cytosolic free calcium concentration in both control and depolarized neurons over 4 hr
(Fig. 1B). We conclude, therefore, that our calcium-free media supplemented with
EGTA effectively prevented calcium influx.
To assess presynaptic silencing after depolarization in the absence of calcium
influx, we performed FM1-43FX labeling in the presence of calcium followed by
retrospective immunostaining for vesicular glutamate transporter 1 (vGluT-1) to identify
active glutamatergic terminals. In agreement with previous experiments under normal
calcium conditions (Moulder et al., 2004), neurons depolarized in calcium-free media
plus EGTA exhibited a decrease in the percentage of vGluT-1 terminals that co-localize
with FM1-43FX (Fig. 1C, D). This suggests that calcium influx is not necessary to
induce adaptive presynaptic silencing.

Depolarization silences presynaptic terminals in the absence of intracellular free calcium:
Although influx of extracellular calcium is not necessary for induction of adaptive
presynaptic silencing, calcium rises from intracellular sources may participate. To
prevent intracellular calcium rises, we loaded cells with the fast intracellular calcium
chelator BAPTA using the cell-permeant precursor BAPTA-AM. Because normal action
potential-driven neurotransmitter release is dependent on fast rises in local presynaptic
calcium concentration and would be depressed by BAPTA-AM incubation, we used
calcium-independent hypertonic sucrose-evoked excitatory postsynaptic currents
(EPSCs) to determine the size of the readily-releasable pool of vesicles (Rosenmund and
Stevens, 1996), which is proportional to the total number of active synapses (Moulder et
al., 2004). For these experiments, we used autaptic neurons in microisland cultures and
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applied hypertonic sucrose to evoke EPSCs during whole-cell recordings. Autaptic
neurons were used because their isolation eliminates confounding polysynaptic effects
during electrophysiological measurements. Similar to previous results (Rosenmund and
Stevens, 1996), sucrose-evoked EPSCs were unaffected by 4 hr incubation with 20 μM
BAPTA-AM in calcium-free media (Fig. 2A, B). In contrast electrically-evoked EPSCs,
which are dependent on presynaptic calcium influx, were strongly depressed after 4 hr
BAPTA chelation (Fig. 2A, B). These results suggest that 4 hr BAPTA incubation
strongly chelates intracellular free calcium.
To test if intracellular rises in calcium concentration are necessary for presynaptic
silencing, we depolarized neurons for 4 hr in 30 mM KCl in the presence of 2 mM
calcium or in calcium-free media containing 20 μM BAPTA-AM. To ensure that
intracellular calcium rises during induction did not saturate the ability of BAPTA to
chelate calcium, we performed calcium imaging of treated neurons using the calcium
indicator fluo-4. Briefly raising extracellular calcium from 0 mM to 0.5 mM increased
cytosolic free calcium concentration in control neurons after 4 hr depolarization in
calcium-rich media, as assessed by changes in somatic fluo-4 fluorescence (45.5 ± 4.5%
increase; n = 40; Fig. 2C). This rise in cytosolic free calcium was not observed in
neurons after incubation in calcium-free media supplemented with BAPTA-AM (1.0 ±
1.2% increase; n = 40; p = 1.0 x 10-15; Fig. 2C). BAPTA, therefore, effectively chelates
intracellular free calcium, even following a sustained depolarization.
To test whether BAPTA-AM incubation blocks presynaptic silencing, we
incubated in BAPTA-AM and compared neurons after the KCl challenge to neurons
challenged with an equimolar NaCl control. As shown previously, the 4 hr depolarizing
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Figure 2. Depolarization-induced presynaptic silencing is not dependent on
increases in intracellular free calcium from any source. A. Representative examples
of sucrose-evoked excitatory postsynaptic currents (EPSCs) and action potential-evoked
EPSCs elicited in autaptic neurons after 4 hr treatment in normal calcium-containing
media (control) or calcium-free media supplemented with 20 μM of the cell-permeant
fast calcium chelator BAPTA-AM. B. Summary of results for sucrose-evoked EPSC
charge and action potential-evoked EPSC amplitude after treatment with control or with
calcium-free, BAPTA-AM-supplemented extracellular media in sister cultures (n = 9-11
neurons). *p < 0.05. C. Example fields of neurons filled with the calcium indicator fluo-4
before (0 mM) and after (0.5 mM) perfusion of CaCl2. Neurons were pre-treated for 4 hr
with 30 mM KCl in either calcium-containing media (depolarized) or calcium-free media
supplemented with 20 μM BAPTA-AM (depolarized BAPTA-AM). Scale bar denotes 50
μm. D. Representative examples of sucrose-evoked EPSCs in autaptic neurons after 4 hr
treatment in calcium-free media supplemented with 20 μM BAPTA-AM and either 30
mM NaCl (baseline) or 30 mM KCl (depolarized).
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challenge in calcium-rich media depressed sucrose-evoked EPSCs by ~45% (control:
1224.9 ± 147.7 pC; depolarized: 670.1 ± 135.7 pC; n = 29-30 neurons; p < 0.01; see also
Moulder et al., 2004). Despite BAPTA-AM incubation in calcium-free media, the charge
of sucrose-evoked EPSCs was still significantly depressed in KCl-challenged neurons
compared with sibling controls (control: 581 ± 100 pC; depolarized: 168 ± 27 pC; n = 2629; p < 0.0001; Fig. 2D). These results argue strongly that adaptive presynaptic silencing
is calcium-independent.

Activation of inhibitory G-proteins is necessary for depolarization-induced presynaptic
silencing:
Indirect evidence has previously implicated decreased cAMP levels in
depolarization-induced presynaptic silencing (Moulder et al., 2008). Thus, prolonged
activation of inhibitory G-proteins, which inhibit adenylyl cyclase activity and cAMP
production, could participate in adaptive muting. We, therefore, tested the hypothesis
that inhibitory G-proteins are necessary for depolarization-induced silencing.
We pre-incubated neurons for 24 hr in 500 ng/ml pertussis toxin, which, by
adenosine diphosphate-ribosylation of the αi/o subunit, prevents inhibitory G-protein
activation. This interferes with α subunit signaling and blocks the association of Gαi/o
subunits with their upstream GPCRs (Brown and Sihra, 2008). To confirm that pertussis
toxin treatment itself did not induce toxicity, we used trypan blue staining to identify
unhealthy neurons. The percentage of healthy neurons did not differ between control
neurons and those treated 24 hr with 500 ng/ml pertussis toxin (control: 92.2 ± 1.6%;
pertussis toxin: 93.5 ± 1.0%; n = 4 dishes; p = 0.54). After 24 hr in pertussis toxin, we
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co-incubated with 30 mM KCl or an equimolar control during an additional 4 hr in
pertussis toxin. After treatment, we assessed synaptic function by measuring EPSC
amplitudes in autaptic neurons and vGluT1/FM1-43FX correspondence in mass cultures.
Pertussis toxin had no effect on EPSC amplitude in non-depolarized neurons, confirming
that the toxin did not compromise cell health, but it prevented depolarization-induced
depression of EPSC amplitude (Fig. 3A, B). Pertussis toxin did not, however, alter
paired-pulse depression in any of the experimental groups (control: 29.9 ± 5.6%;
pertussis toxin: 18.0 ± 4.3%; depolarized: 8.3 ± 6.2%; depolarized + pertussis toxin: 20.7
± 5.9%; n = 13-14 neurons per condition; p > 0.05; also see supplemental Fig. 1A), as is
expected from acute effects of GPCR activation on vesicle release probability
(Mennerick and Zorumski, 1995; Dobrunz and Stevens, 1997; Zucker and Regehr, 2002;
Brown and Sihra, 2008). Similarly pertussis toxin prevented the depolarization-induced
decrease in active synapses measured via FM1-43FX/vGluT-1 correspondence (Fig. 3C,
D). Together these results suggest that activation of inhibitory G-proteins is necessary
for depolarization-induced presynaptic silencing.

A1 receptor activation is not required for depolarization-induced presynaptic silencing:
To explore the role of GPCRs upstream of inhibitory G-proteins in presynaptic
silencing, we examined whether the G-protein-coupled A1 adenosine receptor is
involved. The A1 receptor is an excellent candidate since increased adenosine levels in
the extracellular space occur via calcium-independent mechanisms: conversion from
adenosine triphosphate (Latini and Pedata, 2001), which is released from astrocytes
(Wang et al., 2000), and release by transporters (Dunwiddie and Masino, 2001).
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Figure 3. Activation of inhibitory G-proteins is necessary for depolarization-induced
presynaptic silencing. A. Example action potential-evoked EPSCs from autaptic neurons
treated 24 hr with or without 500 ng/ml pertussis toxin before 4 hr co-application with 30
mM NaCl (baseline) or 30 mM KCl (depolarized). B. Summary of EPSC amplitudes
from autaptic neurons treated as in A (n = 13-14 neurons). *p < 0.05 with Bonferroni
correction for multiple comparisons. C. Example images of vGluT-1 (red) and FM143FX (green) correspondence in neurons treated 24 hr with or without 500 ng/ml
pertussis toxin before 4 hr baseline or depolarized. Scale bar denote 5 μm. D. Summary
of conditions represented in C (n = 25 fields from 5 independent experiments). *p < 0.05
with Bonferroni correction for multiple comparisons.
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Adenosine release has also been implicated in neuroprotection, in part through acute A1
receptor-mediated inhibition of presynaptic glutamate release (Stone et al., 2009).
Additionally, A1 receptors selectively inhibit synaptic transmission at excitatory, not
inhibitory, terminals in the hippocampus (Yoon and Rothman, 1991), possibly explaining
the selectivity of adaptive presynaptic silencing for excitatory over inhibitory terminals
(Moulder et al., 2004).
To test whether A1 receptor activation is necessary for depolarization-induced
presynaptic silencing, we incubated neurons with depolarizing KCl or equimolar NaCl
control in the presence of the selective A1 antagonist 200 nM DPCPX. The decrease in
EPSC amplitude in depolarized neurons treated with DPCPX was comparable to ESPC
depression from neurons incubated in the absence of DPCPX (Fig. 4A, B). DPCPX
incubation also did not alter paired-pulse depression (control: 11.8 ± 4.8%; DPCPX: 16.4
± 5.1%; depolarized: 11.0 ± 8.7%; depolarized + DPCPX: 7.3 ± 11.7%; n = 9 neurons per
condition; p > 0.05; also see supplemental Fig. 1B). Additionally, we assessed
presynaptic silencing by measuring the percentage of active glutamatergic presynaptic
terminals via FM1-43FX/vGluT-1 correspondence. In neurons treated 4 hr with 30 mM
KCl, the percentage of vGluT-1-positive presynaptic terminals that co-localize with
FM1-43FX fluorescence was decreased from control, regardless of whether the neurons
had been co-incubated with DPCPX (Fig. 4C, D). We noticed a trend-level difference in
the percentage of active synapses in depolarized neurons treated with DPCPX compared
to depolarized neurons without DPCPX (depolarized: 10.6 ± 1.5%; depolarized +
DPCPX: 17.4 ± 2.1%; p = 0.052 after correction for multiple comparisons), potentially
suggesting a minor role of adenosine A1 receptors in depolarization-induced silencing.
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Figure 4. A1 adenosine receptor activation is not necessary for depolarizationinduced presynaptic silencing. A. Example action potential-evoked EPSCs from
autaptic neurons treated 4 hr with 30 mM NaCl (baseline) or 30 mM KCl (depolarized) in
the presence or absence of 200 nM DPCPX, an A1 receptor antagonist. B. Summary of
EPSC amplitudes from autaptic neurons treated as in A (n = 9 neurons). All comparisons
were significantly different (p < 0.05 with Bonferroni correction for multiple
comparisons) except those indicated (N.S.). C. Example images of vGluT-1 (red) and
FM1-43FX (green) correspondence in neurons treated 4 hr under baseline or depolarized
conditions in the presence or absence of 200 nM DPCPX. Scale bar denotes 5 μm. D.
Summary of conditions represented in C (n = 65 fields from 13 independent
experiments). All comparisons were significantly different (p < 0.05 with Bonferroni
correction for multiple comparisons) except those indicated (N.S.).
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Despite this trend, however, there was still a significant decrease in the percentage of
active synapses in the presence of DPCPX compared to control (DPCPX: 42.6 ± 3.4%;
depolarized + DPCPX: 17.4 ± 2.1%; p = 1.7 x 10-8 after correction for multiple
comparisons). Together these data suggest that blocking A1 receptor activation during
depolarization does not prevent the induction of adaptive presynaptic silencing.

GABAB, metabotropic glutamate, CB1, and kainate receptors are not required for
depolarization-induced presynaptic silencing:
Although A1 adenosine receptor activation is not necessary to induce adaptive
presynaptic silencing (Fig. 4), activation of inhibitory G-proteins is critical (Fig. 3).
Multiple GPCRs linked to inhibitory G-proteins are expressed in rodent hippocampus.
Our culture preparation, however, does not contain modulatory projection neurons from
outside the hippocampus, so the list of GPCRs with ligands available in vitro is restricted.
The calcium independence of induction also excludes transmitters/modulators released by
classical calcium-dependent exocytosis. Nevertheless, reverse transport of γaminobutyric acid (GABA; Schwartz, 1982; Gaspary et al., 1998), reverse transport of
glutamate (Nicholls and Attwell, 1990; Szatkowski et al., 1990), and non-classical
cannabinoid signaling (Di Marzo and Deutsch, 1998; Di Marzo et al., 1998; Wilson and
Nicoll, 2001) could elevate ambient modulator levels and induce silencing in response to
depolarization.
We first tested whether the G-protein-coupled GABAB receptor is responsible for
inducing adaptive presynaptic silencing. To prevent GABAB receptor activation, we
incubated neurons in the presence of the GABAB receptor antagonist SCH50911 (50
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μM). To test effectiveness of SCH50911 in our system, we co-applied SCH50911
acutely to our autaptic neurons with the GABAB receptor agonist baclofen (10 μM).
Baclofen depressed evoked EPSCs and IPSCs by 65.4 ± 8.1%, and addition of
SCH50911 recovered the PSCs to 96.0 ± 4.8% of their original amplitude (n = 10
neurons; Fig. 5A). Incubation of mass cultures in SCH50911 for 4 hr significantly
increased the percentage of active glutamatergic presynaptic terminals from baseline
(Fig. 5B), suggesting a small endogenous GABAB receptor tone in this data set. Despite
this effect on baseline silent synapses, SCH50911 did not prevent the decrease in the
percentage of active synapses induced by depolarization (Fig. 5B). These results
demonstrate that, despite effectiveness of SCH50911, GABAB receptor activation is not
involved in depolarization-induced adaptive presynaptic silencing. Similar results were
obtained with the GABAA receptor antagonists bicuculline and picrotoxin (supplemental
Fig. 2), confirming that GABA signaling is not involved in depolarization-induced
presynaptic silencing.
Other plausible candidate GPCRs for the induction of adaptive presynaptic
silencing include Gi/o-coupled metabotropic glutamate receptors (mGluRs). LY341495, a
non-selective mGluR antagonist at concentrations above 22 μM (Schoepp et al., 1999),
reversed acute EPSC depression by a near-saturating concentration of the mGluR agonist
ACPD (33.9 ± 7.2% depression in 50 μM ACPD; 92.2 ± 6.8% recovery in ACPD plus 25
μM LY341495; n = 7-8 neurons; Fig. 5C). However, LY341495 failed to alter baseline
active glutamatergic synapses or presynaptic silencing in response to depolarization (Fig.
5D). These results indicate that antagonism of mGluR activation does not prevent
depolarization-induced presynaptic silencing.
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Figure 5. None of likely candidate GPCRs is necessary for depolarization-induced
silencing. A. Example action potential-evoked IPSCs from a single autaptic neuron after
acutely-applied extracellular saline (control), 10 μM baclofen (a GABAB receptor
agonist), or 10 μM baclofen plus 50 μM SCH50911 (a GABAB receptor antagonist). B.
Summary of experiments measuring vGluT-1/FM1-43FX correspondence in neurons
treated 4 hr with 30 mM NaCl (baseline) or 30 mM KCl (depolarized) in the presence or
absence of 50 μM SCH50911 (n = 35 fields from 7 independent experiments). All
comparisons were significantly different (p < 0.05 with Bonferroni correction for
multiple comparisons) except those indicated (N.S.). C. Example action potential-evoked
EPSCs from a single autaptic neuron after acutely-applied control, 50 μM ACPD (a
mGluR agonist), or 50 μM ACPD plus 25 μM LY341495 (a mGluR antagonist). D.
Summary of experiments measuring vGluT-1/FM1-43FX correspondence in neurons
treated for 4 hr under baseline or depolarized conditions in the presence or absence of 25
μM LY341495 (n = 25 fields from 5 independent experiments). All comparisons were
significantly different (p < 0.05 with Bonferroni correction for multiple comparisons)
except those indicated (N.S.). E. Example action potential-evoked EPSCs from two
different autaptic neurons: one after acutely-applied control or 200 nM WIN55,212-2 (a
CB1 agonist) and the other after 1-2 hr pre-treatment with 1 μM AM251 (a CB1
antagonist), and continued AM251 application or AM251 plus WIN55,212-2. The
AM251 pretreatment with between-cell comparison was used to mitigate against the very
slow reversibility of WIN55,212-2. F. Summary of experiments measuring vGluT1/FM1-43FX correspondence in neurons treated for 4 hr under baseline or depolarized
conditions in the presence or absence of 1 μM AM251 (n = 20 fields from 4 independent
experiments). All comparisons were significantly different (p < 0.05 with Bonferroni
correction for multiple comparisons) except those indicated (N.S.). G. Summary of
experiments measuring vGluT-1/FM1-43FX correspondence in neurons treated for 4 hr
under baseline or depolarized conditions in the presence or absence of 200 nM DPCPX,
50 μM SCH50911, 25 μM LY341495, and 1 μM AM251 (cocktail; n = 20 fields from 4
independent experiments). All comparisons were significantly different (p < 0.05 with
Bonferroni correction for multiple comparisons) except those indicated (N.S.). H.
Summary of experiments measuring EPSC amplitude in neurons treated 4 hr under
baseline or depolarized conditions in the presence of either 1 μM NBQX or 10 μM
NBQX to ensure kainate receptor block (n = 14-16 neurons). Neurons treated for 4 hr
with 1 μM NBQX were treated acutely (~1 min) with 10 μM NBQX prior to recording as
a control for any residual acute NBQX effects. All comparisons were significantly
different (p < 0.05 with Bonferroni correction for multiple comparisons) except those
indicated (N.S.).
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To test G-protein-coupled CB1 cannabinoid receptor involvement, we incubated
mass cultures in 1 μM 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1piperidinyl-1H-pyrazole-3-carboxamide (AM251), a CB1 antagonist, during depolarizing
or control challenge. To ensure that AM251 inhibited CB1 activation, we applied the
CB1 agonist (R)-(+)-WIN55,212-2 (WIN; 200 nM) acutely to autaptic neurons. WIN
acutely depressed PSCs by 34.6 ± 8.6% (Fig. 5E) while pre-incubation in AM251
prevented the WIN-induced depression (101.1 ± 2.5% of baseline; n = 8 neurons per
condition; Fig. 5E). AM251 incubation during the 4 hr depolarization challenge,
however, altered neither the baseline percentage of active glutamatergic synapses nor
depolarization-induced silencing (Fig. 5F). We conclude that CB1 activation does not
participate in depolarization-induced presynaptic silencing.
It is plausible that multiple GPCRs are simultaneously activated by strong
depolarization. If this occurs, then each receptor might contribute individually to a small,
statistically insignificant effect on the percentage of active presynaptic terminals.
Simultaneous activation, however, may synergistically upregulate the activity of
downstream signaling cascades. To test this hypothesis, we incubated mass cultures for 4
hr in a cocktail of GPCR antagonists (200 nM DPCPX, 50 μM SCH50911, 25 μM
LY341495, and 1 μM AM251) to simultaneously block the activation of A1 adenosine
receptors, GABAB receptors, mGluRs, and CB1 receptors. This antagonist cocktail did
not alter the percentage of active glutamatergic presynaptic terminals at baseline (Fig.
5G), indicating that transmitter tone over 4 hr was not sufficient to induce additional
muting. Additionally, this cocktail of GPCR antagonists did not prevent silencing in
response to depolarization (Fig. 5G). Interestingly, we failed to observe the trend-level
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increase in the percentage of active synapses produced in depolarized neurons exposed to
DPCPX (Fig. 4D). This suggests that these four receptor classes, although linked to
inhibitory G-proteins, are not responsible for the induction of depolarization-induced
presynaptic silencing.
Although 1 μM NBQX was present during all depolarization challenges to
prevent ionotropic glutamate receptor activation, kainate receptors may not be blocked at
this concentration (Bureau et al., 1999; Crowder et al., 2002). Kainate receptors can
induce metabotropic effects dependent on G-proteins in addition to their ionotropic
effects (Cunha et al., 1999; Lerma, 2003; Rodriguez-Moreno and Sihra, 2007). To ensure
that kainate receptors and their downstream metabotropic signaling cascades are not
activated during 4 hr depolarization, we co-incubated with 10 μM NBQX, which should
block both kainate receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors (Lauri et al., 2001; Delaney and Jahr, 2002). After a 4 hr depolarizing
or control challenge, we recorded EPSC amplitudes in autaptic neurons. Control cultures
were treated acutely for 1 min with 10 μM NBQX just before recording to account for
any residual effects of the high NBQX concentration on AMPA receptors. The higher
concentration of NBQX did not prevent depolarization-induced silencing and did not
alter the EPSC amplitude compared with control neurons (Fig. 5H). This suggests that
metabotropic effects downstream of kainate receptor activation are unimportant for
depolarization-induced silencing.

A1 receptor activation and GABAB receptor activation induce presynaptic silencing:
It is intriguing that A1 receptor, GABAB receptor, mGluR, CB1, and kainate
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receptor activation are not necessary for induction of presynaptic silencing despite our
evidence that depolarization-induced silencing depends on pertussis toxin-sensitive Gproteins. These results suggest that inhibitory G-proteins are activated during strong
depolarization but not by activation of these particular receptors. To further test our
hypothesis that a G-protein-dependent mechanism, regardless of the source of activation,
controls adaptive presynaptic silencing, we tested whether direct activation of several
GPCR classes induces silencing.
We first determined whether increases in exogenous extracellular adenosine
concentration induce presynaptic silencing. We incubated cultures in the presence of 100
μM adenosine for 4 hr. A high concentration was chosen to counteract any degradation
that may occur from the natural activity of extracellular enzymes or uptake through
transporters (Dunwiddie and Masino, 2001). We used FM1-43FX loading of presynaptic
terminals followed by vGluT-1 immunostaining to determine the percentage of active
glutamatergic terminals. Incubation for 4 hr with 100 μM adenosine decreased the
percentage of active synapses (Fig. 6A, B). To determine if this effect of adenosine
resulted from activation of the A1 receptor, we co-incubated with DPCPX (200 nM).
DPCPX incubation alone did not alter the percentage of active glutamatergic synapses,
but it prevented the adenosine-induced silencing (Fig. 6A, B). This result also serves as
an effective positive control for experiments testing DPCPX effects on depolarizationinduced muting (Fig. 4). Note that FM1-43FX uptake should be immune to the wellknown transient, acute effects of adenosine agonists on pr since agonists and antagonists
were washed out of the cultures before the FM1-43FX challenge (Wu and Saggau, 1994;
Brown and Sihra, 2008). Also, FM1-43FX loading was conducted during 2 min of a
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Figure 6. A1 adenosine receptor activation and GABAB receptor activation induce
presynaptic silencing. A. Example images of vGluT-1 (red) and FM1-43FX (green)
correspondence in neurons treated 4 hr with control or 100 μM adenosine in the presence
or absence of 200 nM DPCPX. Scale bar denotes 5 μM. B. Summary of conditions
represented in A (n = 40 fields from 8 independent experiments). *p < 0.05 with
Bonferroni correction for multiple comparisons. C. Summary of experiments measuring
vGluT-1/FM1-43FX correspondence in neurons treated 4 hr with control medium, with
10 nM CCPA, or with 10 nM CCPA co-applied with 200 nM DPCPX (n = 35 fields from
7 independent experiments). *p < 0.05 with Bonferroni correction for multiple
comparisons. D. Example action potential-evoked EPSCs recorded from autaptic neurons
after acute (< 1 min; control) or 4 hr treatment with 10 nM CCPA. E. Summary of EPSC
amplitudes from autaptic neurons treated acutely (< 1 min; control) or for 4 hr with 50
μM baclofen (n = 9-10 neurons) and FM1-43FX/vGluT-1 correspondence after 4 hr
control or 50 μM baclofen treatment (n = 30 fields from 6 independent experiments). *p
< 0.05.
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strong depolarization designed to empty the entire recycling pool of vesicles regardless of
pr. Thus, these results suggest that extracellular adenosine induces presynaptic silencing
through an A1 receptor-dependent mechanism.
Results with adenosine do not exclude a contribution from A2 or A3 receptors,
although this contribution is presumably minimal because the A1-specific antagonist
DPCPX blocked the silencing. To confirm that A1 receptor activation alone is sufficient
for presynaptic silencing induction, we incubated mass cultures in the presence of the
highly selective A1 receptor agonist CCPA. CCPA (10 nM for 4 hr) decreased the
percentage of active glutamatergic terminals, and the CCPA effect was blocked by coincubation with 200 nM DPCPX (Fig. 6C). We also confirmed that CCPA persistently
depressed presynaptic action potential-driven vesicle release by measuring autaptic EPSC
amplitudes after 4 hr of CCPA incubation. Electrophysiological recordings were
performed in extracellular recording saline in the absence of CCPA, so acute effects are
unlikely. However, to ensure that EPSC depression was not caused by residual acute
effects of CCPA, a high-affinity ligand which might have failed to dissociate from A1
receptors during the media exchange (Lohse et al., 1988), we used neurons from sibling
cultures acutely exposed to 10 nM CCPA (< 1 min) as our control. EPSC amplitudes
were significantly decreased in neurons recorded after 4 hr treatment with CCPA
compared to those treated acutely with CCPA (control: -8.92 ± 1.19 nA; 4 hr CCPA: 2.59 ± 1.10 nA; n = 10; p = 0.001; Fig. 6D). Additionally, we measured paired-pulse
depression in order to assess if lingering CCPA altered vesicle pr. An increased pairedpulse ratio (e.g. a decreased paired-pulse depression) is typically interpreted to reflect
decreased pr, which could be caused by presynaptic GPCR activation (Mennerick and
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Zorumski, 1995; Dobrunz and Stevens, 1997; Zucker and Regehr, 2002; Brown and
Sihra, 2008). The paired-pulse depression in neurons treated acutely with CCPA (23.4 ±
5.5%; n = 10) was not significantly different from the depression in neurons treated for 4
hr (25.8 ± 7.0%; n = 9; p = 0.79; supplemental Fig. 1C). Together, these results suggest a
novel presynaptic muting by prolonged selective activation of A1 adenosine receptors.
Presynaptic silencing outlives agonist exposure and does not result from altered pr.
We next incubated neurons in 50 μM baclofen, the GABAB receptor agonist, for 4
hr before evaluation in baclofen-free solutions. Baclofen, in the absence of any
depolarizing stimulus, persistently depressed autaptic EPSC amplitudes and reduced the
percentage of active glutamatergic presynaptic terminals (Fig. 6E). Baclofen did not,
however, have a persisting effect on the paired-pulse depression (control: 20.8 ± 7.3%;
baclofen: 1.1 ± 7.7%; n = 9; p = 0.08; supplemental Fig. 1D). Additionally, we have
confirmed that the effects of CCPA and baclofen on FM1-43FX/vGluT-1 correspondence
do not result from transient actions of these agonists. We co-applied CCPA and baclofen
for 4 hr and allowed 10 min of recovery in untreated media before FM1-43FX loading.
Neurons treated with CCPA and baclofen maintained a decreased percentage of active
glutamatergic presynaptic terminals after this period of recovery (control + recovery: 79.0
± 4.3%; CCPA/baclofen + recovery: 51.5 ± 4.5%; n = 20 fields from 4 coverslips; p =
0.00009). In contrast, saturating concentrations of neither ACPD nor another mGluR
agonist L-AP4 induced silencing (supplemental Fig. 3A, B). Similarly, CB1 agonist
WIN did not induce silencing at a saturating concentration (supplemental Fig. 3C), and
kainate receptor agonist kainic acid did not produce silencing at concentrations of 1 μM
or 10 μM (supplemental Fig. 3D, E). These results suggest that GPCR-induced silencing
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is induced by only a select group of receptors. The lack of silencing induced by mGluR
and CB1 activation may be caused, for example, by low receptor expression levels in
presynaptic terminals of cultured hippocampal neurons (as suggested by the weak acute
effects of near-saturating agonist concentrations in Figure 5C, E) or by divergent
downstream signaling cascades.

GPCR-induced silencing is proteasome-dependent:
Inhibitory G-protein activation links depolarization-induced silencing and GPCR
agonist-induced silencing, but it is unclear whether GPCR-dependent presynaptic
silencing invokes similar downstream signaling cascades as depolarization-induced
presynaptic silencing. For instance, maximum GPCR agonist-induced silencing tends to
be weaker than depolarization-induced silencing (see Fig. 6C, E), which could hint at
different underlying mechanisms. It was recently shown that depolarization-induced
muting is ultimately dependent on activity of the ubiquitin proteasome system (UPS).
Depolarization-induced presynaptic silencing is prevented by co-incubation with the
proteasome inhibitor MG-132 (Jiang et al., 2010). To test whether GPCR agonistinduced silencing also recruits the UPS, we blocked proteasome activity by 30 min preincubation with MG-132 alone before co-applying MG-132 with GPCR agonists for 4 hr.
To maximize the inhibitory G-protein signal, we co-applied 10 nM CCPA and 50 μM
baclofen to simultaneously activate both A1 receptors and GABAB receptors. This
treatment did not result in more silencing than either agonist alone (compare Fig. 6C, D,
E with Fig. 7) as expected from convergent downstream signaling in the two receptor
systems (Brown and Sihra, 2008). MG-132 and CCPA/baclofen treatment did not alter
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paired-pulse depression in autaptic neurons (control: 21.1 ± 4.0%; MG-132: 24.3 ± 5.7%;
CCPA/baclofen: 22.3 ± 5.8%; CCPA/baclofen + MG-132: 24.7 ± 7.9%; n = 14-15
neurons per condition; p > 0.05; also see supplemental Fig. 1E). To confirm that a pr
change should have been detected by paired-pulse measurements with our protocols and
sample sizes, we tested the effect of acute 10 μM baclofen application on EPSC pairedpulse depression. As expected, paired-pulse modulation was significantly altered by
acute baclofen (3.7 ± 5.2% depression in saline control; 32.3 ± 15.6% facilitation in
baclofen; n = 12; p = 0.04; supplemental Fig. 1F). MG-132 alone did not alter the
baseline EPSC amplitude, but it prevented silencing normally induced by GPCR agonist
application (Fig. 7A, B). This was confirmed with FM1-43FX labeling of presynaptic
terminals. The percentage of active glutamatergic presynaptic terminals was not altered
by MG-132 alone, but co-incubation with GPCR agonists prevented presynaptic silencing
(Fig. 7C, D). These results suggest that GPCR agonist-induced silencing also recruits a
proteasome-dependent mechanism, supporting our hypothesis that persistent GPCRdependent depression utilizes similar signaling cascades as depolarization-induced
silencing. This also supports our model that depolarization-induced silencing occurs
through a calcium-independent inhibitory G-protein-dependent mechanism that
ultimately depends on activation of the UPS.
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Figure 7. GPCR-dependent silencing requires proteasome activity. A. Example
action potential-evoked EPSCs from autaptic neurons treated acutely (< 1 min; control)
or for 4 hr with 10 nM CCPA and 50 μM baclofen with or without 3 μM MG-132. MG132 was added 30 min prior to the start of (and remained during) the 4 hr treatment. B.
Summary of EPSC amplitudes from autaptic neurons treated as in A. *p < 0.05 with
Bonferroni correction for multiple comparisons (n = 15 neurons). C. Example images of
vGluT-1 (red) and FM1-43FX (green) correspondence in neurons treated 4 hr with or
without 10 nM CCPA and 50 μM baclofen in the presence or absence of 3 μM MG-132.
MG-132 was added 30 min prior to the start of the 4 hr treatment. Scale bar denotes 5
μm. D. Summary of experiments measuring vGluT-1/FM1-43FX correspondence in
neurons treated as in C. *p < 0.05 with Bonferroni correction for multiple comparisons (n
= 35 fields from 7 independent experiments).
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Discussion
Adaptive modulation at synapses has been studied extensively, but induction
mechanisms remain unclear (see Pozo and Goda, 2010). We tested whether calcium and
G-protein signaling, two potential upstream regulators of cAMP, are necessary for
presynaptic muting. Surprisingly, depolarization-induced presynaptic silencing is not
dependent on calcium rises from extracellular or intracellular sources. Depolarizationinduced muting is pertussis toxin-sensitive, implicating Gi/o signaling, and prolonged,
direct activation of two classes of Gi/o-linked GPCRs induces silencing, suggesting novel
presynaptic Gi/o-induced modulation. Blocking five receptor classes failed to prevent
depolarization-induced silencing, suggesting that G-protein signaling is activated by a
pathway that remains untested. Furthermore, GPCR-dependent silencing is proteasomedependent, as previously documented for depolarization-induced silencing. Our results
support the model that prolonged depolarization upregulates inhibitory G-protein
signaling, possibly independent of receptor activation, to ultimately degrade vital
regulators of neurotransmission.

Calcium and persistent forms of synaptic plasticity:
Calcium from neither the extracellular space (Fig.1) nor intracellular stores (Fig.
2) is necessary for adaptive presynaptic silencing. This result is surprising because
multiple persistent forms of hippocampal synaptic plasticity depend on calcium
(Dunwiddie et al., 1978; Wigstrom et al., 1979; Lynch et al., 1983; Williams and
Johnston, 1989; Wickens and Abraham, 1991; Mulkey and Malenka, 1992; Xie et al.,
1992; Tzounopoulos et al., 1998; Patenaude et al., 2003; Kellogg et al., 2009). Other
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adaptive forms of plasticity, including synaptic scaling and plasticity of intrinsic
excitability, require changes in intracellular calcium (Thiagarajan et al., 2002; Cudmore
and Turrigiano, 2004; Frank et al., 2006; Ibata et al., 2008; Wu et al., 2008). Although it
is possible that depolarization-induced presynaptic silencing requires postsynaptic
depolarization, our BAPTA-AM experiments exclude an important induction role for any
source of calcium, including presynaptic, postsynaptic, and glial sources. These results
are consistent with our previous finding that calcium-sensitive adenylyl cyclase isoforms
play no role in silencing induction (Moulder et al., 2008).
Depolarization-induced muting is among a few examples of calcium-independent
plasticity. These include short-term, frequency-dependent synaptic depression (Betz,
1970; Stevens and Tsujimoto, 1995; Garcia-Perez et al., 2008), transient modulation by
non-traditional messengers like nitric oxide and steroid hormones (Meffert et al., 1996;
Zadran et al., 2009), and some forms of hippocampal mGluR-dependent long-term
depression (Fitzjohn et al., 2001; Ireland and Abraham, 2009). Because none of these
mechanisms is implicated in presynaptic muting, the silencing described herein appears
to be unique.

Presynaptic inhibition by G-protein activation:
Acute activation of pertussis toxin-sensitive presynaptic and postsynaptic
inhibitory G-proteins induces well-known, rapidly reversible effects on calcium currents
and inwardly rectifying potassium channels (Brown and Sihra, 2008). Although acute
presynaptic depression elicited by Gi/o stimulation persists for at least 4 hr in the
continued presence of agonist (Wetherington and Lambert, 2002a, b), several major
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features distinguish the depolarization-induced and GPCR-induced presynaptic silencing
observed here from this classical presynaptic GPCR-induced depression.
First, acute Gi/o activation causes synaptic depression with rapid onset and rapid
offset upon agonist withdrawal (Brown and Sihra, 2008). Presynaptic muting, in
contrast, requires prolonged stimulation, and recovery requires hours (Moulder et al.,
2004). GPCR agonist-induced silencing failed to recover within 10 min in imaging
experiments and persisted for at least an hour after agonist removal in our
electrophysiology experiments (Fig. 6, 7). Furthermore, only 2 of 5 receptor classes
tested induced presynaptic silencing. It is possible that persistent silencing requires
stronger Gi/o stimulation than acute depression, since CB1 and mGluR stimulation
yielded weak acute depression and no detectable silencing (Fig. 5C, E and supplemental
Fig. 3).
Second, acute depression depends on Gβγ-dependent presynaptic inhibition of
calcium channels to reduce vesicle pr (Brown and Sihra, 2008). Decreases in pr are
reflected as increased paired-pulse ratios (Dobrunz and Stevens, 1997; Zucker and
Regehr, 2002). Depolarization-induced and GPCR-induced muting did not alter pairedpulse ratios (supplemental Fig. 1) and may involve degradation of important presynaptic
proteins through the UPS (Jiang et al., 2010). This is an unusual profile for presynaptic
change and might explain why GPCR-induced silencing has been overlooked. Thus,
persistent GPCR-dependent presynaptic silencing invokes different mechanisms than
acute GPCR-dependent synaptic depression.
Other forms of slowly-induced synaptic depression dependent on GPCRs have
been described in the hippocampus. For example, GPCR activation is necessary for

127

certain forms of long-term depression or depotentiation of long-term potentiation (Oliet
et al., 1997; Palmer et al., 1997; Chevaleyre and Castillo, 2004; Izumi and Zorumski,
2008; Kellogg et al., 2009). Although a presynaptic change has been implicated in some
of these examples, presynaptic muting has not been implicated because these are
calcium-dependent and/or require activation of receptors that we have shown are
unnecessary for depolarization-induced presynaptic silencing.
The finding that prolonged A1 and GABAB receptor activation induces silencing
is reminiscent of evidence for tonic GPCR activation in situ. A1 receptors and GABAB
receptors are constitutively active at low levels under physiological conditions (Canning
and Leung, 2000; Thummler and Dunwiddie, 2000; Jensen et al., 2003; Kukley et al.,
2005; but see Ariwodola and Weiner, 2004). Thus, GPCR-induced silencing may
contribute to basally silent terminals in situ. Evidence for basal GPCR contributions to
presynaptically mute synapses in our cultures was limited (Fig. 5B), possibly because of
much larger dilution of transmitters than occurs in situ. Because evoked accumulation of
adenosine and GABA likely achieves higher local concentrations over more prolonged
periods in intact tissue (Mitchell et al., 1993; Masino and Dunwiddie, 1999; de Groote
and Linthorst, 2007; Ghijsen et al., 2007), GPCR-induced silencing could play a dynamic
role in sculpting the pattern of silent and active terminals.

Relationship between G-proteins and proteasome activity:
Multiple downstream signaling cascades are activated by GPCRs. Our data
implicate that, ultimately, GPCR agonist-induced presynaptic silencing is dependent
upon activity of the UPS since the proteasome inhibitor MG-132 blocked silencing
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induction (Fig. 7). One potential model is that inhibition of adenylyl cyclase by Gproteins decreases cAMP accumulation and associated protein phosphorylation by
protein kinase A. We speculate that phosphorylation may protect key presynaptic
proteins from degradation by the UPS. This view is consistent with evidence that
downregulation of cAMP signaling leads to silencing (Moulder et al., 2008) and that
depolarization-induced silencing is proteasome-dependent (Jiang et al., 2010). In
addition Munc13-1 and Rim1α, presynaptic proteins essential for vesicle priming
(Augustin et al., 1999; Betz et al., 2001; Koushika et al., 2001), are selectively degraded
relative to other presynaptic proteins after stimuli that induce presynaptic silencing (Jiang
et al., 2010). This mirrors work in Drosophila showing that the Munc13 ortholog
Dunc13 is regulated in a G-protein-dependent, cAMP-dependent, and proteasomedependent manner (Aravamudan and Broadie, 2003) as well as work at the calyx of Held
showing that GABAB receptor activation inhibits vesicle recruitment via reduced cAMP
levels (Sakaba and Neher, 2003). Since Rim1α is a protein kinase A and UPS substrate
(Lonart et al., 2003; Yao et al., 2007), phosphorylation-induced Rim1α stability could
link increased cAMP levels to preserved presynaptic function. This speculative scenario
does not preclude the possibility that induction stimuli modulate proteasome activity
directly in a cAMP-independent manner (Jiang et al., 2010). Future work may clarify
whether cAMP-independent G-protein signaling upregulates proteasome activity or
whether depolarization increases proteasome activity by a pathway divorced from Gprotein signaling.

G-protein signaling in depolarization-induced silencing:
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Although depolarization-induced presynaptic silencing requires activation of
inhibitory G-proteins, how G-proteins are activated during prolonged depolarization
remains unclear. We excluded four primary candidate GPCRs as well as metabotropic
actions of kainate receptors (Fig. 4, 5). Depolarization may cause release of a ligand for
Gi/o-linked GPCRs that we did not test. For example, neuromodulatory GPCRs like
dopamine and serotonin receptors are possible candidates (Catapano and Manji, 2007),
but monoaminergic cells are absent from our cultures, making ligand presence extremely
unlikely. Furthermore the calcium independence of presynaptic muting excludes an
important role of synaptic release of these potential mediators. Clearly, if a ligand is
involved in induction of depolarization-induced muting, it is released through a nonclassical mechanism. Alternatively, cell autonomous mechanisms such as voltagesensitive proteins, including inhibitory GPCRs activated directly by voltage, could
mediate silencing induction (Reddy et al., 1995; Ben-Chaim et al., 2006; Parnas and
Parnas, 2007; Okamura et al., 2009). One intriguing possibility is that of receptorindependent activation of G-proteins, for instance through recently-described activators
of G-protein signaling (AGS; Blumer et al., 2007). AGS proteins interact with G-protein
subunits to initiate downstream signaling in the absence of receptor activation. Some
AGS proteins are expressed in hippocampal neurons, but it is unclear how they are
activated (Fang et al., 2000; Blumer et al., 2002; Takahashi et al., 2003).
Although we have learned much about the induction of presynaptic silencing in
excitatory neurons (Tong et al., 1996; Ma et al., 1999; Moulder et al., 2004; Voronin and
Cherubini, 2004; Atasoy and Kavalali, 2006; Moulder et al., 2006; Yao et al., 2006;
Moulder et al., 2008; Jiang et al., 2010), many segments of the signaling cascade have
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remained obscure. We show here that calcium-independent, G-protein-dependent, and
proteasome-dependent mechanisms induce presynaptic muting, suggesting a unique form
of synaptic plasticity. Because adaptive synaptic plasticity may counteract potentially
damaging changes in neuronal activity (Turrigiano and Nelson, 2004), further
clarification of silencing induction pathways may lead to new therapeutic strategies.
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Supplemental Figure 1. Acute, but not prolonged, treatments alter paired-pulse
modulation in excitatory autaptic neurons. A. Left panel: example action-potential
evoked EPSCs with 50 ms interstimulus interval from autaptic neurons treated 24 hr with
or without 500 ng/ml pertussis toxin before 4 hr co-application with 30 mM NaCl
(baseline) or 30 mM KCl (depolarized). Right panel: summary of percentage change in
EPSC amplitude during 50 ms paired-pulse stimulus in neurons treated as described in
the left panel. p = 0.09-1.00 with Bonferroni correction for multiple comparisons (n = 1314). B. Left panel: example action-potential evoked EPSCs with 50 ms interstimulus
interval from autaptic neurons treated 4 hr with 30 mM NaCl (baseline) or 30 mM KCl
(depolarized) in the presence or absence of 200 nM DPCPX. Right panel: summary of
percentage change in EPSC amplitude during 50 ms paired-pulse stimulus in neurons
treated as described in the left panel. p = 0.59-1.00 with Bonferroni correction for
multiple comparisons (n = 9). C. Left panel: example action-potential evoked EPSCs
with 50 ms interstimulus interval from autaptic neurons treated either acutely (< 1 min;
control) or for 4 hr with 10 nM CCPA. Right panel: summary of percentage change in
EPSC amplitude during 50 ms paired-pulse stimulus in neurons treated as described in
the left panel. p = 0.79 (n = 9-10). D. Left panel: example action-potential evoked EPSCs
with 50 ms interstimulus interval from autaptic neurons treated either acutely (< 1 min;
control) or for 4 hr with 50 μM baclofen. Right panel: summary of percentage change in
EPSC amplitude during 50 ms paired-pulse stimulus in neurons treated as described in
the left panel. p = 0.08 (n = 9). E. Left panel: example action-potential evoked EPSCs
with 50 ms interstimulus interval from autaptic neurons treated acutely (< 1 min; control)
or for 4 hr with 10 nM CCPA and 50 μM baclofen with or without 3 μM MG-132. MG132 was added 30 min prior to the start of (and remained during) the 4 hr treatment. Right
panel: summary of percentage change in EPSC amplitude during 50 ms paired-pulse
stimulus in neurons treated as described in the left panel. p = 0.66-0.97 without correction
for multiple comparisons (n = 14-15). F. Left panel: example action-potential evoked
EPSCs with 50 ms interstimulus interval from autaptic neurons treated acutely with
locally perfused saline control or 10 μM baclofen. Right panel: summary of percentage
change in EPSC amplitude during 50 ms paired-pulse stimulus in neurons treated as
described in the left panel. *p = 0.04 (n = 12).
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Supplemental Figure 2. Blocking GABAA receptors does not prevent depolarizationinduced silencing. A. Summary of experiments measuring vGluT-1/FM1-43FX
correspondence in neurons treated 4 hr with 30 mM NaCl (baseline) or 30 mM KCl
(depolarized) in the presence or absence of 50 μM bicuculline, a GABAA receptor
antagonist. *p < 0.05 with Bonferroni correction for multiple comparisons (n = 25 fields
from 5 independent experiments). B. Summary of experiments measuring vGluT-1/FM143FX correspondence in neurons treated 4 hr with 30 mM NaCl (baseline) or 30 mM KCl
(depolarized) in the presence or absence of 100 μM picrotoxin, another GABAA receptor
antagonist. *p < 0.05 with Bonferroni correction for multiple comparisons (n = 30 fields
from 6 independent experiments).

143

Supplemental Figure 3. mGluR, CB1, and kainate receptor agonists do not induce
silencing. A. Summary of experiments measuring vGluT-1/FM1-43FX correspondence
in neurons treated 4 hr with or without 200 μM ACPD (mGluR agonist; n = 30 fields
from 6 coverslips; p = 0.81). B. Summary of experiments measuring vGluT-1/FM1-43FX
correspondence in neurons treated 4 hr with or without 10 μM L-AP4 (mGluR agonist; n
= 15 fields from 3 coverslips; p = 0.69). C. Summary of experiments measuring vGluT1/FM1-43FX correspondence in neurons treated 4 hr with or without 1 μM WIN55,212-2
(CB1 agonist; n = 40 fields from 8 coverslips; p = 0.54). D. Summary of experiments
measuring EPSC amplitude in neurons treated 4 hr with or without 1 μM kainic acid
(KA; kainate receptor agonist; n = 12 neurons; p = 0.82). E. Summary of experiments
measuring EPSC amplitude in neurons treated 4 hr with or without 10 μM kainic acid (n
= 11 neurons; p = 0.47).
144

Chapter 4
Astrocyte-derived thrombospondins mediate the
development of hippocampal presynaptic
plasticity

This chapter contains a manuscript submitted for publication:
Crawford DC, Jiang X, Taylor A, Mennerick S. Astrocyte-derived thrombospondins
mediate the development of hippocampal presynaptic plasticity. [submitted]

Author contributions for the citation above:
D.C.C. designed and performed experiments, analyzed data, and wrote the paper. S.M.
designed experiments, performed experiments for Figure 3, analyzed data, and wrote the
paper. X.J. performed microscopy experiments and analyzed data. A.T. analyzed data.

145

Abstract
Astrocytes contribute to many neuronal functions, including synaptogenesis, but
their role in the development of synaptic plasticity remains unclear. Presynaptic muting
of hippocampal glutamatergic terminals defends against excitotoxicity and has been
demonstrated at diverse synaptic terminals. Here we studied the role of astrocytes in the
development of presynaptic muting at glutamatergic hippocampal synapses. We found
that astrocytes were critical for the development of depolarization-dependent and Gi/odependent presynaptic muting. The ability of cAMP analogues to modulate presynaptic
function was also impaired by astrocyte deficiency. Although astrocyte deprivation
resulted in postsynaptic glutamate receptor deficits, this effect appeared independent of
astrocytes’ role in presynaptic muting. Muting was restored with chronic but not acute
treatment with astrocyte-conditioned medium, indicating that a soluble factor is
permissive for muting. Astrocyte-derived thrombospondins (TSPs) are likely
responsible because TSP1 mimicked the effect of conditioned medium, and gabapentin, a
high-affinity antagonist of TSP binding to the α2δ-1 calcium channel subunit, mimicked
astrocyte deprivation. We found evidence that PKA activity is abnormal in astrocytedeprived neurons but restored by TSP1, so PKA dysfunction may provide a mechanism
by which muting is disrupted during astrocyte deficiency. In summary our results
suggest an important role for astrocyte-derived TSPs, acting through α2δ-1, in maturation
of a potentially important form of presynaptic plasticity.
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Introduction
Correct development and plasticity of glutamate synapses is critical to brain
function. For example, imbalances between excitatory glutamate and inhibitory GABA
actions are postulated to underlie brain disturbances as diverse as schizophrenia (Lewis
and Moghaddam, 2006), developmental disability (Wetmore and Garner, 2010), and
epilepsy (McCormick and Contreras, 2001). Diverse cues regulate proper synaptic
development. Neuron-to-neuron signaling is clearly important for synaptogenesis (Craig
et al., 2006), but astrocytic factors are also important (Eroglu and Barres, 2010; Pfrieger,
2010). Still unclear is the breadth of astrocyte involvement in synapse development and
the signaling systems affected. Astrocytic cues can affect postsynaptic function,
presynaptic function, synaptic plasticity, or combinations of these elements.
Our group and others have studied a form of adaptive presynaptic plasticity
termed muting whereby the number of terminals releasing transmitter is reduced. Mute
presynaptic terminals have been studied in a variety of preparations (Tong et al., 1996;
Bolshakov et al., 1997; Kannenberg et al., 1999; Ma et al., 1999; Kim et al., 2003;
Losonczy et al., 2004; Moulder et al., 2004; Cousin and Evans, 2011; Crawford and
Mennerick, 2012). Reversible presynaptic muting of hippocampal glutamatergic
synapses occurs in cultured autaptic neurons, conventional mass cultures, and acute
hippocampal slices (Moulder et al., 2004; Crawford et al., 2011). Muting is induced by
electrical stimulation, depolarization challenges, prolonged Gi/o G-protein activation, and
hypoxic environmental exposures (Moulder et al., 2004; Moulder et al., 2006; Moulder et
al., 2008; Crawford et al., 2011; Hogins et al., 2011; Crawford and Mennerick, 2012).
Presynaptic muting may play a role in defending against excitotoxic glutamate release
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(Hogins et al., 2011), but it is also engaged by physiological changes in activity (Moulder
et al., 2006). Despite the wide variety of preparations and conditions under which muting
occurs (Crawford and Mennerick, 2012), factors controlling development of muting have
not been explored.
Muting occurs in single-neuron networks in culture, but because these neurons
contact astrocytes it is unclear whether muting is cell autonomous or whether astrocyte
signals modulate or induce muting. Here we explored muting mechanisms in a
reductionist environment where astrocyte numbers could be reduced. We found that
global, permissive astrocytic signaling rather than local, instructive astrocytic signaling is
important for the development of muting. Astrocyte deprivation prevented muting in
response to both depolarization and G-protein-coupled receptor stimulation. Chronic, but
not acute, treatment with astrocyte-conditioned medium rescued muting.
Thrombospondin (TSP), an astrocyte-derived glycoprotein previously implicated in
glutamate synapse development (Asch et al., 1986; Christopherson et al., 2005; Eroglu et
al., 2009; Xu et al., 2010), also rescued muting. Gabapentin, an antagonist of the TSP
receptor α2δ-1 (Gee et al., 1996; Eroglu et al., 2009), mimicked the effects of astrocyte
deprivation by preventing muting competence. Gabapentin additionally prevented
adaptive network plasticity. Although the downstream pathways initiated by TSP
binding to α2δ-1 remain unclear, astrocyte deprivation led to altered PKA activity, as
suggested by abnormal responses to cAMP analogues and over-phosphorylation of PKA
substrates. TSP treatment corrected these abnormalities. Our results suggest that
astrocyte-derived TSPs are important developmental modulators of presynaptic plasticity.
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Materials and Methods

Primary Hippocampal Cultures:
All experiments were performed in accordance with National Institutes of Health
guidelines and were approved by the Washington University Animal Studies Committee.
For microcultures, culture dishes (35 mm) were first covered with a thin layer of 0.15%
agarose and then stamped with 150-200 μm diameter microdots of 0.5 mg/ml collagen
using a polydimethylsiloxane microstamp as previously described (Moulder et al., 2007).
Cortical astrocytes from postnatal d 4 male and female rat pups were seeded on these
islands in Eagle’s medium (Life Technologies) supplemented with 5% heat-inactivated
horse serum, 5% fetal bovine serum, 17 mM D-glucose, 400 μM glutamine, 50 U/ml
penicillin, and 50 μg/ml streptomycin. Glial preplates were maintained in a humidified
and atmospherically controlled incubator (5% CO2/95% air at 37°C) prior to neuronal
plating. Astrocyte-poor cultures were prepared 7-10 d after plating by fixation with 4%
paraformaldehyde/0.2% glutaraldehyde in phosphate-buffered saline (PBS) at room
temperature (RT) for 5 min prior to at least 3 washes in PBS. Alternatively, 70% ethanol
at -20ºC was applied for 30 min prior to PBS rinses. Although most experiments used
aldehyde fixation, both astrocyte fixation protocols produced the finding shown in Figure
1B. For mass cultures used in Figure 5, a confluent layer of polylysine/laminin was
applied to the culture dish prior to neuronal plating.
Hippocampal neurons were dispersed on fixed or live astrocyte beds for
microcultures while astrocytes and neurons were co-plated for mass cultures as
previously described (Mennerick et al., 1995). Briefly, male and female postnatal d 0-3
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Sprague Dawley rat hippocampi were dissected, incubated with 1 mg/ml papain, and
mechanically dissociated. To encourage the formation of autaptic (solitary) neurons in
microcultures, cells were plated at low density (~100 cells/mm2). For mass cultures, cells
were plated at high density (~650 cells/mm2) to encourage neuron-astrocyte co-cultures
to form. After 3-4 d, 6.7 μM cytosine arabinoside was added to inhibit cell division. One
half of the culture medium was exchanged with Neurobasal medium (Life Technologies)
plus B27 supplement at DIV 4-5. Conditioned media were from astrocyte cultures or
from neuron-astrocyte co-cultures; similar results were obtained with both. Nonconditioned medium was fresh Neurobasal without supplements. Unless otherwise
stated, all experiments were performed at 10-14 DIV, and controls were sibling cultures
used the same day.

Electrophysiology:
Whole-cell voltage-clamp recordings were performed on autaptic neurons in
microisland culture unless otherwise stated. Data were collected using pClamp 9
software with a Multiclamp 700B or Axopatch 200B amplifier and Digidata1322A data
acquisition board (Molecular Devices). Recording saline typically contained 138 mM
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES, and 25
μM D-APV (Tocris Bioscience) at a pH of 7.25. For experiments requiring NMDA
receptor activation, 10 μM glycine (Tocris Bioscience) was added to the saline solution
and MgCl2 was excluded. Pipette solution contained 140 mM potassium gluconate, 4
mM NaCl, 0.5 mM, 0.5 mM CaCl2, 5 mM EGTA, and 10 mM HEPES at a pH of 7.25.
For experiments in which both excitatory and inhibitory postsynaptic currents (EPSCs
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and IPSCs) were collected during the same recording session from autaptic neurons,
potassium gluconate was replaced with 140 mM KCl. For network activity experiments
measuring spontaneous EPSCs and IPSCs in mass cultures, 130 mM cesium
methanesulfonate replaced potassium gluconate.
Recordings were performed at room temperature. Electrode pipettes were pulled
from borosilicate glass (World Precision Instruments) and had 3-6 MΩ resistance.
Access resistance was compensated 85-100%, and membrane potential was typically held
at -70 mV. For network activity experiments in mass cultures, neurons were voltageclamped at -30 mV or -35 mV, midway between IPSC and EPSC reversal potentials,
without compensation to measure spontaneous network activity due to excitation and
inhibition simultaneously. Input resistance (astrocyte-rich: 189.3 ± 39.3 MΩ; astrocytepoor: 212.4 ± 76.3 MΩ; n=11-12 neurons; p=0.77, Student’s unpaired t test) and cell
capacitance (astrocyte-rich: 73.3 ± 7.3 pF; astrocyte-poor: 94.0 ± 10.3 pF; n=14-16
neurons; p=0.11, Student’s unpaired t test) were similar in neurons from astrocyte-poor
cultures compared with sibling astrocyte-rich cultures. Autaptic EPSCs and IPSCs were
evoked by a 1.5 ms pulse depolarization to 0 mV. Paired-pulse responses were obtained
by evoking two such depolarizing pulses 50 ms apart. Signals were sampled at 10 kHz
and low-pass filtered at 4 kHz, except for miniature EPSCs collected at 5 kHz and filtered
at 1 kHz and spontaneous EPSCs and IPSCs collected at 5 kHz and filtered at 2 kHz.
Autaptic EPSCs were recorded up to 1 h after switch to recording saline. When solutions
were applied acutely to neurons, a multibarrel perfusion system was used with a common
port placed within 0.5 mm of the neuron; solution exchange times were ~100 ms.
Glutamate receptor blockers (50 μM D-APV and 1 μM NBQX) were present
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during all depolarization challenges (30 mM KCl for depolarization or NaCl as a nondepolarized osmotic control) to prevent toxicity and NMDA receptor-dependent
plasticity. Control treatments for all other experiments consisted of vehicle treatment
unless otherwise specified.

Immunostaining and Microscopy:
FM1-43 dye labeling was performed as previously described (Moulder et al.,
2010). Briefly, microisland cultures were treated for 2 min with 10 μM fixable FM1-43
(FM1-43FX; Life Technologies) in recording saline supplemented with 45 mM KCl and
1 μM NBQX. Immediately following, the culture dishes were briefly washed (5s) in
saline supplemented with 500 μM Advasep-7 (CyDex) and 1 μM NBQX. Cells rested
during 10 min of washes with saline plus 1 μM NBQX and were then fixed for 10 min.
Fixation prior to immunostaining was 4% paraformaldehyde at RT, 4%
paraformaldehyde/0.2% glutaraldehyde at RT, 4% paraformaldehyde/0.02%
glutaraldehyde at RT, or 100% methanol at -20 ºC. All culture dishes were washed with
PBS at RT followed by 2% normal goat serum in PBS blocking solution plus 0.1% or
0.04% Triton X-100. Primary antibodies were vesicular glutamate transporter 1 (vGluT1; 1:2000; Millipore), MAP2 (1:2000; Millipore), phospho-synapsin (1:400; Millipore),
synapsin (1:2000; Millipore), phospho-cAMP response element binding protein
(phospho-CREB; 1:400; Millipore), γ-aminobutyric acid (GABA; 1:500), and phosphodynamin 1 (1:100; Santa Cruz Biotechnology). Primary antibodies were applied for 2-3 h
at RT before PBS wash, 30-40 min secondary antibody incubation with Alexa Fluor
conjugates (Life Technologies), and glass coverslipping with Fluoromount G (Southern
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Biotechnology Associates).
FM1-43FX and immunostaining images were acquired on an inverted Eclipse
TE2000-S microscope with a 60X objective (1.4 numerical aperture) using a C1 scanning
confocal laser (488, 543, and/or 633 nm) and EZ-C1 software (Nikon). Alternating laser
lines were used to obtain z-stack images while all gain and acquisition settings were held
constant within a given experiment. Two-dimensional projected images were created and
analyzed using MetaMorph 7 software (Universal Imaging).
Live cell images were obtained on an Eclipse TE2000-S inverted microscope
(Nikon) with a 40X objective (0.6 numerical aperture; Nikon) and a metal halide lamp.
Images were acquired with MetaMorph 7 software and a cooled 12-bit CCD camera
(Photometrics).

Data Analysis:
Data were analyzed and graphed using MetaMorph 7, Clampfit 9 (Molecular
Devices), Mini Analysis 6 (Synaptosoft Inc.), Excel 2007 (Microsoft), and/or SigmaPlot
10 (Systat) software. Unless otherwise stated, data are displayed as mean ± SEM, and
Student’s unpaired t test was used to compare 2 groups while a Bonferroni correction was
applied when experiments contained more than 2 groups. A corrected p value of < 0.05
was required to reach significance. The reported n refers to the sample size of each group
within an experiment.
At least 3 EPSC amplitudes were averaged for each autaptic neuron. For each
recording day, responses from experimental treatments were normalized to the average
response in the control-treated sibling culture. For dual-component autaptic EPSCs, peak
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EPSC amplitude estimated the AMPA receptor component while the average current 80100 ms following the peak estimated the NMDA receptor component (Hestrin et al.,
1990). Miniature EPSCs were elicited by perfusion of 100 mM sucrose and analyzed
using Mini Analysis software with manual confirmation. The first 57 miniature EPSC
inter-event interval and amplitude values were used for Kolmorgorov-Smirnov tests
while values for all miniature EPSCs from a given neuron were averaged for MannWhitney U tests.
At least 10 fields per culture dish were used to calculate the percentage of live
(calcein-positive) islands. For the percentage of FM1-43-positive vGluT-1 synapses,
regions of interest were manually drawn around 10 vGluT-1 puncta per field for 5 fields
per culture dish. As previously described (Crawford et al., 2011), FM1-43 images were
thresholded before analyzing vGluT-1-defined regions, and synapses were considered
active if at least 10 pixels reached threshold. Similarly, 10 vGluT-1-defined regions were
manually drawn per field before analyzing synapsin and phospho-synapsin images. The
number and intensity of vGluT-1-positive synapses in autaptic neurons was quantified via
automatic detection in thresholded images using MetaMorph 7 software. Most
immunostaining experiments used glutamatergic autaptic neurons, identified by vGluT-1
immunoreactivity. Glutamatergic neurons on multi-cell islands were analyzed for
nuclear phospho-CREB experiments, however, and antibody incompatibility precluded
double labeling in phospho-dynamin 1 experiments. For display in figures, all images
within a panel were pseudocolored and adjusted for brightness and contrast equivalently.
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Materials:
Rp-cAMPS and 2-chloro-N6-cyclopentyladenosine (CCPA) were obtained from
Tocris Bioscience, kainic acid was purchased from BioVectra, calcein-AM was
purchased from AnaSpec, Inc., human recombinant thrombospondin 1 (TSP1) was
obtained from Haematologic Technologies, Inc., and tumor necrosis factor alpha (TNFα)
was obtained from EMD4 Biosciences. All other materials were obtained from SigmaAldrich unless otherwise specified.

155

Results
We reduced glial signaling in rat hippocampal cultures by growing neurons on
fixed or live astrocyte beds (Fig. 1A). This strategy permitted identical culture conditions
for astrocyte-rich and astrocyte-poor cultures, except for the number of viable astrocytes.
It also allowed control neurons the full benefit of local and global astrocytic cues, unlike
preparations where control neurons only receive soluble astrocytic signals (Kaech and
Banker, 2006). EPSCs from day in vitro (DIV) 10-14 autaptic neurons in astrocyte-rich
microcultures were persistently depressed with as little as 60 min depolarization, as
assessed up to 1 h following the removal of depolarization (Fig. 1B and 1C), while 30
minutes of depolarization yielded insignificant muting (p=0.45). We have shown
previously that this depolarization-induced depression is selective for glutamate synapses
and arises from muting in the absence of synapse loss or postsynaptic receptor changes
(Moulder et al., 2004; Moulder et al., 2006). By contrast, neurons in astrocyte-poor
cultures exhibited no EPSC depression with up to 4 h depolarization, which produced
strong muting in astrocyte-rich cultures (Fig. 1B and 1C). Muting, therefore, is impaired
in astrocyte-poor cultures.
To evaluate whether astrocyte-deprived neurons simply failed to depolarize
properly, and to test an alternative method of muting induction, we incubated cells in
Gi/o-coupled receptor agonists CCPA (an A1 adenosine receptor agonist) and baclofen (a
GABAB receptor agonist) or in cAMP-activated protein kinase A (PKA) antagonist RpcAMPS, both of which have been shown to induce presynaptic muting (Moulder et al.,
2008; Crawford et al., 2011). These agents depressed EPSCs in astrocyte-rich cultures,
as expected, but significantly increased EPSC amplitudes in astrocyte-poor cultures (Fig.
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Figure 1. Astrocyte deprivation impairs presynaptic muting but not G-protein
activation. A. Phase-contrast and fluorescence images of autaptic neurons on viable
(control) or non-viable (4% paraformaldehyde/0.2% glutaraldehyde-fixed) glial “islands”
acquired 30 min after 5 μg/ml calcein-AM treatment. Fewer islands contained live
(calcein-positive) astrocytes in fixed cultures (control: 98.8 ± 0.9% live islands; fixed:
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17.6 ± 2.8% live islands; n=6 dishes; p=7.9 x 10-11, Student’s unpaired t test). Scale bar
represents 40 μm. B. Representative autaptic EPSCs from astrocyte-rich or astrocyte-poor
microcultures recorded in normal saline up to 1 h after 4 h control (30 mM NaCl) or
depolarization (30 mM KCl). C. Summary EPSCs from DIV 10-14 astrocyte-rich (+) or
astrocyte-poor (-) autaptic neurons after indicated treatment times with 30 mM KCl
(black bars), 10 nM CCPA (A1 adenosine receptor agonist) plus 50 μM baclofen
(GABAB receptor agonist) (C+B; yellow bars), or 50 μM Rp-cAMPS (Rp; cyan bars).
EPSCs were normalized to the average EPSCs from control-treated sibling neurons for
each recording day (n=14-22 neurons; *p<0.05 vs. treatment controls, Student’s unpaired
t test). D. Left: EPSCs from astrocyte-rich or astrocyte-poor cultures after acute perfusion
with recording saline (control) or 20 μM baclofen. Right: summary of EPSC depression
from acute perfusion of baclofen (n=11 neurons; p=0.14, Student’s unpaired t test). E.
Left: EPSCs from astrocyte-rich or astrocyte-poor cultures after acute perfusion with
recording saline (control) or 10 nM CCPA. Right: summary of EPSC depression from
acute perfusion of CCPA (n=11 neurons; p=0.08, Student’s unpaired t test). The same
neurons were used for panel D and panel E experiments, using an interleaved protocol
between saline and agonist-containing solutions.
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1C). This unexpected reversal of EPSC depression indicated an abnormality in muting
induction. Meanwhile, canonical acute presynaptic depression, mediated by Gβγ subunit
signaling (Brown and Sihra, 2008), did not differ in astrocyte-poor cultures (Fig. 1D and
1E). Therefore, the muting deficit in astrocyte-deprived neurons is likely downstream of
depolarization and Gαi/o subunit-mediated cAMP signaling.
Basal EPSC amplitude was smaller in astrocyte-deprived cultures than in
astrocyte-rich cultures (astrocyte-rich: -18.3 ± 5.7 nA; astrocyte-poor: -5.0 ± 1.4 nA;
n=15-16; p=0.037, Student’s unpaired t test); however, IPSCs were similar (astrocyterich: -7.6 ± 2.5 nA; astrocyte-poor: -8.7 ± 1.9 nA; n=14 neurons; p=0.74, Student’s
unpaired t test), suggesting that the basal deficit in amplitude in astrocyte-poor cultures
localized specifically to glutamatergic synapses. The decreased amplitude was not
explained by differences in local astrocytic signaling because neurons in astrocytedeprived cultures on an island containing one of the few contaminating live astrocytes did
not have larger EPSCs than neurons associated with non-viable islands, as assessed by a
vital stain (Fig. 2A). A global deficit in astrocyte-poor cultures, therefore, likely explains
the basal EPSC depression.
Decreased functionally active presynaptic terminals did not explain the basal
EPSC depression or the deficient stimulus-induced muting in astrocyte-poor cultures.
The percentage of basally mute terminals, as measured via absence of stimulus-induced
FM1-43FX dye labeling of vesicles at vGluT-1-immunoreactive synapses, was similar in
astrocyte-rich and astrocyte-poor cultures (Fig. 2B). Furthermore, neither the number nor
the intensity of vGluT-1 puncta per cell differed, suggesting normal synapse and vesicle
numbers (Fig. 2C). Paired-pulse EPSC depression was also normal, suggesting similar
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Figure 2. Astrocyte deprivation does not impair basal presynaptic function. A.
EPSCs from autaptic neurons in astrocyte-poor cultures from islands with residual live
astrocytes (calcein-positive) or no live astrocytes (calcein-negative). The few local
astrocytes in astrocyte-poor cultures did not significantly affect EPSC amplitude (n=1316 neurons; p=0.13, Student’s unpaired t test). B. Left: images of 10 μM FM1-43FX
labeling of presynaptic terminals (green) after 2 min 45 mM KCl and subsequent vGluT1 immunostaining (magenta) in autaptic neurons from astrocyte-rich and astrocyte-poor
cultures (30 min -20ºC 70% EtOH-fixed astrocytes). Scale bar represents 5 μm. Right:
quantification of the percentage of active synapses, as defined by FM1-43 co-localization
with vGluT-1 (n=8 dishes; p=0.44, Student’s unpaired t test). C. Left: vGluT-1 (magenta)
and MAP2 (cyan) immunostaining in autaptic neurons showing similar density and
intensity of presynaptic terminals. Scale bar represents 20 μm. Right: summary of vGluT1 puncta per autaptic neuron (n=35 neurons; p=0.74, Student’s unpaired t test) and
vGluT-1 integrated fluorescence intensity (n=35 neurons; p=0.80, Student’s unpaired t
test).
160

vesicle release probability (astrocyte-rich: 5.1 ± 9.2%; astrocyte-poor: 18.2 ± 8.6%;
n=15-16; p=0.3, Student’s unpaired t test). No deficits in presynaptic function, therefore,
were detected with reduced astrocytic signaling.
A postsynaptic deficit, rather, appeared to explain the basal EPSC depression in
astrocyte-poor cultures. AMPA receptor and NMDA receptor components of EPSCs
were reduced in parallel (Fig. 3A), and this parallel depression was associated with
decreased responsiveness to exogenously applied selective agonists for both receptor
types (Fig. 3B). Additionally, miniature EPSC (mEPSC) amplitude was reduced (Fig.
3C), further suggesting that postsynaptic receptor levels are decreased in astrocyte-poor
cultures. Frequency of mEPSCs also trended toward reduction (Fig. 3C), but it was
unclear whether this resulted from an undetected presynaptic change or whether the
smallest mEPSCs fell below the detection threshold. To ask whether the decreased basal
EPSC amplitude contributed to the muting deficit in astrocyte-poor cultures, we
attempted to induce muting in young (DIV 7-8), astrocyte-rich cultures. Despite smaller
basal EPSC amplitudes similar to those found in DIV 10-14 astrocyte-poor cultures (3.75 ± 0.95 nA; n=17), these younger neurons in astrocyte-rich cultures expressed muting
in response to a 4 h depolarization challenge (Fig. 4A and 4E). Conversely, older (DIV
21), astrocyte-poor cultures with larger basal EPSC amplitudes (-10.27 ± 4.02 nA; n=12)
did not exhibit muting (Fig. 4E). Together with prior published studies suggesting that
postsynaptic glutamate receptor function is not required for muting induction (Moulder et
al., 2004; Moulder et al., 2006), these data suggest that the postsynaptic changes caused
by astrocyte deficiency do not explain the muting deficits. Because glial modulation of
glutamate receptor levels and function has been studied previously (Beattie et al., 2002;
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Figure 3. Glutamate receptor levels are decreased in astrocyte-poor cultures. A.
Left: Representative dual-component (NMDA and AMPA receptor-mediated) EPSCs
elicited in autaptic neurons from astrocyte-rich or astrocyte-poor cultures. Right:
quantification of the ratio of the NMDA to AMPA receptor component of EPSCs (n=1415 neurons; p=0.34, Student’s unpaired t test). B. Top traces: currents from autaptic
neurons in astrocyte-rich or astrocyte-poor cultures in response to acute kainic acid (KA)
perfusion, a non-desensitizing AMPA receptor agonist. Bottom traces: currents from
autaptic neurons in astrocyte-rich or astrocyte-poor cultures in response to acute NMDA
perfusion to selectively activate NMDA receptors. Right: quantification of the current
density in response to KA (n=14-15 neurons; p=0.004, Student’s unpaired t test) or of the
ratio of the NMDA response to the KA response (n=14-15 neurons; p=0.16, Student’s
unpaired t test). Although the overall response to receptor activation was depressed in
astrocyte-poor cultures, NMDA to AMPA receptor current ratios did not differ
significantly. C. Left: representative miniature EPSCs from astrocyte-rich or astrocytepoor cultures elicited by acute perfusion of 100 mM sucrose. Right: cumulative
probability plots of inter-event interval (p<0.001 with D=0.3860) and amplitude (p<0.001
with D=0.2175) of miniature EPSCs from 10 astrocyte-rich and 10 astrocyte-poor
neurons (Kolmogorov-Smirnov test). Insets: average ± SEM miniature EPSC inter-event
interval (n=10 neurons; p>0.05, Mann-Whitney U test) and amplitude (n=10 neurons;
p<0.01, Mann-Whitney U test).
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Stellwagen and Malenka, 2006; Perea et al., 2009; Sullivan et al., 2011), we did not
further characterize the mechanisms responsible for this postsynaptic deficit in astrocytepoor cultures.
Astrocytes could directly instruct muting during depolarization (e.g. through
gliotransmission), or they could permit development of muting competence (e.g. through
global cues). In support of the latter, conditioned medium from mature, live-astrocyte
cultures added to astrocyte-poor cultures at DIV 7 rescued muting, even when
conditioned medium was replaced with fresh medium during the depolarization challenge
(Fig. 4B and 4E). Conditioned medium was ineffective if applied only during the muting
induction protocol (Fig. 4C and 4E). Thus, glial factors are not released instructively
during muting induction and are, instead, released permissively during synapse
development. Because older (DIV 21), astrocyte-poor cultures failed to express muting
(Fig. 4E), it is unlikely that muting competence is delayed in the absence of astrocytes.
Rather, it appears that astrocytes provide a fundamental developmental cue that permits
muting competence.
We hypothesized that astrocytes release a permissive substance for muting
development rather than remove a non-permissive factor. We tested effects of adding
human thrombospondin 1 (TSP1; 5 μg/ml) to astrocyte-poor cultures because astrocytederived TSPs foster presynaptic maturation via binding to the neuronal α2δ-1 subunit of
voltage-gated calcium channels or to neuroligin 1 (Eroglu et al., 2009; Xu et al., 2010).
Incubation in human TSP1 starting at DIV 7 rescued presynaptic muting competence in
astrocyte-poor cultures (Fig. 4D and 4E). In contrast, tumor necrosis factor alpha (TNFα;
1 ng/ml), an astrocyte-derived factor involved in postsynaptic plasticity (Beattie et al.,
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Figure 4. Soluble, astrocyte-derived thrombospondin rescues presynaptic muting
competence. A-D. Representative DIV 7-12 autaptic EPSCs after 4 h control (30 mM
NaCl) or depolarization (30 mM KCl). Cultures were (A) astrocyte-rich and challenged
at DIV 7 without additional treatments, (B) astrocyte-poor and treated with astrocyteconditioned medium (CM) at DIV 7 and challenged at DIV 10-12, (C) astrocyte-poor and
challenged at DIV 10-12 in CM, or (D) astrocyte-poor and treated with 5 μg/ml human
thrombospondin 1 (TSP) at DIV 7 and challenged at DIV 10-12. E. Summary of EPSCs
after 4 h 30 mM KCl or 50 μM Rp-cAMPS (Rp) with indicated pretreatments and/or cotreatments (n=12-20 neurons; *p<0.05 vs. treatment controls, Student’s unpaired t test).
EPSCs were normalized as in Figure 1C. Abbreviations: astrocyte-rich cultures (+),
astrocyte-poor cultures (-), 1 ng/ml tumor necrosis factor alpha (TNFα), 32 μM
gabapentin (GBP), and fresh, non-conditioned medium (FM).
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2002; Stellwagen and Malenka, 2006), did not rescue muting in astrocyte-poor cultures
(Fig. 4E). These data suggest that TSP1 is capable of promoting muting competence but
do not clarify whether TSPs are the endogenous astrocytic factors responsible.
To test for the receptor through which TSP1 promotes muting, we blocked TSP
binding to the candidate receptor α2δ-1 using gabapentin, a clinically used drug for the
treatment of neuropathic pain and epilepsy. Gabapentin interferes with TSP binding to
α2δ-1 and prevents TSP’s synaptogenic effects in retinal ganglion neurons (Gee et al.,
1996; Eroglu et al., 2009). In astrocyte-poor cultures, gabapentin (32 μM) abolished
conditioned medium rescue of depolarization-induced muting (Fig. 4E), suggesting that
TSPs are likely the astrocyte-derived regulators of muting competence. We also
evaluated the effect of gabapentin in live-astrocyte cultures, where ongoing production of
astrocytic TSPs was an additional consideration. In these cultures, a single treatment
with gabapentin at DIV 7 was ineffective in preventing silencing, as assessed at DIV 1012 (Fig. 5A and 5C); however, 3-5 d maintenance of gabapentin by partial medium
exchange in astrocyte-rich cultures eliminated depolarization-induced muting (Fig. 5B
and 5C). These results suggest that gabapentin also blocks endogenously-released factors
important for muting when the ongoing production of the factors is taken into account.
To test whether use of this drug to block endogenous TSP could have implications
for neural network function, we measured spontaneous network activity after muting
induction in control- and gabapentin-treated cultures. These astrocyte-rich, conventional
mass cultures exhibited decreased spontaneous activity after muting induction (Fig. 5D
and 5E), consistent with an adaptive role for muting (Hogins et al., 2011; Crawford and
Mennerick, 2012). In gabapentin-treated cultures, however, a non-significant increase in
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Figure 5. Gabapentin prevents the development of muting competence. A.
Representative DIV 10-12 autaptic EPSCs after 4 h control (30 mM NaCl) or depolarized
(30 mM KCl). Astrocyte-rich cultures were treated with 32 μM gabapentin at DIV 7 (1x
GBP). B. DIV 10-12 autaptic EPSCs after 4 h control or depolarized. Astrocyte-rich
cultures were treated with 32 μM gabapentin at DIV 7 followed by half-media switches
of fresh 32 μM gabapentin in astrocyte-conditioned medium every day (3-5x GBP). C.
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Summary of DIV 10-12 autaptic EPSCs after 4 h 30 mM KCl with indicated
pretreatments (n=12-14 neurons; *p<0.05 vs. treatment controls, Student’s unpaired t
test). EPSCs were normalized as in Figure 1C. D. Spontaneous activity in DIV 11-13
mass cultures after 4 h control (30 mM NaCl) or depolarized (30 mM KCl). Cultures
were treated at DIV 7 with or without 32 μM gabapentin followed by daily half media
switches with astrocyte-conditioned medium (CM) or CM plus 32 μM gabapentin (3-5x
GBP). EPSCs and IPSCs were measured simultaneously at -35 mV. E. Summary of total
spontaneous synaptic activity (EPSC + IPSC points) in DIV 11-13 mass cultures,
normalized to control (CM, NaCl) for each recording day (n=23 neurons; *p<0.05,
Bonferroni corrected).
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network activity was observed (Bonferroni corrected p=0.16), but no change in network
activity occurred after the muting induction protocol (Fig. 5D and 5E), suggesting that
muting was not induced. Together, these results argue that TSP binding to α2δ-1 fosters
development of presynaptic muting competence.
Although the signaling pathways downstream of α2δ-1 are unclear, we
hypothesized that PKA signaling, which regulates muting (Moulder et al., 2008), is
altered in astrocyte-deprived neurons. This hypothesis was based in part on the
observations that both Gi/o-coupled receptor agonist-induced muting and Rp-cAMPSinduced muting were dysfunctional (Fig. 1C). To test whether PKA activity was normal
in astrocyte-poor cultures, we measured phosphorylation levels of PKA substrates in
neurons. We found that phosphorylation levels of the presynaptic protein synapsin at its
PKA phosphorylation site were increased in astrocyte-poor cultures despite unchanged
levels of total synapsin (Fig. 6). Phosphorylation of cAMP response element-binding
protein, another PKA substrate, was also abnormally high in neuronal nuclei from
astrocyte-deprived cultures (Fig. 7A). In contrast, phosphorylation of dynamin 1, a PKC
substrate, was unchanged in astrocyte-poor cultures (Fig. 7B), suggesting that the overphosphorylation phenotype was restricted to PKA phosphorylation sites. TSP1 reversed
abnormal presynaptic phospho-synapsin (Fig. 6A and 6B), so TSP appears to restore
normal PKA targeting and/or activity. Furthermore, TSP1 incubation reinstated normal
Rp-cAMPS-induced persistent EPSC depression in astrocyte-poor cultures (Fig. 4E).
Together, these results suggest that TSP promotes muting competence via normalization
of signaling downstream of cAMP pathways.
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Figure 6. PKA-dependent hyper-phosphorylation is normalized by thrombospondin.
A. Phospho-synapsin (PKA phosphorylation site) immunostaining in DIV 10-12 autaptic
neurons from astrocyte-rich or astrocyte-poor cultures with or without 5 μg/ml
thrombospondin (TSP) treatment at DIV 7. Red circles are representative regions of
interest defined by vGluT-1 immunoreactivity (not shown). Scale bar represents 5 μm. B.
Summary of background-subtracted phospho-synapsin at vGluT-1-positive synapses in
DIV 10-12 autaptic neurons (n=35 neurons; *p<0.05, Bonferroni corrected). C. Left:
synapsin immunostaining in autaptic neurons from astrocyte-rich or astrocyte-poor
cultures. Right: summary of background-subtracted synapsin immunoreactivity (n=35
neurons; p=0.51, Student’s unpaired t test) at vGluT-1-defined synapses (red circles are
representative). Scale bar represents 5 μm.
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Figure 7. A PKA target, but not a non-PKA target, is hyper-phosphorylated in
astrocyte-poor cultures. A. Left: MAP2, GABA, and phospho-CREB (PKA
phosphorylation site) immunoreactivity in neurons on multi-cell islands from astrocyterich or astrocyte-poor cultures. Scale bar represents 20 μm. Right: quantification of
background-subtracted phospho-CREB intensity from GABA-negative nuclei (n=60-89
neurons; p=3.7x10-13, Student’s unpaired t test). B. Left: phospho-dynamin 1 (PKC
phosphorylation site) immunoreactivity in autaptic neurons from astrocyte-rich and
astrocyte-poor cultures. Scale bar represents 20 μm. Right: quantification of backgroundsubtracted phospho-dynamin 1 intensity from a single primary and two secondary
dendrites averaged per neuron (n=30 neurons; *p<0.05, Bonferroni corrected). As a
positive control, we treated for 30 min with phorbol ester (1 μM PDBu) to increase PKCdependent phosphorylation.
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Discussion
Here we have demonstrated that astrocytes serve as permissive partners in the
development of a form of persistent synaptic depression, presynaptic muting. In
glutamatergic neurons from astrocyte-poor cultures, basal presynaptic function remained
intact, suggesting that astrocytes modulate presynaptic plasticity competence differently
than they regulate other types of presynaptic development. Astrocytic signaling was
permissive, but not acutely instructive, for muting induction. Astrocyte-derived TSPs
promoted the development of muting ability, as induced with varied stimuli, likely
through α2δ-1 calcium channel subunits. Although the signaling pathways immediately
downstream of α2δ-1 remain to be clarified, PKA appears to be an important downstream
effector. PKA-dependent phosphorylation and synaptic behavior were abnormal in
astrocyte-poor cultures but restored by TSP1 treatment, providing a potential mechanism
by which TSP modulates muting competence.
TSPs are a class of proteins originally discovered in intact human blood platelets
(Baenziger et al., 1971). In the brain, at least 4 TSPs are expressed in various regions and
cell types (Iruela-Arispe et al., 1993; Adams and Tucker, 2000). TSPs are released from
astrocytes and known to promote synaptogenesis (Asch et al., 1986; Christopherson et al.,
2005; Xu et al., 2010), but because TSP-induced glutamate synapses in retinal ganglion
cells are postsynaptically silent (Christopherson et al., 2005; Eroglu et al., 2009), TSPs
may be involved mainly in presynaptic rather than postsynaptic differentiation. This is
especially interesting given that TSPs act postsynaptically to produce these presynaptic
effects (Eroglu et al., 2009; Xu et al., 2010). TSP increases the total number of synapses
in retinal ganglion cells (Christopherson et al., 2005; Eroglu et al., 2009) but accelerates
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synaptogenesis without altering total synapse number in hippocampal neurons (Xu et al.,
2010). This regional difference in TSP’s synaptogenic effects could explain why
astrocyte deprivation failed to change total synapse number in our study of hippocampal
neurons and why these effects of TSP on hippocampal plasticity have been previously
overlooked. Because TSP expression increases after injury and is important for
behavioral recovery after stroke (Lin et al., 2003; Liauw et al., 2008), TSP may be
important generally for adaptive neuronal responses. Presynaptic muting, which reduced
network activity during an excitatory insult during this study, and protected neurons
against hypoxia in a prior study (Hogins et al., 2011), could be one such TSP-mediated
synaptic ability contributing to adaptive neural responses during brain insults.
TSP promoted muting competence through its interaction with the α2δ-1 calcium
channel subunit. This subunit serves as the TSP receptor for synaptogenesis in retinal
ganglion cells (Eroglu et al., 2009) and as the receptor for the antinociceptive and
anticonvulsant drug gabapentin (Gee et al., 1996). Gabapentin’s therapeutic effects may
arise from alterations in calcium channel organization (Arikkath and Campbell, 2003;
Field et al., 2006; Bauer et al., 2009; Bauer et al., 2010; Hoppa et al., 2012), among other
neuronal changes (Freiman et al., 2001; Gu and Huang, 2001; Stefani et al., 2001; Surges
et al., 2003). Gabapentin binding to α2δ-1 antagonizes TSP-induced synaptic
development in retinal ganglion neurons (Eroglu et al., 2009), and we found that
gabapentin prevented the development of muting competence in hippocampal neurons,
implicating TSP binding to α2δ-1 in this effect.
Muting incompetence due to gabapentin could also have clinical implications.
Previous studies have demonstrated a wide variety of effects of gabapentin on synaptic
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and behavioral plasticity including no effect (Cilio et al., 2001; Heidegger et al., 2010),
reduced plasticity (Blake et al., 2007; Eroglu et al., 2009; Kurokawa et al., 2011), and
enhanced learning (Buccafusco et al., 2010). In our study gabapentin blocked adaptive
network changes in response to a stimulus known to selectively induce muting. Although
we saw a non-significant increase in total network activity after gabapentin treatment,
this likely does not explain the lack of muting since muting is promoted by increased
network activity (Moulder et al., 2004; Moulder et al., 2006). Our study and a previous
study (Eroglu et al., 2009) suggest that synaptogenic periods might be particularly
vulnerable to unintended effects of gabapentin.
Our work implicates PKA signaling in TSP’s promotion of muting competence.
Gi/o-linked receptor agonists and PKA inhibitors, which normally produce muting
(Moulder et al., 2008; Crawford et al., 2011), persistently potentiated EPSCs in astrocytepoor cultures. Additionally, PKA substrates in the presynaptic terminal and the nucleus
were hyper-phosphorylated in astrocyte-deprived cultures, indicating an abnormal
increase in PKA site phosphorylation or a decrease in dephosphorylation. This surprising
synaptic facilitation may suggest that multiple cAMP-dependent pathways regulate
synaptic transmission. It is possible that PKA inhibition normally suppresses
transmission by dominating or masking other potentiating effects that are then revealed in
the context of astrocyte deprivation and hyper-phosphorylated PKA substrates, although
our work does not definitively address whether these changes alter synaptic transmission
presynaptically, postsynaptically, or both. Astrocyte-released TSPs, therefore, may
restrain PKA activity, or phosphorylation levels of downstream substrates, during
synapse development so that PKA inhibition can produce a meaningful decrease in
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synaptic function upon exposure to the depolarization challenge. Other models to explain
these results are possible, and future work may distinguish them.
In addition to effects on synaptic plasticity, we also observed effects of astrocyte
deprivation on basal postsynaptic function. Neuronal responses to AMPA and NMDA
receptor agonists were depressed in parallel, supporting prior work suggesting that
astrocytes are important for postsynaptic development (Beattie et al., 2002; Stellwagen
and Malenka, 2006; Perea et al., 2009; Sullivan et al., 2011). Because neurons near
astrocytes in astrocyte-poor cultures produced EPSCs with the same amplitude as those
that were not, this postsynaptic effect of astrocytes likely resulted from a deficit in global
astrocytic signaling rather than a deficit in local signaling. Astrocyte-derived TNFα
controls postsynaptic receptor levels (Stellwagen et al., 2005; Stellwagen and Malenka,
2006; Steinmetz and Turrigiano, 2010), but TNFα did not alter muting competence in our
study, suggesting that the reduction in postsynaptic receptors was not responsible for the
muting deficit in astrocyte-deprived cultures. Additional evidence that postsynaptic
receptors do not mediate muting includes current and prior work demonstrating muting in
the presence of complete blockade of AMPA and NMDA receptor function (Moulder et
al., 2004; Moulder et al., 2006) and the failure to mute in older, astrocyte-deprived
cultures with larger basal EPSCs. Our results do not exclude a role for TSP and α2δ-1 in
basal postsynaptic development, however, but TSP’s role in muting appears independent
of postsynaptic receptor function.
In summary, astrocyte-derived TSPs permit presynaptic muting at hippocampal
glutamate terminals. TSPs likely act through α2δ-1 binding to normalize PKA signaling
in developing synapses. These results reveal a novel mechanism by which glial-neuronal
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communication controls adaptive synaptic malleability.
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Discussion and future directions
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Summary and significance
Synapses are critical points of communication between neurons and, therefore,
mediate information transfer throughout the nervous system. Because of this vital role in
neurobiological function, synaptic dysfunction likely contributes to many
neurodevelopmental and neuropsychiatric disorders (Johnson et al., 2008; Betancur et al.,
2009; Waites and Garner, 2011; Bhakar et al., 2012). Understanding synaptic function
and modulation, therefore, is a fundamental goal in neuroscience that has the potential to
inform processes mediating learning, behavior, and pathology. Presynaptic muting of
glutamate release in response to strong depolarization or prolonged increases in neuronal
activity is one such form of synaptic modulation that is poorly understood. This
dissertation project aimed to clarify some of the mechanisms mediating muting induction
in order to better understand adaptive synaptic phenomena.

Calcium is not necessary for muting induction:
In Chapter 2, I explored how introducing ligand-gated cation channels into
neurons alters synaptic and neuronal function. I transfected cultured hippocampal
neurons with TRPV1 or TRPM8 channels, which are thermosensitive cation channels
important in sensory function (Talavera et al., 2008), with the original intention of
controlling the activity of individual neurons in a cellular network. TRPV1-transfected
neurons responded robustly to a saturating concentration of the TRPV1 agonist capsaicin.
Similarly, TRPM8-transfected neurons responded robustly to menthol, a TRPM8 agonist.
Non-transfected neurons did not respond to either capsaicin or menthol application.
Prolonged ligand application reduced, but did not eliminate, channel-associated current,
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suggesting that long-term application of agonists could be used effectively for tonic
depolarization of a subset of neurons within a neuronal network. Although optogenetic
strategies have become increasingly popular for manipulating activity of individual
neurons within a neural network (Fenno et al., 2011; Tye and Deisseroth, 2012), this
ligand-gated ion channel technique could have advantages in particular model systems.
For example, neurons located far from each other could be activated with the same
stimulus via widespread agonist application, and equipment and materials may be less
costly than with optogenetics. Recently, exogenous expression of TRPV1 was used to
control activity of neurons in vivo in mice (Arenkiel et al., 2008; Guler et al., 2012),
demonstrating the promise of this technique for selectively controlling network activity in
large, intact networks.
One important observation made after transfection with TRP channels was that
TRPV1-transfected neurons expressed a basal leak current that was larger than that
expressed in TRPM8-transfected and non-transfected neurons. This current was reduced
with the TRP channel blocker ruthenium red, suggesting that it arises from the expression
of TRPV1 and not from an artifact of the transfection. TRPV1, therefore, may be
activated endogenously in our preparation, which is plausible given TRPV1’s many
known activating stimuli that could be present in our culture conditions (Schumacher,
2010; Vay et al., 2012). Additionally, I saw evidence of more agonist-induced toxicity in
TRPV1-transfected than TRPM8-transfected neurons. After a 4 h exposure to agonist, a
higher percentage of TRPV1-transfected neurons, but not TRPM8-transfected neurons,
were unhealthy. This TRPV1 activation-associated toxicity was reduced in calcium-free
extracellular medium, suggesting that calcium influx contributed to cell damage and
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death. This dependence on calcium is consistent with prior literature exploring
excitotoxicity mechanisms (Choi, 1987, 1992). TRPV1-transfected neurons may be more
sensitive to calcium-dependent damage than TRPM8-transfected neurons due to
TRPV1’s higher relative calcium permeability as well as its tendency dilate after
prolonged activation (Caterina et al., 1997; McKemy et al., 2002; Meyers et al., 2003;
Chung et al., 2008). Calcium is not just an important component of excitotoxic signaling
cascades; it is also an important induction signal for prolonged forms of synaptic
plasticity like long-term depression and long-term potentiation (Malenka, 1991; Malenka,
1994; Teyler et al., 1994). A leak of calcium ions into the cell, therefore, may have
explained the depressed autaptic, action potential-evoked postsynaptic currents (PSCs) in
TRPV1-transfected neurons compared to TRPM8-transfected and synaptophysin-YFPtransfected neurons. This synaptic depression was not explained by transfection-induced
alterations in synapse formation because both TRPV1- and TRPM8-transfected neurons
released transmitter upon agonist exposure, as measured by miniature PSCs onto a
postsynaptic neuron. I hypothesized, therefore, that influx of calcium through TRPV1
under basal conditions induced presynaptic muting. Because of the wide range of
depolarizing stimuli that induce muting (Moulder et al., 2004; Moulder et al., 2006;
Moulder et al., 2008; Hogins et al., 2011), it is plausible that depolarization from calcium
influx contributes to muting induction. The role of calcium in muting induction and in
the observed synaptic depression was not further clarified in this study, however, but
future work should ask whether this basal EPSC depression in TRPV1-transfected
neurons arose from muting. Future work should also clarify whether muting is cell
autonomous by activating single neurons, potentially via menthol application to TRPM8-
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transfected neurons, and assessing if muting is induced in the absence of input from other
cells.
To elucidate whether muting requires calcium, I prevented calcium signaling
during muting induction as described in Chapter 3. I used a 4 h high extracellular
potassium stimulation to depolarize neurons and induce muting in the absence of other,
confounding neuronal and synaptic changes. Buffering extracellular calcium with the
slow calcium chelator EGTA did not prevent muting, as assessed by action potentialevoked excitatory PSCs (EPSCs) in autaptic neurons and by FM1-43 dye uptake into
presynaptic terminals. This suggested that calcium entry from the extracellular space
during neuronal depolarization is not required for muting induction. This did not,
however, rule out the possibility that calcium from other sources, like intracellular
calcium stores, contributed to muting induction. To prevent all intracellular calcium
signaling, I loaded cells with the fast calcium chelator BAPTA by applying the
extracellular precursor BAPTA-AM. BAPTA, although capable of preventing fast,
calcium-dependent vesicle fusion in response to action potentials, did not prevent muting
induction, as assessed by calcium-independent hypertonic sucrose-evoked EPSCs. As
mentioned in Chapter 3, many forms of synaptic plasticity, especially those that are
slowly and persistently induced, require calcium signaling (Wigstrom et al., 1979;
Wickens and Abraham, 1991; Xie et al., 1992; Tong et al., 1996; Patenaude et al., 2003;
Frank et al., 2006; Kellogg et al., 2009; Turrigiano, 2012). These surprising results
suggested that muting induction is calcium-independent. Muting, therefore, is a unique
form of synaptic plasticity that uses novel, calcium-independent induction mechanisms.
Calcium-independent, long-term synaptic plasticity is rarely described, but a few known
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forms are dependent on activation of metabotropic glutamate receptors (Fitzjohn et al.,
2001; Ireland and Abraham, 2009; Kasten et al., 2012). I hypothesized, therefore that
muting depends on calcium-independent release of a ligand that activates surface
receptors important for modulating synaptic function.

G-protein signaling is required for muting induction:
Because muting did not require calcium, many potential molecular mediators of
muting induction were excluded as candidates. For example, ligands released via
calcium-dependent vesicle fusion, like many neurotransmitters and neuromodulators, are
likely not involved in muting induction. Our lab recently showed, however, that levels of
cyclic adenosine monophosphate (cAMP) correlate with the percentage of active
glutamatergic synapses (Moulder et al., 2008), so cAMP modulators not dependent on
calcium signaling remained viable candidates. It was unclear from this study, however, if
reduced cAMP levels were instructive for depolarization-induced muting and, if so,
which upstream signaling cascades mediate this cAMP change. In Chapter 3 I asked
whether inhibitory G-proteins, which are activated through calcium-dependent and
calcium-independent mechanisms to reduce cAMP levels and can mediate long-term
synaptic plasticity (Hanoune and Defer, 2001; Poser and Storm, 2001; Brown and Sihra,
2008), mediate muting induction. Pertussis toxin, which prevents inhibitory G-protein
signaling, blocked muting induction, as assessed with autaptic action potential-evoked
EPSCs and FM1-43 dye uptake into glutamatergic terminals. This supported my
hypothesis that inhibitory G-proteins are necessary for muting induction, but it did not
clarify which G-proteins are activated and how.
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To probe whether particular G-protein-coupled receptors (GPCRs) upstream of
inhibitory G-proteins mediate muting induction, I asked if activation of inhibitory Gproteins by GPCR agonists was sufficient to induce muting. Adenosine and CCPA,
which are nonselective and selective A1 adenosine receptor agonists, respectively,
induced muting, as evidenced by persistent EPSC depression and a decrease in the
percentage of glutamatergic terminals that labeled with FM1-43. Baclofen, a GABAB
receptor agonist, also produced muting. These results supported the hypothesis that Gprotein activation produces muting. Interestingly, agonists for other GPCRs (CB1
cannabinoid and metabotropic glutamate) and kainate receptors, which can have
metabotropic actions (Huettner, 2003), did not produce muting. This receptor behavior
suggests some selectivity in the signaling cascades responsible for muting induction.
Additionally, application of baclofen and CCPA together produced no more muting than
either agonist alone, which would suggest that prolonged A1 and GABAB receptor
activation converge on the same downstream targets. Future work should clarify whether
G-protein cascades activated by A1 and GABAB receptors differ from those of
metabotropic glutamate, CB1, and kainate receptors via molecular identity, activation
levels, or spatial organization. For example, I showed in Chapter 3 that muting produced
by A1 and GABAB receptors was prevented by MG-132, a proteasome inhibitor. This
result suggested that GPCR agonist-induced muting requires proteasome activity and
aligned with prior published evidence from our lab showing that depolarization-induced
muting requires proteasome activity (Jiang et al., 2010). Proteasome activation could be
induced more strongly by A1 and GABAB receptors than by metabotropic glutamate,
CB1, and kainate receptors, but more experiments measuring proteasome activity during
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receptor activation would be required to substantiate this hypothesis. One complication
is that the magnitude of muting was smaller after A1 and GABAB activation than after
depolarization challenges. It is possible that proteasome activity is more weakly
activated by agonists for these GPCRs than by depolarization or that depolarization
activates additional signaling cascades beyond A1 and GABAB-linked G-proteins.
Pertussis toxin’s ability to prevent muting suggested that G-protein-dependent cascades
are responsible for muting, but these experiments did not clarify whether A1 and GABAB
receptors are the receptors activated by depolarization.
To ask which GPCR is responsible for muting induction, my initial strategy was
to test likely candidates individually. Blocking metabotropic glutamate, CB1
cannabinoid, A1 adenosine, GABAB, and kainate receptors individually with
pharmacological agents, however, did not prevent muting after a depolarization
challenge. This was surprising given A1 and GABAB receptor agonists’ ability to induce
muting and suggested either that these receptors are not responsible for muting induction
or that these receptors each contribute only a small fraction of the muting observed after
the depolarization challenge. To test whether synergistic activation of multiple GPCRs
contributes to muting induction, I pharmacologically blocked multiple receptors
simultaneously. Blocking multiple receptors did not prevent muting induction,
suggesting that none of the tested receptors are required for muting induction. As
discussed in Chapter 3, this leaves some interesting questions unanswered, including
whether other, untested receptors are required for muting induction or whether receptorindependent signals, like activators of G-protein signaling (AGS proteins), are
responsible. One possibility is that an orphan GPCR or known inhibitory GPCRs like
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neuropeptide Y or somatostatin receptors are responsible (Herzog et al., 1992; Cervia et
al., 2003), but alternatively GPCR activation could be mediated or facilitated by voltage
instead of a ligand (Ben-Chaim et al., 2006; Parnas and Parnas, 2007; Kupchik et al.,
2011). Another possibility is that receptor-independent activation is responsible. If AGS
proteins were tested for their role in muting, then AGS1 would be a good candidate
because it is sensitive to pertussis toxin and activates inhibitory G-protein signaling
cascades (Cismowski et al., 1999; Cismowski et al., 2000; Graham et al., 2004; Blumer et
al., 2007). Clarifying the G-protein activation mechanism employed during muting
induction remains an important goal.

Astrocytic signaling is required for the development of muting competence:
Because it was not known which receptor, if any, mediates muting induction, no
additional clues were available to answer whether muting is cell autonomous. If muting
requires GPCR activation, then this implies that a ligand is released extracellularly, likely
from a different cell than the one undergoing muting, and binds to the GPCR; however,
receptor-independent or ligand-independent activation could occur through cell
autonomous signaling cascades. At this point, evidence for a cell autonomous
mechanism included the expression of muting in autaptic neurons since autaptic neurons
are physically isolated from other neurons. Additionally, intercellular communication
during muting induction through calcium-dependent release of a GPCR ligand is unlikely
because muting is calcium-independent and not induced via likely candidate GPCRs.
Depolarization with high extracellular potassium, which depolarizes neurons above a
membrane potential at which action potentials are blocked, and action potential
stimulation, which repeatedly but briefly depolarizes neurons, both induce muting
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(Moulder et al., 2004; Moulder et al., 2006), so voltage could serve as a cell autonomous
induction signal. Arguments against cell autonomy, however, included the potential for
retrograde messengers to pass from postsynaptic membranes to presynaptic terminals in
autaptic neurons as well as the possibility that astrocytes acutely release gliotransmitters
that modulate autaptic neuron behavior. Clarifying whether muting is cell autonomous
could pinpoint the source of muting induction and narrow the list of candidate activators
of G-protein signaling during depolarization. I, therefore, tested whether astrocytes are
required for muting induction.
If muting occurs without communication with astrocytes, then muting induction
may be either a cell autonomous phenomenon or one that requires local retrograde
signaling at the synapse; in contrast, if muting is absent without astrocytes, then
intercellular communication is required for muting induction. I tested for astrocytic
contributions to muting induction by eliminating astrocytes from astrocyte-neuron cocultures. As described in Chapter 4, I killed astrocytes using light aldehyde or ethanol
fixation prior to neuronal plating. This technique allowed for the reduction of live
astrocytes in the cultures while otherwise maintaining the same culture conditions as
those used in the previous studies described here. Other methods for astrocyte
elimination like glial toxins (Takada and Hattori, 1986; Hassel et al., 1992; Swanson and
Graham, 1994; Menard et al., 1997), adjusting culture substrates and media to discourage
astrocyte adhesion (Brewer et al., 1993; Ghosh et al., 1997; Recknor et al., 2004; Peretz
et al., 2007), or genetic models preventing gliotransmission (Zhang et al., 2004; Li et al.,
2005; Petravicz et al., 2008) have clear disadvantages including loss of astrocyte tissue
adhered to the culture dish, which serves as the substrate for neuronal attachment, or
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prevention of only some subtypes of astrocyte-neuron communication. In Chapter 4, I
showed that astrocyte fixation efficiently killed astrocytes in our cultures without
abolishing autaptic neuron adhesion and development, validating this method as a way to
probe the effects of astrocyte deficiency on neuronal and synaptic function.
Elimination of astrocytes from the co-culture network prior to synapse maturation
prevented muting induction in response to depolarization, GPCR agonists, and cAMP
signaling antagonists, suggesting that astrocytes are important for this form of synaptic
plasticity. This failure to silence in astrocyte-poor cultures was not linked to an obvious
deficit in presynaptic function; the probability of vesicle release, number of presynaptic
terminals per neuron, number of vesicles per synapse, neuronal input resistance, and
percentage of active glutamatergic synapses were not detectably different in astrocytepoor cultures. Allowing the astrocyte-poor cultures to mature longer also did not restore
muting, suggesting that the deficiency is fundamental to the lack of astrocytes instead of
due to delayed development. A postsynaptic change occurred in astrocyte-poor cultures,
however, as evidenced by the decreased EPSC amplitude that was linked to diminished
AMPA and NMDA receptor function, which is consistent with prior literature (Beattie et
al., 2002; Stellwagen and Malenka, 2006; Perea et al., 2009; Sullivan et al., 2011). The
similar EPSC amplitudes between neurons from live (calcein-positive) astrocyte islands
and dead (calcein-negative) astrocyte islands in astrocyte-poor cultures argued that the
basal EPSC amplitude decrease was due to loss of global astrocytic cues rather than loss
of local astrocytic cues. It was unclear if this postsynaptic deficiency indirectly altered
presynaptic plasticity; for example, altered retrograde signaling from molecules released
by the postsynaptic terminal that modulate presynaptic function may cause presynaptic
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changes. I demonstrated, however, that young neurons from astrocyte-rich cultures with
smaller basal EPSC amplitudes expressed muting while older neurons from astrocytepoor cultures with larger basal EPSC amplitudes did not express muting. These results
suggested that the basal EPSC amplitude does not determine muting competence,
although this did not distinguish the contribution of total glutamate receptor levels to
basal EPSC amplitude from that of total synapse number. Because of this evidence, a
postsynaptic explanation for the loss of presynaptic plasticity in astrocyte-poor cultures
seemed unlikely. Reduced astrocytic signaling, therefore, seems to unmask a deficit in
presynaptic plasticity without altering presynaptic function per se, which may be why
this synaptic effect has been overlooked in prior literature.
To clarify whether acute, instructive or global, permissive astrocytic signals were
responsible for muting, I applied astrocyte-conditioned medium at different times relative
to the depolarization challenge. When present for multiple days prior to muting induction
attempts, astrocyte-conditioned medium rescued muting. Muting was also rescued by
days of astrocyte-conditioned medium exposure even when replaced with nonconditioned medium during the depolarization challenge. The presence of muting in the
absence of acute astrocytic signaling suggested that soluble factors released by astrocytes
early in synaptic development permit muting competence. Astrocytes were not
instructive for muting, arguing against the hypothesis that gliotransmission is involved in
muting induction. This was supported by another experiment in which astrocyteconditioned medium added only during the depolarization challenge did not restore
muting induction. It appeared, therefore, that astrocytic factors promote muting
competence via synaptic development, and synapses with a history of astrocyte signaling
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do not require further astrocytic signaling to induce muting. This finding was especially
interesting and suggested that astrocytes are metaplastic modulators of synapses; factors
released by astrocytes mediate the synapse’s ability to undergo future plasticity.
Astrocytes have a complicated relationship with muting; therefore, muting is not clearly
cell autonomous or cell non-autonomous. Intercellular communication was clearly
required for muting competence to develop in the presynaptic terminal, but synapses with
a history of astrocytic signaling did not require exposure to acute astrocytic factors for
plasticity induction. Cell autonomous mechanisms may be activated upon exposure to
the depolarization challenge once non-cell autonomous signals have successfully
promoted maturation, but dilute global signals released by the sparse neurons in the
culture dish or retrograde signaling from postsynaptic compartments have not been ruled
out entirely. Together, these results highlighted an important and novel role for
astrocytes in synaptic development and narrowed the possible cellular sources of muting
to either cell autonomous or a small range of cell non-autonomous mechanisms.
This novel role of astrocytes in the development of muting competence prompted
a search for the molecular signals responsible. As described in Chapter 4, one major
candidate was thrombospondin, a matricellular glycoprotein released by astrocytes that
was recently found to be important for synapse development (Asch et al., 1986;
Christopherson et al., 2005; Eroglu et al., 2009; Xu et al., 2010). Thrombospondins
promote glutamatergic synaptogenesis in retinal ganglion neurons via binding to the
structural calcium channel subunit α2δ-1 on the postsynaptic membrane (Christopherson
et al., 2005; Eroglu et al., 2009). Interestingly, these thombospondin-induced synapses
are presynaptically functional but postsynaptically silent, meaning that AMPA receptors
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are absent from the postsynaptic membrane (Christopherson et al., 2005). This suggests
that thrombospondin specifically promotes presynaptic development. In hippocampal
neurons, however, thrombospondins appear to modulate the speed of synaptogenesis, but
not the total number of synapses that develop, via binding to the postsynaptic cell
adhesion protein neuroligin 1 (Xu et al., 2010). These findings from hippocampal
neurons suggesting that thrombospondin is not required for synaptogenesis may explain
why astrocyte deficiency did not reduce the total number of presynaptic terminals during
experiments performed in Chapter 4. Thrombospondin, therefore, was an excellent
candidate for modulating presynaptic plasticity. Thrombospondin application to
astrocyte-poor cultures a few days prior to the depolarization challenge rescued muting
induction. Another astrocytic factor important for synaptic plasticity, tumor necrosis
factor α, did not promote muting competence, suggesting that boosting synaptic function
does not promote muting competence non-selectively. Although these results did not rule
out a contribution to muting competence from other astrocyte-derived factors, they did
suggest that thrombospondins are a class of molecules capable of mediating the
development of muting ability.
To clarify whether thrombospondin endogenously mediates muting competence, I
blocked thrombospondin signaling during synapse development. Prior literature suggests
that thrombospondin’s synaptogenic effects occur through activation of α2δ-1 calcium
channel subunits or through neuroligin 1 (Eroglu et al., 2009; Xu et al., 2010), but it was
unclear whether either of these receptors was recruited for thrombospondin’s effects on
synaptic plasticity competence. One pharmacological tool that allowed us to test the role
of α2δ-1 in muting was the clinically used drug gabapentin. Gabapentin is known to bind
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to α2δ-1 and prevent thrombospondin’s synaptogenic effects in retinal ganglion cells
(Gee et al., 1996; Eroglu et al., 2009). Adding gabapentin to astrocyte-conditioned
medium prevented muting competence from developing in astrocyte-poor cultures.
Gabapentin also prevented muting competence in astrocyte-rich cultures if the cultures
were treated with fresh drug daily. These effects of gabapentin not only implicated α2δ-1
as the thrombospondin receptor that promotes muting competence, but they also implied
that thrombospondin is a major, if not the only, contributor to muting competence in our
cultures. Future work should probe the role of neuroligin 1 in muting competence,
however, since it was not tested in these studies.
One potentially translational finding from Chapter 4 was that gabapentin altered
adaptive changes in network activity. In mass cultures, where large networks of neurons
develop, the depolarization challenge silenced excitatory and inhibitory spontaneous
network activity. This was consistent with muting induction and subsequent failure of
excitatory signaling, which likely caused a parallel reduction in spontaneous inhibitory
signaling. This decrease in spontaneous activity after an excitatory stimulus further
suggested that muting is an adaptive change; as shown in the Appendix (Hogins et al.,
2011), muting is neuroprotective against excitotoxic insults like hypoxia, likely through
dampened neuronal excitation. After chronic gabapentin treatment, however, this
adaptive network change was absent. Interestingly, a non-significant increase in total
network activity occurred after gabapentin treatment, potentially due to its effects on
ionic conductances (Freiman et al., 2001; Stefani et al., 2001; Surges et al., 2003; Hoppa
et al., 2012). It is unclear whether these ionic conductances modulate muting
competence, but because thrombospondin promoted muting competence during the study,
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it is likely that gabapentin’s property as a thrombospondin receptor antagonist played a
large role. The prevention of muting and adaptive network changes by gabapentin could
have broader implications for patients treated with this drug. For example, children still
undergoing intense synapse development could be more severely impaired than adults by
gabapentin treatment because thrombospondin signaling appears important for synapse
maturation. Also, patients taking gabapentin could experience additional neuronal
toxicity during excitatory insults like stroke due to the lack of homeostatic network
dampening during the insult. Future work should clarify whether the lack of adaptive
plasticity in gabapentin-treated neurons renders networks more vulnerable to excitotoxic
death, but the results described here indicate that gabapentin treatment should be
employed judiciously.
The synapse-modifying signaling cascades downstream of thrombospondin-bound
α2δ-1 were unknown prior to the study described in Chapter 4. Application of GPCR
agonists or a PKA inhibitor not only failed to induce muting but also increased autaptic
EPSCs in astrocyte-poor cultures, suggesting that an abnormality developed along this
signaling cascade due to the lack of astrocytes. Acute GPCR agonist effects, thought to
work through Gβγ subunit signaling (Brown and Sihra, 2008), were intact in astrocytepoor cultures, however. This result suggested that signaling downstream of Gα was
disrupted in astrocyte-poor cultures but that G-protein signaling itself was functional.
PKA targets were over-phosphorylated in astrocyte-poor cultures while a PKC target
displayed normal levels of phosphorylation, so PKA activation downstream of Gα may
be rampant, or dephosphorylation impaired, in the absence of astrocyte-derived
thrombospondin. Tellingly, thrombospondin normalized PKA phosphorylation levels,
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which means that one mechanism by which thrombospondin signaling promotes muting
competence is likely by maintaining PKA phosphorylation within a functional dynamic
range. In a few prior studies, PKA inhibitors have blocked gabapentin-mediated neuronal
and behavioral phenotypes (Martin et al., 2002; Lee et al., 2008; Takasu et al., 2008;
Takasu et al., 2009), suggesting that these phenotypes require PKA-dependent pathways.
Facilitated signaling through α2δ-1, therefore, could conceivably inhibit PKA-dependent
pathways. I hypothesize that the increased PKA substrate phosphorylation in astrocytepoor cultures overly stabilizes presynaptic priming proteins and, thereby, prevents protein
degradation and muting induction. Future work should clarify the signaling cascade
responsible for PKA-related alterations downstream of α2δ-1; one plausible hypothesis is
that enhanced calcium signaling through α2δ-1-dependent calcium channel assembly
inhibits calcium-inhibited adenylyl cyclases (Hanoune and Defer, 2001; Hoppa et al.,
2012), thereby reducing cAMP and PKA signaling. Overall, these experiments revealed
a novel role for astrocytes in promoting synaptic plasticity competence, but not induction
of plasticity per se, through release of thrombospondins that alter signaling cascades
important for muting induction.

Current muting induction model:
In summary, muting is induced by a complicated interplay between the state of
the synapse before an excitatory insult and the signaling cascades recruited by the insult.
The current model of muting induction is displayed in Figure 1. This model states that
this adaptive, reversible form of synaptic plasticity requires astrocytic release of
thrombospondin during synapse development to activate α2δ-1 calcium channel subunits
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and normalize PKA signaling. I hypothesize that PKA activity after thrombospondin
signaling and α2δ-1 activation, therefore, is reduced and maintained within a dynamic
range able to produce meaningful changes in protein phosphorylation. A strong
depolarization challenge or prolonged increased activity that decreases cAMP signaling
via inhibitory G-protein activation, therefore, is capable of reducing PKA activity enough
to decrease vesicle priming protein phosphorylation levels and render these proteins
vulnerable to proteasomal degradation. The parallel increase in proteasome activity from
the excitatory stimulus then causes protein degradation and loss of vesicle priming,
thereby muting the synapse.
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Figure 1. Signaling cascades participating in muting. During development (blue lines),
astrocytic release of thrombospondin activates α2δ-1 receptors postsynaptically,
presynaptically, or both, resulting in a normalization of PKA signaling. After synaptic
maturity (black lines), prolonged strong depolarization or increased action potential firing
induces presynaptic muting through activation of the ubiquitin-proteasome system and
through activation of inhibitory G-proteins. Depolarization increases proteasome activity
through unknown mechanisms, but both depolarization- and G-protein-coupled receptor
(GPCR) agonist-induced muting require proteasome activity. Inhibitory actions of the Gα
subunit on adenylyl cyclase (AC) reduce cAMP and protein kinase A (PKA) signaling
during muting induction. PKA phosphorylates presynaptic priming proteins like Rim1α, a
modification that may render Rim1α resistant to proteasomal degradation; therefore, less
Rim1α phosphorylation is expected after depolarization. Increased proteasome activity,
combined with a vulnerable presynaptic protein population, leads to priming protein
degradation. This model provides a plausible mechanism for priming protein level
reduction and muting induction by depolarization. Postsynaptic protein levels are
unaltered by induction of presynaptic muting. Modified from Crawford and Mennerick,
2012.
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Future directions
Interesting questions about the mechanisms, roles, and clinical potential of
adaptive presynaptic muting emerged during these studies. Some of the immediate
questions that should be answered include clarifying additional molecular mediators of
muting competence or induction. For example, it remains unclear how thrombospondin
signaling alters PKA activity. As described in the Summary and Significance, α2δ-1dependent calcium channel assembly is one candidate downstream effect (Hoppa et al.,
2012) since the role of calcium in the development of muting competence was never
tested. Whether presynaptic or postsynaptic α2δ-1 is important for muting is also
unclear. One potential strategy to test this would be to genetically knock down α2δ-1 in
single neurons before assessing synaptic function on dendrites or axons of these neurons.
This would reveal whether thrombospondin’s effects are directly altering presynaptic
function or indirectly altering presynaptic function through a retrograde signal. To
clarify how quickly thrombospondin alters muting ability in presynaptic terminals, more
experiments over differing time scales could be performed. For example,
thrombospondin could be added 0-24 h prior to the depolarization challenge to ask
whether shorter treatments promote muting competence. Additionally, thrombospondin’s
actions may have a critical window during synapse development. Would adding
gabapentin later in development or for shorter periods of time prevent and/or reverse the
development of muting competence? Do neurons from neonatal animals behave
differently than those from adult animals? These studies could clarify the developmental
role of thrombospondin and have important implications for gabapentin’s clinical use.
It also remains unknown how inhibitory G-protein signaling is activated by
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depolarization. If GPCRs are activated by a ligand during increased neuronal excitation,
this ligand must be released by neurons, not astrocytes, since astrocytic signaling is not
acutely required for muting induction. It is possible, however, that a non-canonical
GPCR or G-protein activator is responsible. Genetic manipulations to knock down AGS
proteins or other known GPCRs linked to inhibitory G-proteins in the hippocampus could
identify the responsible G-protein activation mechanism, although this may require a
high-throughput screening approach. Also, the dependence of muting on inhibitory Gprotein signaling implies that stimulatory G-protein signaling (Gs) could mediate
recovery from muting. Prior work has implicated calcium-dependent adenylyl cyclases
in muting recovery (Moulder et al., 2008), but whether G-proteins, calcium, and/or
another molecule are responsible for the adenylyl cyclase activation remains to be tested.
The dependence of recovery from muting on PKA activity (Moulder et al., 2008) and the
proteasome-dependence of muting (Jiang et al., 2010) also suggest that protein synthesis
may be required, potentially through PKA-dependent activation of transcription factors
like cAMP response element-binding protein (CREB; Sassone-Corsi, 1998).
Unpublished data from our lab suggest that muting induction does not require protein
synthesis, but recovery back to basal function does, and that phosphorylation of CREB by
PKA is a plausible candidate mediator for this protein synthesis. Future work will have
to explore the potentially causative role for CREB in recovery from muting.
As mentioned in the Summary and Significance, whether muting is cell
autonomous remains unclear despite much work eliminating many intercellular signaling
pathways during induction. Astrocytic signaling is not required during muting induction,
as long as astrocytes are able to communicate with synapses prior to the induction
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challenge, and autaptic neurons undergo muting. It is likely, therefore, that muting is cell
autonomous, but the possibility of retrograde signaling from the postsynaptic neuron to
the presynaptic neuron has not been excluded. To test for a retrograde signal, future
work could genetically manipulate single neurons within a neural network. For example,
optimizing transfection of TRPM8 in cultured hippocampal neurons would allow for
studies that use tonic channel activation to depolarize neurons and attempt to induce
muting. Other methods, like expression of channelrhodopsin and using light exposure to
activate the channel (Fenno et al., 2011; Tye and Deisseroth, 2012), remain as
alternatives to TRP channel transfection. If muting is induced selectively in one neuron
on a two-neuron microisland using one of these techniques, for example, then paired
recordings of these two neurons could parse out whether synapses onto the nondepolarized neuron or synapses onto the depolarized neuron undergo muting. Clarifying
whether muting is cell autonomous or whether it requires a retrograde signal would
narrow the list of candidate activators of G-protein signaling even further. Additionally,
identifying the source of the signal to mute could have implications for how muting
interacts with network activity. For example, does the neuron being overly activated
prevent itself from further propagating the overexcitation, or does it signal to the neuron
prior to it in the circuit to reduce its own overactivation? Although evidence currently
supports the hypothesis that muting is cell autonomous (i.e. the presynaptic terminals
within the neuron being activated are muted without intercellular communication),
further work is required to clarify this definitively.
More fundamentally, the role of mute terminals in information processing in the
nervous system remains unclear. For example, why is muting binary, in that the synapse
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is entirely non-functional but structurally preserved? Because of this binary nature, does
muting alter the electrical transfer of information in the same way as synaptic pruning but
with the added benefit of saving time and cellular resources? Understanding the
mechanisms involved in muting could lead to the ability to strategically silence particular
synapses (within a single neuron, a single circuit, or an entire brain region) and observe
the consequences on neuronal excitation, subcellular electrical summation, and network
activation. It also remains unclear if the synapses that mute in response to depolarization
are randomly distributed to dampen general excitability or strategically placed to
modulate firing of particular postsynaptic neurons. The probability of vesicle release and
readily releasable pool size increase with distance along the axon from the cell body in
hippocampal neurons (Peng et al., 2012), so it is possible that the basal state of the
synapse or its location could determine the probability that a synapse will undergo
muting. One could measure muting and unmuting using live-cell imaging to determine if
the same terminals are vulnerable to muting with repeated depolarization challenges and
whether the location along the axon or dendrite correlates with this tendency. Also,
because cAMP is an important mediator of muting induction, cAMP levels could be
measured in axonal compartments, using techniques like the FRET construct Epac1camps (Nikolaev et al., 2004), to determine whether basal cAMP levels or the dynamic
range of CAMP levels near particular synapses correlate with a tendency to mute.
Alternatively, the total percentage of mute terminals, if distributed randomly, may
correlate with somatic cAMP levels.
The location of mute terminals may also have important implications for how
muting interacts with other forms of synaptic plasticity like homeostatic postsynaptic
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receptor scaling or Hebbian long-term potentiation. Synaptic scaling purportedly acts at
all synapses in a neuron (Turrigiano, 2012), but long-term potentiation is specific to
synapses experiencing strong, correlated presynaptic and postsynaptic activity, leaving
nearby synapses unaffected (Bear and Malenka, 1994; Kelleher et al., 2004). Muting
would be predicted to enhance the effects of reduced postsynaptic receptor levels on
overall network activity but may cancel the effects of Hebbian plasticity at particular
synapses. Computer modeling would facilitate the study of how these forms of plasticity
interact and what effects simultaneous inductions have on neural computation and
network activity. As techniques evolve for inducing multiple forms of synaptic plasticity
simultaneously or sequentially in living tissue, the physiological consequences of their
interactions should be tested.
One major open question remaining about muting induction is what role it plays
in vivo. In mammals, evidence determining whether muting even occurs in vivo is
needed. At this time, work outside of cultured neuron networks, like in acute
hippocampal slices (Moulder et al., 2004; Crawford and Mennerick, 2012; Chapter 1),
have merely shown correlates of muting due to the technical limitations involved. Future
directions should include techniques like high resolution microscopy of presynaptic
vesicle function or sophisticated electrophysiological measures of individual neurons to
measure muting in vivo (Kalb et al., 2004; DeWeese, 2007; Ako et al., 2011; Herzog et
al., 2011; Kodandaramaiah et al., 2012). Once the presence of and mechanisms for in
vivo muting have been established, then the field is poised for exploring how muting
alters learning, behavior, or disease. For example, establishing whether muting occurs in
all brain regions and neurotransmitter systems will be important for developing
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hypotheses about its role in brain function. Because muting occurs in hippocampal
glutamatergic neurons and has the potential to interact with Hebbian plasticity, it could
disrupt or enhance learning and memory. To test this, muting would need to be induced
in vivo prior to or during learning and memory tasks. Muting may also be regulated by
sleep and circadian rhythms, as has been proposed for Hebbian plasticity (Tononi and
Cirelli, 2006). Inducing muting during different phases of the circadian cycle, therefore,
may cause different behavioral outcomes. Similarly, neurons may be more or less
susceptible to muting early in development than later in development, so the effects of
muting at different developmental ages should also be assessed. Potentially the most
translational open question would be whether muting occurs in pathophysiological
contexts. Do changes in muting levels mediate alterations in the balance of excitation
and inhibition observed during disease (Eichler and Meier, 2008; Baroncelli et al., 2011;
Kapogiannis and Mattson, 2011; Ramamoorthi and Lin, 2011), and could manipulating
muting in vivo restore balance to unbalanced networks? Could clinical induction of
muting be used to prevent or reduce damage from excitatory insults like stroke or
seizure? Although these questions will not be answered immediately, clarifying the role
of muting in cognition, learning, or disease will provide insight about the role of synapses
in brain function.
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Conclusions
Synaptic function and plasticity are vital to information processing within the
nervous system. Presynaptic muting of glutamatergic synapses represents an
underappreciated form of synaptic plasticity present in hippocampal glutamatergic
neurons. For this dissertation project, I have clarified some of the molecular mediators of
muting development and induction. Calcium, an important mediator of synaptic
plasticity, was surprisingly not necessary for muting induction while inhibitory G-protein
signaling, best known for its role in short-term plasticity, was necessary. Astrocytederived thrombospondins promoted muting competence of presynaptic terminals, but
astrocytes were otherwise not necessary for muting induction. This work revealed novel
mechanisms by which synapses are regulated and revealed some potentially translational
implications of muting and the pharmacological agents that modulate it. Although much
remains to be learned about the mechanisms responsible for muting, and the contexts
under which they are recruited, this work has laid a strong foundation for future work in
the field of synaptic development and plasticity.
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Abstract
Glutamate release is a root cause of acute and delayed neuronal damage in
response to hypoxic/ischemic insults. Nevertheless, therapeutics that target the
postsynaptic compartment have been disappointing clinically. Here we explored whether
presynaptic silencing (muting) of glutamatergic terminals is sufficient to reduce
excitotoxic damage resulting from hypoxia and oxygen/glucose deprivation. Our
evidence suggests that strong depolarization, previously shown to mute glutamate
synapses, protects neurons by a presynaptic mechanism that is sensitive to inhibition of
the proteasome. Postsynaptic Ca2+ rises in response to glutamate application and toxicity
in response to exogenous glutamate treatment were unaffected by depolarization
preconditioning. These features strongly suggest that reduced glutamate release explains
preconditioning protection. We addressed whether hypoxic depolarization itself induces
presynaptic silencing, thereby participating in the damage threshold for hypoxic insult.
Indeed, we found that the hypoxic insult increased the percentage of mute glutamate
synapses in a proteasome-dependent manner. Furthermore, proteasome inhibition
exacerbated neuronal loss to mild hypoxia and prevented hypoxia-induced muting. In
total our results suggest that presynaptic silencing is an endogenous neuroprotective
mechanism that could be exploited to reduce damage from insults involving excess
synaptic glutamate release.
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Introduction
For decades we have known that glutamate excitotoxicity (Olney et al., 1971)
results in damage to neurons following a wide variety of insults including hypoxia,
ischemia, seizures (Gidday, 2006; Goldberg and Choi, 1993; and Rothman, 1984), and
neuropsychiatric disorders (Olney, 2003; and Zorumski and Olney, 1993). Therapeutic
approaches have centered on blocking glutamate receptors and other downstream,
postsynaptic targets involved in the excitotoxic cascade. Unfortunately, these approaches
have proven disappointing in human studies because of poor efficacy or unacceptable
side effects (Gidday, 2006; and Moskowitz et al., 2010). Thus fresh approaches and new
basic insights are needed. One alternative might be to study and exploit endogenous
homeostatic synaptic mechanisms as strategies. By augmenting endogenous pathways of
adaptive synaptic plasticity, such strategies might circumvent some of the problems that
have arisen with previous interventions.
We have been studying a form of persistent presynaptic plasticity involving
depression of glutamate vesicle availability in hippocampal neurons. This depression is
characterized by presynaptic silencing, or muting, that outlives the inducing stimulus.
Muting is induced at glutamate, but not γ-aminobutyric acid (GABA), synapses by strong
depolarization (Moulder et al., 2004). It reverses over several hours (Moulder et al.,
2008) and is characterized by involvement of inhibitory G-protein signaling (Crawford et
al., 2011) and the ubiquitin/proteasome system (UPS) (Jiang et al., 2010).
Two issues relevant to excitotoxic pathophysiology emerge from our previous
observations. First, because the source of glutamate during excitotoxic insults may not be
purely synaptic (Rossi et al., 2000), it is unclear whether presynaptic interventions, such
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as induction of presynaptic muting, are effective neuroprotectants. Second, because
presynaptic silencing has been induced only under controlled experimental conditions, it
is unclear whether depolarizing insults such as hypoxia can induce muting rapidly and
strongly enough to provide endogenous neuroprotection. If so, muting may normally help
set the threshold for damage during insults. Support for these two ideas would help
establish the plausibility of augmentation of presynaptic muting as a neuroprotective
intervention and would offer new basic insights into the roles of synaptic plasticity in
nervous system function and dysfunction.
Our results demonstrate that presynaptic silencing induced by strong
depolarization protects neurons in in vitro hypoxia and oxygen-glucose deprivation
(OGD) models, consistent with the idea that synaptic glutamate is important for the
damage. Although depolarizing preconditioning paradigms have been shown to be
neuroprotective in other models through postsynaptic mechanisms (Grabb and Choi,
1999; Grabb et al., 2002; and Meller et al., 2008), we show that presynaptic mechanisms,
most likely involving presynaptic muting, are most important in our paradigm. Further,
our results suggest that a hypoxic insult induces muting to limit damage. Proteasome
inhibition, among other likely effects, prevents hypoxia-induced silencing and
exacerbates damage through a presynaptic mechanism, suggesting that muting helps set
the threshold for hypoxic damage. These results yield insights and suggest new
approaches that might be exploited for benefit in disorders involving dysfunction of
glutamate synapses.

218

Materials and methods

Cell culture:
Hippocampal cultures were prepared as described previously (Mennerick et al.,
1995). In brief, dissected postnatal (postnatal days 0–3) male and female rat hippocampi
were incubated with papain, mechanically dissociated, and plated at 650 cells/mm2 on
collagen substrate. Plating media consisted of Eagle's medium (Invitrogen) supplemented
with heat-inactivated horse serum (5%), fetal bovine serum (5%), 17 mM glucose, 400
μM glutamine, 50 U/mL penicillin, and 50 g/mL streptomycin. Cultures were maintained
at 37 °C in a humidified incubator with 5% CO2/95% air. Cytosine arabinoside at 6.7 μM
was added at 3–4 days after plating to inhibit cell division. At 1 day a media exchange
was performed with Neurobasal medium (Invitrogen) plus B27 supplement. Cells were
used for experiments at 13–15 days in vitro. Neurons exhibited increased sensitivity to all
forms of glutamate toxicity with maturation.

Preconditioning:
Fresh filtered Neurobasal (Invitrogen) medium without L-glutamine was used as a
base for preconditioning media and media exchanges. The original conditioned media
was removed and replaced with the preconditioning media. The cultures were returned to
their original media just before hypoxic exposure. For depolarizing preconditioning, the
preconditioning media contained Neurobasal plus 30 mM KCl. Control preconditioning
media included 30 mM NaCl in place of KCl as an equimolar non-depolarizing control.
In our typical protocol, this resulted in control and experimental preconditioning
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solutions that were ~ 60 mOsm hyperosmotic. To ensure that hypertonicity did not
interact with the effects of depolarization, we performed a subset of preconditioning
experiments in media that were isotonic (142 mM total monovalent cation concentration,
KCl substitution for NaCl, n = 5 experiments). These experiments produced similar
preconditioning protection as our standard protocol (27.7 ± 9.66% cell survival with
hypoxia, 62.8 ± 3.58% survival with hypoxia plus KCl preconditioning, compare with
Fig. 1). We did not routinely perform experiments in the isotonic media because of the
high expense of custom media preparation. Unless otherwise noted, all control and
depolarizing preconditioning solutions also included 0.5 μM 2,3-dihydroxy-6-nitro-7sulfonyl-benzo[f]quinoxyline (NBQX), and 25 μM D-2-amino-5-phosphonovalerate (DAPV) to prevent induction of glutamate-receptor dependent forms of preconditioning
protection or plasticity during preconditioning. In some experiments we omitted
extracellular Ca2+ (0.1 mM EGTA added to chelate residual Ca2+) or included
carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG-132; Sigma, 3 μM) in preconditioning
solutions. Unless otherwise noted, the media was exchanged immediately before hypoxic
exposure to remove glutamate receptor antagonists and the preconditioning stimulus.

Hypoxia exposure:
A commercially available chamber (Billups-Rothenberg Company) was used for
hypoxia induction and maintenance. Cells were incubated in a humidified environment
saturated with 95% nitrogen and 5% CO2 at 37 °C for the specified amount of time (2–
2.5 h depending on the experiment). The gas exchange was performed according to the
specifications of the chamber manufacturer (flow of 20 L per minute for 4 min to achieve
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100% gas exchange). After the insult, we removed cells from the chamber and incubated
them under standard conditions until the cell death assay (24 h). When used during the
insult to demonstrate neuroprotection, the glutamate receptor antagonists were 1 μM
NBQX and 100 μM D-APV, but antagonists were not routinely present during hypoxia or
OGD insults. For OGD experiments the method of oxygen deprivation was the same, and
just prior to oxygen deprivation culture media was switched to Neurobasal without Lglutamine and without glucose. Control cultures received the same media with glucose
(25 mM). Procedures for sham insults indicated in figures included all media changes and
incubation times relevant to the insult conditions. For experiments in which exogenous
glutamate exposure was used in place of hypoxia, media was exchanged with fresh
Neurobasal without L-glutamine and with the indicated concentration of glutamate. The
cultures were then returned to their original media for 24 h until the cell death assay was
performed.

Cell death assay:
To assess cell death, trypan blue dye (Sigma) was used. 24 h after the insult,
culture media was removed and replaced with 1 mL of 0.4% trypan blue dissolved in
phosphate buffered saline. Cells were incubated in dye at 37 °C for 5 min and washed
with phosphate buffered saline. Cultures were then fixed with 4% paraformaldehyde and
0.2% glutaraldehyde at room temperature. Cells were visualized with a 20× objective
using both phase-contrast and brightfield microscopy to confirm healthy neuronal profiles
(phase-contrast) and verify trypan blue uptake (brightfield). In one experiment the
designation of healthy neurons was verified 24 h after hypoxia treatment by calcein AM
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(acetoxymethyl) uptake (2 μM calcein-AM incubation for 30 min). Cells deemed healthy
by morphology under phase-contrast optics were always calcein positive (n = 5 fields,
20–40 cells per field). The total numbers of dead and intact neurons were counted and
expressed as a percentage of trypan blue positive dead cells to total cells. The average of
ten microscope fields for each condition was treated as a single data point for purposes of
statistics.

Calcium indicators and imaging:
Fluo4-AM (high affinity indicator; Invitrogen) and Fluo3-FF-AM (low affinity
indicator; Teflabs) fluorescent calcium indicators were used. We incubated neurons in
preconditioning solutions as noted above. After the 4 h preconditioning period cells were
incubated for 30 min at 37 °C in normal media containing 2 μM of the AM indicator. 5–7
fields per condition were imaged. Fluorescence images were obtained with a CoolSnap
ES2 camera (Photometrics) every 600 ms, using a fluorescein filter set and metal halide
light source. We selected 3 cells randomly from each field from a phase contrast image,
without reference to fluorescence images, for a total of 15–21 cells per condition as
indicated. Regions of interest were analyzed in the soma cytoplasm adjacent to the
nucleus. Background fluorescence was subtracted from each image using a cell-free
region of the field. Image acquisition and analysis were performed using Metamorph
(MDS).

FM1-43fx labeling, immunochemistry, and imaging:
Details have been previously published (Crawford et al., 2011). Briefly, cells
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were removed from preconditioning (Fig. 2) or the hypoxia chamber (Fig. 7), and after a
saline wash (~ 30 s) FM1-43fx (10 μM; Invitrogen) was loaded into active presynaptic
terminals during a brief (2 min) 45 mM KCl depolarization. vGluT-1 primary antibody
(1:2000) was applied after aldehyde fixation, permeabilization, and block. Alexa Fluor
647 goat anti-guinea pig secondary antibody (Invitrogen) was used at 1:500.
Fluorescence images were acquired using a Nikon C1 confocal microscope and analyzed
using Metamorph software. Parameters for image acquisition and analysis were constant
for each independent experiment.
To identify active glutamatergic synapses, an observer naïve to the experimental
conditions identified 10 vGluT-1-positive puncta as regions of interest from 5 fields for
each experimental condition. Next, FM1-43fx images were thresholded, after which
vGluT-1 regions were loaded into the FM1-43fx image. Active synapses were defined as
puncta that reached or exceeded 10 thresholded pixels in the FM1-43fx image (Crawford
et al., 2011).

Data analysis:
Data analysis was performed in Excel (Microsoft) and Sigma Plot 10.0 (Systat
Software). Student's unpaired t-test was used to test for significance. Where indicated, the
Bonferroni correction for multiple comparisons was used. Except where otherwise
indicated, values for n in the text and figure legends represent independent experiments
on separate cultures.

Materials:
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All reagents were obtained from Sigma Chemical Company unless otherwise
indicated. Culture media were from Invitrogen, guinea pig vGluT-1 antibody was from
Chemicon.
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Results

Hypoxic damage is attenuated by depolarization preconditioning:
We explored the hypothesis that strong depolarization, a stimulus that induces
presynaptic muting in hippocampal neurons, protects neurons from subsequent hypoxic
damage. Unlike other forms of preconditioning, which exhibit a latent period during
induction of hours or days (Gidday, 2006; and Kitagawa et al., 1991), presynaptic muting
is induced by strong depolarization, and recovers within a few hours of removal of the
inducing stimulus (Moulder et al., 2004). Therefore, we designed our paradigm to capture
the likely protective effect of presynaptic muting immediately after induction, without
invoking previously described mechanisms of preconditioning protection with longer
latencies. We incubated synaptically mature cultured hippocampal neurons (13–15 days
in vitro) with 4 h of high KCl (30 mM), a stimulus that silences 75–80% of glutamate
presynaptic terminals, or 4 h of NaCl (30 mM) as an osmotic, non-depolarizing control
(Moulder et al., 2004). Both control preconditioning and depolarizing preconditioning
were always performed in the presence of D-APV and NBQX to prevent glutamate
receptor activation. This ensured that other forms of synaptic plasticity dependent on
glutamate receptors were not activated by preconditioning; presynaptic silencing is not
glutamate receptor-dependent (Crawford et al., 2011; Moulder et al., 2006; and Moulder
et al., 2004). After preconditioning, the neurons were then removed from the
preconditioning stimulus, including receptor antagonists, by media exchange and
immediately exposed to hypoxia for 2.5 h. In addition to terminating the preconditioning
stimulus, this media exchange also eliminated glutamate receptor antagonists and any
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Figure 1. Depolarization preconditioning protects against hypoxia. A. Schematic of
preconditioning/hypoxic exposure paradigm. B. Photomicrographs from a single
experiment demonstrating depolarization protection. Upper left: brightfield image from a
normoxic control stained with trypan blue 24 h post-preconditioning with 4 h of 30 mM
NaCl (control preconditioning) and 2.5 h sham hypoxia. Upper right: a field from a dish
preconditioned with 30 mM NaCl and subjected to 2.5 h hypoxia. Trypan blue positive
pyknotic nuclei are apparent. Lower left: a field from a dish preconditioned with 30 mM
KCl for 4 h and then subjected to 2.5 h hypoxia. Lower right: a protection control in
which 1 μM NBQX and 100 μM D-APV, ionotropic glutamate receptor (GluR)
226

antagonists, were included in the hypoxia media. C. Summary of experiments like that
depicted in panel B, showing protection afforded by KCl depolarization preconditioning.
Cell survival is expressed as the percentage of trypan blue negative cells averaged over
ten fields evaluated with a 20× objective (n = 7 independent experiments). Asterisks
designate p < 0.05 compared with NaCl hypoxia (unpaired, two-tailed t-tests with
Bonferroni correction for multiple comparisons). Gray bar emphasizes the major
hypothesized result of KCl preconditioning protection.
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contributions of substances secreted during preconditioning (see Materials and methods).
Thus, only persisting cellular changes contributed to neuroprotection during hypoxia. We
used trypan blue staining, a well-validated probe of membrane integrity, 24 h after the
insult to assess cell death (Fig. 1A). With sham treatment, we found only mild attritional
cell death (84 ± 1.3% healthy neurons; Figs. 1B and C), consistent with previous work
(Shute et al., 2005). In cells rendered hypoxic after control (NaCl) preconditioning, a 2.5
h hypoxic insult resulted in 30 ± 3.2% survival (Figs. 1B and C). By contrast,
depolarizing preconditioning strongly and reliably protected neurons from hypoxia (59 ±
2.6% survival, Figs. 1B and C). Postsynaptic glutamate receptor blockade during the
insult nearly fully protected neurons (77 ± 1.4% survival, Figs. 1B and C), as previously
shown (Rothman, 1984), and verifying the pivotal role of glutamate release and
glutamate receptor activation in hypoxic cell loss.

Depolarization preconditioning works through a presynaptic mechanism:
These results suggest that a stimulus known to induce presynaptic silencing
protects neurons from damage by endogenous glutamate. To verify presynaptic muting
by the preconditioning paradigm, we performed analysis of FM1-43fx labeling of
glutamatergic presynaptic terminals (defined by vGluT-1 immunoreactivity). As
previously observed (Crawford et al., 2011; Jiang et al., 2010; and Moulder et al., 2004),
4 h depolarization preconditioning silenced a majority of glutamate terminals (Figs. 2A
and B). Because the FM1-43fx loading protocol used 2 min of strong depolarization to
induce vesicle cycling, loading should overcome changes in vesicle release probability
that could occur, for instance, by decreases in Ca2+ influx during dye loading. This
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protocol has been shown to label the entire pool of vesicles capable of exo/endocytosis
(Mozhayeva et al., 2002). Therefore, terminals appear functionally silenced in response
to the preconditioning stimulus, a state that would be expected to effectively reduce
glutamate release during major insults such as hypoxia. In this set of experiments we also
noted a mild decrease in FM1-43fx uptake at remaining, active synapses (Fig. 2A), which
could indicate a graded change in the number of releasable vesicles (Murthy et al., 2001).
We have previously shown that changes in FM1-43fx uptake quantitatively match
depression of EPSCs, suggesting that postsynaptic changes do not contribute significantly
to the effects of depolarization conditioning (Moulder et al., 2004). Furthermore,
depolarization preconditioning does not induce detectable postsynaptic changes measured
by mEPSC analysis, response to exogenous glutamate agonists, or AMPA receptor
immunoreactivity (Moulder et al., 2006; and Moulder et al., 2004). These past
experiments do not exclude the possibility that depolarization conditioning alters
postsynaptic Ca2+ influx or handling downstream of receptor activation. To test whether
depolarization preconditioning influences the postsynaptic Ca2+ signals presumably
important for hypoxic damage (Choi, 1985; and Choi, 1987), we loaded cells with Fluo3FF and then challenged depolarization-preconditioned cells and control cells with brief
applications of 10 μM glutamate (Figs. 2C and D). Because cells were stimulated by
exogenous glutamate applied to somatodendritic postsynaptic receptors, Ca2+ signals
measured near the soma should reflect any changes in receptor-mediated Ca2+ influx or
intracellular handling that might participate in neuroprotection. Preconditioned neurons
did not differ in amplitude or half decay time (t1/2) of somatic Ca2+ signals evoked by a 5
s application of 10 μM glutamate, indicating that preconditioning did not affect Ca2+
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Figure 2. Preconditioning induces presynaptic muting but no detectable
postsynaptic changes. A. Images of vGluT-1 positive puncta from representative fields
from cultures preconditioned by 4 h KCl (30 mM) depolarization or by 30 mM NaCl
control preconditioning. Middle panels show uptake of FM1-43fx during brief
depolarization in the same field. The merged images reveal more inactive (FM1-43fx
negative) vGluT-1 positive puncta after depolarizing preconditioning. Green = FM143fx. Red = vGluT-1. Red puncta with no green overlap are mute synapses, while yellow
indicates overlap and active synapses. White arrowheads indicate examples of co-labeled,
active glutamatergic synapses. B. The percentage of FM1-43fx positive (FM (+))
terminals is summarized from 5 experiments like that depicted in A. C. Representative
fluorescence images from somatic Ca2+ signals measured in control (n = 18 cells in 6
fields) and depolarization-conditioned (n = 15 cells in 5 fields) cells. Cells were loaded
with a 30 min bath application of 2 μM Fluo3-FF AM. Representative regions of interest
(labeled with ‘1’) show typical locations of measurement in the soma, chosen based on a
phase contrast image (not shown). Dendrites and axons are below the plane of focus.
Images of baseline (prior to glutamate perfusion), peak fluorescence (5 s following 10
μM glutamate onset), and return to baseline (30 s wash) fluorescence are shown. Region
2 indicates a region devoid of cells and typical of regions from which background
fluorescence was measured. D. Summary of glutamate-evoked somatic intracellular Ca2+
signals measured over the entire experiment (67 images over 40 s) with controlconditioned and depolarization-conditioned cells overlaid.
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handling or buffering in the postsynaptic compartment (peak ΔF/F = 1.8 ± 0.4, and t1/2 =
3.3 ± 0.6 s for NaCl control; peak ΔF/F = 2.0 ± 0.3, and t1/2 = 3.2 ± 0.3 s for KCl
preconditioning, p > 0.05, n = 18 cells for control, n = 15 cells for KCl preconditioning;
Figs. 2C and D). We used the low-affinity dye Fluo3-FF to prevent dye saturation, but to
ensure that the indicator was not saturated by our glutamate challenge, we applied 100
μM glutamate to 15 additional cells and found that peak ΔF/F from these cells was 4.5 ±
0.6, much larger than the 2.0 ± 0.3 ΔF/F average peak 10 μM glutamate signal,
confirming the lack of dye saturation.
It is possible that the low-affinity indicator may not reveal differences in the
decay phase of glutamate-induced Ca2+ rises, where the Ca2+ concentration falls below
detection limits of the dye. Therefore, we examined decay t1/2 values using the highaffinity indicator Fluo4-AM. As expected, the decays using the high-affinity dye were
slower than those observed with the low-affinity dye, reflecting the sensitivity to low
Ca2+ concentrations. However, there was still no difference between depolarizationpreconditioned neurons and control-preconditioned neurons (t1/2 = 17.4 ± 3.2 s for control
cells, t1/2 = 15.1 ± 2.2 s for depolarization preconditioned cells, p > 0.05, n = 18 and 21
cells per respective condition).
In a final test of whether preconditioning recruited postsynaptic adaptations, we
evaluated the effect of depolarization preconditioning on toxicity induced by exogenous
glutamate. This experiment exploited the pivotal role of glutamate receptor
overstimulation in hypoxic cell death (Choi and Rothman, 1990). Direct overstimulation
of postsynaptic receptors by-passes endogenous glutamate release contributing to
hypoxic damage. Thus, if depolarization preconditioning acts through presynaptic
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mechanisms, it should be ineffective against exogenous glutamate toxicity. If, however,
preconditioning works through postsynaptic mechanisms, it should retain effectiveness
and protect against direct glutamate excitotoxicity. We found that depolarization
preconditioning was not effective in protecting neurons against exogenously applied
glutamate (Fig. 3). In control cultures preconditioned with 30 mM NaCl, application of
10 μM glutamate for 5 min killed over 60% of neurons, evaluated 24 h post-insult
(Fig. 3). This was indistinguishable from cell loss in cultures preconditioned with
depolarizing KCl (Fig. 3). Glutamate-induced cell loss following control preconditioning
was similar to or slightly milder than that achieved in our hypoxia model. This result
strongly suggests that the neuroprotection from hypoxia by strong depolarization
preconditioning is of presynaptic origin, consistent with a potential role for presynaptic
muting.

Preconditioning protection extends to oxygen/glucose deprivation:
Fig. 1 shows that depolarization preconditioning protects against a 2.5 h hypoxic
insult, which normally kills approximately 70% of neurons in our paradigm. Previous
studies in cortical neurons have shown that deprivation of both oxygen and glucose may
be a more severe insult than hypoxia alone (Goldberg and Choi, 1993). We wanted to test
whether this potentially more severe insult is also attenuated by presynaptic muting
induced by depolarization preconditioning. As in the hypoxia paradigm we exposed cells
to 4 h of high KCl (30 mM) or 4 h of a non-depolarizing NaCl control. After
preconditioning, the neurons were removed from the preconditioning stimulus and
immediately subjected to OGD for 2.5 h. The cells were then returned to their original
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Figure 3. Exogenous glutamate toxicity is unaffected by depolarization
preconditioning. A. Brightfield photomicrographs of trypan blue-stained fields from the
indicated conditions in a single experiment. Exogenous glutamate (Glu; 10 μM for 5 min)
replaced hypoxia in the preconditioning/insult paradigm. Upper left: control cells 24 h
post-preconditioning with 30 mM NaCl and sham glutamate exposure that included
media exchange. Upper right: protection control cells preconditioned with 30 mM NaCl,
subjected to 10 μM glutamate (5 min) with ionotropic GluR antagonists present (1 μM
NBQX + 100 μM D-APV). Lower left: cells preconditioned with 30 mM NaCl, subjected
to 10 μM glutamate for 5 min. Lower right: cells preconditioned with 30 mM KCl, then
subjected to 5 min of 10 μM glutamate. B. Summary graph of the conditions shown in A
(n = 5). Glutamate significantly increased trypan blue staining compared with the NaCl
sham condition in this dataset (p < 0.05, Bonferroni corrected t-test). However,
depolarization preconditioning did not significantly alter the severity of cell loss. As with
hypoxia, GluR block (1 μM NBQX, 100 μM D-APV) effectively protected neurons from
glutamate-induced death, consistent with the pivotal role of excitotoxicity in both insults.
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media and were allowed to incubate under normal conditions for 24 h, after which we
performed trypan blue staining. As expected, OGD for 2.5 h killed more cells than
hypoxia alone (compare Fig. 4 and Fig. 1). Nevertheless, as with the milder insult,
depolarization preconditioning significantly protected neurons from the more severe
OGD insult (Fig. 4).

Depolarization preconditioning protection does not involve GABAA receptor activation:
Previous work has suggested that a primary mechanism by which cortical neurons
are desensitized to hypoxic damage after a depolarizing preconditioning stimulus is
through enhancement of GABAA receptor activity during subsequent lethal ischemia
(Grabb et al., 2002). On the other hand, some studies have suggested a more limited
contribution of GABAA receptor activation in other forms of preconditioning (LangeAsschenfeldt et al., 2005). Studies conducted in our lab have shown that muting is
induced at glutamate synapses, but not GABA synapses, by strong depolarization
(Moulder et al., 2004). Therefore, if we are correct that glutamate presynaptic muting is
responsible for neuroprotection in our preconditioning paradigm, we expect no role for
GABA in the protection. To test whether neuroprotection in our paradigm is dependent
on GABAA receptor activity during hypoxia (Grabb et al., 2002), we preconditioned
neurons, followed by blockade of GABAA activity during the insult. The non-competitive
GABAA receptor antagonist picrotoxin (100 μM) was used to circumvent the possibility
that competitive antagonists might be overwhelmed by endogenous GABA release.
Blockade of GABAA receptors during hypoxia did not affect cell survival in our
paradigm (Fig. 5A), and picrotoxin did not affect the protection afforded by KCl
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Figure 4. Depolarization preconditioning protects against oxygen-glucose
deprivation (OGD). A. Brightfield micrographs of trypan blue staining from each
condition: (left to right) control dish 24 h post-preconditioning with 30 mM NaCl and
sham OGD; dish preconditioned with 30 mM NaCl, subjected to OGD for 2.5 h; dish
preconditioned with 30 mM KCl, then subjected to OGD for 2.5 h. B. Summary graph
showing protection afforded by KCl depolarization preconditioning (n = 4). Asterisks
denote p < 0.05 compared with the NaCl OGD condition (Bonferroni corrected t-tests).
Gray bar emphasizes the major hypothesized result of KCl preconditioning protection.
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preconditioning (Fig. 5A). These results support the idea that reduction in presynaptic
glutamate release, rather than altered GABA signaling, is key to the preconditioning
protection from strong depolarization.

Depolarization preconditioning protection does not involve A1 receptors:
A1 adenosine receptor activation may contribute to ischemic preconditioning
tolerance (Nakamura et al., 2002; and Perez-Pinzon et al., 1996) and selectively affect
glutamate transmission in the hippocampus (Yoon and Rothman, 1991). Blockade of A1
adenosine receptors, however, does not abolish depolarization-induced presynaptic
muting of glutamate terminals by high KCl exposure (Crawford et al., 2011). To
distinguish depolarization-induced muting from adenosine-dependent forms of
preconditioning, we co-administered the A1 adenosine receptor blocker 8-cyclopentyl1,3-dipropylxanthine (DPCPX; 200 nM) during depolarization preconditioning. As
before, the cells were subsequently challenged with 2.5 h of hypoxia. The
neuroprotective effects of elevated KCl were not altered by A1 receptor inhibition
(Fig. 5B). This suggests that in our paradigm, unlike other forms of preconditioning
(Nakamura et al., 2002; and Perez-Pinzon et al., 1996), the protection from hypoxia by
presynaptic silencing of glutamate release is unlikely to involve A1 adenosine receptor
activation during preconditioning.

Depolarization preconditioning protection from hypoxia does not require Ca2+ influx:
A unique aspect of the induction of presynaptic silencing by strong depolarization
is that it is Ca2+-independent, unlike most other forms of synaptic plasticity (Crawford et
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al., 2011). Therefore, as an additional test of the involvement of presynaptic muting in
preconditioning protection, we preconditioned cells with KCl in the absence of
extracellular Ca2+ (plus 0.1 mM EGTA to chelate residual Ca2+; Fig. 5C). Removing Ca2+
did not affect the ability of depolarization preconditioning to protect from hypoxic
excitotoxicity (compare Fig. 5C with Fig. 1C). These results demonstrate a signature
feature of presynaptic muting and are additional support for the idea that muting plays a
strong role in preconditioning protection. Furthermore, the finding excludes Ca2+dependent secretion of neurotransmitters and neuromodulators during preconditioning in
the protection.

Proteasome inhibition prevents depolarization preconditioning protection:
The UPS is involved in the regulation of synaptic function, including presynaptic
development and function (Haas and Broadie, 2008; Hegde and DiAntonio, 2002; and
Willeumier et al., 2006). Recently a postsynaptic UPS-dependent mechanism induced by
N-Methyl-D-aspartic acid (NMDA) receptor activation was implicated in rapid ischemic
tolerance, a neuroprotective effect of subtoxic conditioning ischemia (Meller et al.,
2008). Proteasome inhibition also prevents the induction of presynaptic silencing (Jiang
et al., 2010). If presynaptic muting is involved in depolarization preconditioning-induced
neuroprotection, proteasome inhibition should reverse the protection from depolarization
preconditioning. To investigate the role of the UPS in preconditioning neuroprotection,
we co-applied the proteasome inhibitor MG-132 (3 μM) during the preconditioning
period of high KCl (30 mM) exposure. Protection from hypoxia after the high KCl
preconditioning period was completely abolished by proteasome inhibition during
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Figure 5. Depolarization preconditioning protection from hypoxia does not depend
upon GABAA receptor modulation, adenosine A1 receptor activation, or
extracellular Ca2+ influx. A. The non-competitive GABAA antagonist picrotoxin (PTX;
100 μM), applied during hypoxia (2.5 h), did not prevent depolarization protection.
Summary of the indicated experimental conditions (n = 6). ‘N.S.’ indicates lack of
significant difference in comparisons of the effect of PTX with the corresponding
condition in the absence of PTX. B. The A1 receptor antagonists DPCPX (200 nM) did
not block depolarization preconditioning protection. Summary of various 4 h
preconditioning conditions. Hypoxic insult was 2.5 h (n = 5). ‘N.S.’ indicates a lack of
difference for the indicated comparisons. C. Summary graph showing protection afforded
by KCl depolarization preconditioning (n = 5) independent of the addition of 1.8 mM
extracellular Ca2+ to the Ca2+ free conditioning media. For all panels, neuronal survival
was assessed 24 h after insult with trypan blue exclusion. Asterisks denote p < 0.05
comparisons (Bonferroni corrected t-tests).
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preconditioning (Fig. 6A). Taken together with preceding evidence (Fig. 1, Fig. 2 and
Fig. 3) for a presynaptic locus of KCl neuroprotection, this result is consistent with the
idea that UPS-dependent presynaptic silencing induced prior to the insult protects
neurons from hypoxia. Because D-APV and NBQX were present in preconditioning
solutions, it is unlikely that MG-132 acts through these postsynaptic receptor systems to
reverse the presynaptic protection afforded by depolarization. Furthermore, when we bypassed presynaptic terminals and killed neurons by direct exogenous glutamate exposure,
there was no difference in survival following control preconditioning, KCl
preconditioning, MG-132 preconditioning, or a combination of KCl and MG-132
preconditioning (Fig. 6B). Although the effects on the UPS from hypoxia are likely
complex and operate in both presynaptic and postsynaptic compartments, our results
suggest that MG-132 reverses protection in our model by a presynaptic mechanism
induced during preconditioning, upstream of postsynaptic receptor overstimulation.
Control experiments also verified that neither KCl nor MG-132 affected cell survival in
the absence of insult. A 4 h application of 30 mM KCl or 3 μM MG-132 alone was not
toxic to the neurons (Fig. 6C).

Hypoxia induces muting:
The preceding results establish that, in principle, muting of presynaptic glutamate
release induced prior to insult is capable of protecting neurons from subsequent
hypoxic/OGD excitotoxicity, but do neurons employ muting of glutamate synapses
during the insult itself? Depolarization of neurons is an important early consequence of
hypoxic/ischemic insult and is reinforced by subsequent glutamate release and receptor
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Figure 6. Proteasome inhibition prevents depolarization preconditioning protection
through a presynaptic mechanism. A. Summary of neuronal survival after several 4 h
preconditioning conditions and 2.5 h hypoxic exposure (n = 5). MG-132 (3 μM, coapplied for 4 h with 30 mM KCl) prevented the protective effect of depolarization.
Indicated comparisons represent the major hypothesized effects (asterisk denotes p < 0.05
with Bonferroni correction). Other comparisons that showed a significant difference from
insult alone (NaCl hypoxia) were the NaCl sham control and the KCl hypoxia conditions.
There was no difference between the NaCl hypoxia condition and NaCl hypoxia plus
MG-132. B. Summary of cell survival after indicated preconditioning conditions
followed by an insult of exogenously applied glutamate (Glu; 10 μM for 5 min). There
was no effect of KCl or of MG-132 on cell survival using the glutamate insult (n = 5),
suggesting a presynaptic mechanism of depolarization preconditioning protection. No
comparison of the NaCl/glutamate group with any of the other indicated groups yielded a
significant difference. Glutamate treatment caused significant death relative to control (p
< 0.05, Bonferroni corrected t-test for multiple comparisons). C. Control experiment
testing direct effects of KCl and MG-132 on cell survival during various 4 h
preconditioning paradigms in the absence of hypoxia (n = 5). No comparison with the
control sham condition exhibited a significant difference (unpaired t-tests vs. control).
For all experiments depicted in panels A, B, and C neuronal survival was evaluated with
trypan blue 24 h after the insult.
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activation (Moskowitz et al., 2010). If depolarization is rapid and strong enough to induce
muting, presynaptic silencing may be an important endogenous regulator of damage
threshold. To investigate this, we used FM1-43fx uptake to assess presynaptic function
immediately after a 2 h hypoxic event, without any preceding preconditioning. As shown
in Fig. 2, muted glutamate terminals immunolabel with an antibody against the vesicular
glutamate transporter 1 (vGluT-1) but not with the activity-dependent FM dye (Moulder
et al., 2004). Hypoxia exposure clearly increased the number of mute synapses (Fig. 7).
The muting induced by hypoxia was completely prevented by the inclusion of MG-132 (3
μM) during the hypoxic challenge (Fig. 7B), suggesting that hypoxia and depolarization
activate the same proteasome-dependent signaling cascade. As previously observed
(Crawford et al., 2011; and Jiang et al., 2010), MG-132 had no effect on the basal
percentage of silent terminals (Fig. 7B). Further, we failed to find a significant effect of
MG-132 on overall glutamate synapse density (97.8 ± 6.5 vGluT-1 positive synapses per
field in control, 117.0 ± 17.2 puncta mm2 after MG-132 treatment, n = 5 experiments, p >
0.3). Finally, in two previously published papers by our group, we failed to detect any
effect of MG-132 alone on excitatory postsynaptic currents (Crawford et al., 2011; and
Jiang et al., 2010). These results offer direct evidence that proteasome-dependent
presynaptic silencing occurs during hypoxia and suggest that presynaptic muting is an
endogenous cellular defense mechanism that may reduce damage even without prior
preconditioning designed to invoke synaptic muting.

Proteasome inhibition exacerbates neuronal death during a hypoxic insult:
To test directly whether proteasome-dependent presynaptic muting observed in
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Figure 7. Hypoxia induces proteasome-dependent presynaptic silencing. A. FM143fx/vGluT-1 correspondence assay. Green = FM1-43fx. Red = vGluT-1. Red puncta
with no green overlap are mute synapses, while yellow indicates overlap and active
synapses. A 2 h preconditioning period with or without MG-132 (3 μM) was followed by
a 2 h hypoxic insult (or sham), then immediately by the FM1-43fx assay. B. Summary of
experiments depicted in panel A showing the percentage of active synapses after hypoxic
insult with and without MG-132 co-incubation (n = 25 fields from 5 independent
experiments). Asterisk denotes p < 0.05 compared with hypoxia alone (Bonferroni
corrected t-tests). Comparisons of control versus MG-132, control versus hypoxia plus
MG-132, and MG-132 versus hypoxia plus MG-132 showed no differences.
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Fig. 7 reduces the damage wrought by a moderate hypoxic insult, we tested the effect of
proteasome inhibition on neuronal loss induced by hypoxia. We co-applied MG-132
during a 2 h hypoxic event (Fig. 8A). We chose an insult that would provide
approximately 50% neuronal death in order to ensure detection of either protection or
exacerbation of cell death. MG-132 during hypoxia significantly increased neuronal
death (Fig. 8B). Again, MG-132 did not affect neuronal death when applied to neurons
for a total of 4 h without hypoxia (Figs. 6C and 8B). Further, we found that MG-132
preincubation, followed by co-incubation with 10 μM glutamate to bypass presynaptic
effects, did not alter direct, glutamate induced death (Fig. 8C). These results are
consistent with a presynaptic action of MG-132. Taken together, the results of Fig. 7 and
Fig. 8 suggest that presynaptic silencing raises the threshold for neurotoxicity during a
depolarizing insult.
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Figure 8. Proteasome inhibition during hypoxia exacerbates neuronal damage. A.
Brightfield trypan blue-stained fields from a representative experiment. Neurons were
incubated with or without MG-132 for 2 h to allow drug penetration, then subsequently
co-incubated with MG-132 for additional 2 h with or without hypoxia. Culture media was
then exchanged, and cells were incubated normally for 24 h after which trypan blue
staining was performed. Upper left: control with no MG-132 or hypoxia. Upper right: 4 h
total MG-132 exposure (no hypoxia). Lower left: 2 h hypoxia alone. Lower right: 2 h
MG-132 followed by hypoxia/MG-132 co-incubation for 2 h (4 h total exposure to MG132). B. Summary of A showing that MG-132 exacerbates hypoxia-induced death (n =
7). Asterisk denotes p < 0.05 (Bonferroni corrected t-test). C. Summary of control for
postsynaptic effects of MG-132 (n = 5 experiments). 10 μM glutamate (Glu) treatment
was used as a surrogate for hypoxic insult. There was no significant exacerbation of
glutamate-induced damage by MG-132. As with hypoxia experiments in B, cells were
pre-incubated in MG-132 for 2 h prior to insult.
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Discussion
We have shown that a form of synaptic plasticity working through a presynaptic
UPS-dependent mechanism significantly protects neurons from in vitro hypoxic/ischemic
insults. Importantly, muting is endogenously invoked by hypoxia with no prior
conditioning to limit the damage severity inflicted during a moderate insult. Protection is
achieved by invoking an endogenous mechanism that mutes vesicular glutamate release
at presynaptic terminals. Among a growing body of research into preconditioning and
tolerance (Gidday, 2006; and Sapolsky, 2001), presynaptic muting is a previously
unknown UPS-dependent mechanism of tolerance. Because muting is part of a native
cellular defense mechanism in response to stressful depolarization, it might be a good
target for future therapeutics. Our insights into this UPS-dependent mechanism
demonstrate presynaptic regulation of neuronal homeostasis and suggest new approaches
that may benefit disorders involving glutamatergic synaptic dysfunction.
Presynaptic muting appears particularly well suited as an adaptation against
strong insults like hypoxia/ischemia. Strong depolarization and associated sustained Ca2+
influx during these insults are likely to quickly overwhelm many presynaptic adaptive
mechanisms, such as G-protein-mediated decreases in presynaptic Ca2+ influx (Brown
and Sihra, 2008). Because muting effectively eliminates vesicle release competence to
Ca2+ and other secretagogues (Moulder et al., 2006; and Moulder et al., 2004), muting
should be especially effective at disrupting the cycle of pathological depolarization
during the insult. On the other hand, we acknowledge that strategies designed to disrupt
glutamate signaling have to date proved disappointing in clinical settings (Gidday, 2006;
Lipton, 2007; and Moskowitz et al., 2010), and presynaptic muting may be ineffective
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during strong insults that recruit non-synaptic glutamate release (Rossi et al., 2000).
Proteasome inhibition exacerbated damage and also inhibited presynaptic
silencing in response to hypoxic insult (Fig. 7 and Fig. 8). Proteasome activity is
increased during strong depolarization, and proteasome inhibition also prevents
presynaptic silencing during strong depolarization (Jiang et al., 2010). In the present
study, proteasome inhibition prevented the neuronal protection from strong
depolarization followed by hypoxia (Fig. 6A). Similar exacerbation of cell death was
recently described in an ischemia model, where an NMDA receptor and UPS-dependent
postsynaptic remodeling mechanism was implicated in a rapid ischemic tolerance (Meller
et al., 2008). These previous results fit with known UPS roles in the postsynaptic
compartment (Mabb and Ehlers, 2010; and Tai and Schuman, 2008). On the other hand,
the UPS is also important for aspects of presynaptic development and function
(DiAntonio and Hicke, 2004; Jiang et al., 2010; and Willeumier et al., 2006). Our
observations fit more closely with this latter literature. Postsynaptic NMDA receptor
activation is not required for our preconditioning protection, as D-APV was present in all
preconditioning treatments in our experiments to block NMDA receptor-dependent forms
of plasticity. Furthermore, a postsynaptic mechanism of protection is excluded by our
experiments examining preconditioning effects on exogenous glutamate damage and
postsynaptic Ca2+ handling in response to exogenously applied glutamate after
preconditioning (Fig. 2, Fig. 3 and Fig. 6).
Our experiments were designed to isolate presynaptic contributions to selfdefense mechanisms and therefore do not negate contributions of previously described
postsynaptic mechanisms of adaptive neuroprotection under some conditions. These
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mechanisms may be most important in the most severe insults where non-synaptic
glutamate release is recruited (Rossi et al., 2000). Further work is needed to elucidate the
relative importance of presynaptic silencing and other adaptive, self protective
mechanisms.
Although UPS-dependent neuroprotection in our model is mainly presynaptic and
distinct from previously described UPS-dependent and NMDA-dependent forms of
tolerance (Grabb and Choi, 1999), it is possible that complex changes in UPS function
accompany insult. Although proteasome inhibition has been reported following brain
ischemia and is associated with ATP depletion (Asai et al., 2002; and Thompson et al.,
2008), this does not exclude local persistence of or increases in UPS activity in certain
tissue compartments, specific cell types, or specific subcellular compartments. We expect
that UPS-dependent presynaptic muting will be particularly relevant to glutamate
terminals in the penumbra of an insult where a certain degree of neuronal function is
preserved.
Our results demonstrating a role of the UPS in presynaptic muting and cell
survival (Fig. 7 and Fig. 8) also exclude a possible alternative explanation for the muting
observed in response to hypoxia: cell death. Although cell loss was not evident for
several hours after the hypoxic insult and there was little evidence of presynaptic damage
at the time of synaptic imaging (Fig. 7), the presynaptic silencing observed might be a
trivial result of dying neurons rather than a neuroprotective response of viable neurons.
The effect of MG-132 clearly argues against this possibility. MG-132 application during
hypoxia prevented muting (Fig. 7) but exacerbated neuronal damage (Fig. 8). This pattern
of results excludes damage as a cause of muting and strongly suggests that presynaptic
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function is an important determinant of subsequent cell loss.
Additional study of the pathways responsible for presynaptic muting may guide
strategies for therapeutic exploitation of these pathways. Upstream targets may include
pertussis toxin-sensitive Gi/o-linked G-protein receptors (Crawford et al., 2011).
Downstream effectors may include relevant targets of the UPS (Jiang et al., 2010).
Depolarization-induced muting results in decreased levels of the vesicle priming proteins
Rim1α and Munc13-1, and overexpression of Rim1α prevents presynaptic silencing
(Jiang et al., 2010). However, the proteasome also potentially regulates a host of other
synaptic proteins such as SNAP-25, syntaxin, and synaptophysin (Chin et al., 2002; Ma
et al., 2005; Wheeler et al., 2002; and Willeumier et al., 2006) among many other
candidates, befitting the ubiquitous nature of the UPS system. Targeting the specific
proteins responsible for muting may offer a viable, selective therapeutic strategy.
With these results we provide new insight into a homeostatic neuronal defense
mechanism at glutamatergic presynaptic terminals. Pharmacological exploitation of a
mechanism reducing presynaptic glutamate release could potentially treat excitotoxic
damage resulting from stroke, neonatal hypoxia, epilepsy, and head trauma at the time of
injury, where treatment options are quite limited and postsynaptic interventions have
failed. Presynaptic muting appears to render presynaptic terminals incompetent to
exocytose even when challenged with sustained Ca2+ rises. The mechanism we report
here does not require lengthy latent periods for its induction and is immediately available
as a homeostatic mechanism. Additional study of presynaptic muting will increase our
basic understanding of hippocampal synaptic function. Further study may also identify
potential treatment targets related to muting that could benefit various neurological and
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psychiatric disorders involving glutamate dysfunction.
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